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Summary
The objective of the work described in this thesis was to develop novel experimental
and analytical methods to study samples of anisotropically oriented fluorophores.
The primary development was the fluorescence detection method for linear dichroism
spectroscopy (FDLD). The experimental configuration of the measurement has
the detector placed facing the propagation direction of the exciting incident light.
Long-pass edge filters, selected so that their cut-oﬀ wavelength lies between the
excitation and emission maxima of the sample’s fluorophore, were placed between
the sample and detector to block transmitted incident light, whilst allowing Stoke’s
shifted fluorescence emissions to pass freely. The experiment was designed to be
conducted using a commercial circular dichroism (CD) spectropolarimeter, which
has been adapted to measure linear dichroism (LD). A theoretical framework
to calculate FDLD spectra using the output of such an instrument is presented,
and used to generate the FDLD spectra of small molecules oriented on stretched
oxidised polyethylene films and biological samples oriented in Couette flow. It was
found that much of the information that can be obtained from LD may also be
derived from FDLD spectra, however, FDLD possessed two clear advantages: i)
fluorescence detection is highly sensitive, which significantly lowered the sample
volume requirement of a measurement, and ii) fluorescence detection is more selective
than absorption methods, as only chromophores that are also fluorophores are
detected.
xxvii
A method for the cloning, expression and purification of the Escherichia coli actin
homologue MreB is also presented. The composition of secondary structure elements
within the protein obtained was analysed using CD and found to be in good
agreement with literature values, taken from the crystal structure of Caulobacter
crescentus MreB. Fluorescence spectra of the protein were recorded, which indicated
that it may be possible to study its in vitro polymerisation kinetics using FDLD.
Unfortunately, we were unable to obtain our Escherichia coli MreB in a suﬃcient
yield to develop this assay.
Finally, a novel method for detecting the wall shear stress (WSS) exerted on a
specific point of a surface by a fluid flowing over it is reported. This information
was derived from the response to a shear flow of a fluorescently labelled particle of
M13 bacteriophage, which was tethered to the surface. The focus of this thesis was
primarily on the analysis of the fluorescence signals. Using a custom made algorithm,
microscopy images of the tethered phage particle were segmented to define the region
of each image occupied by the particle, and to calculate its orientation and length
at all time points. These data were used to calculate the WSS at the point of the
particle’s attachment, and show that it varied when the surface was not uniform
— highlighting a potential problem with commonly used methods for determining
WSS that average over surface dynamics, such as particle image velocimetry and
particle tracking velocimetry.
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Introduction
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Chapter 1
Investigations of matter using polarised light have been conducted for centuries,
since at least the time of Arago’s observations of optical activity in 1811 [3]. Studies
of dichroism, which is the anisotropic absorption of light by matter, followed quickly,
and among the early reports was Ambronn’s observation of linear dichroism in dye
stained membranes in 1888 [4]. Since this time, the application of polarised light
spectroscopy to biological systems has grown steadily.
The work reported in this thesis is part of a wider programme of research to
develop novel experimental methods for electronic absorption spectroscopies, so to
extend their utility and eﬀectiveness in probing the properties of biological samples.
As biological samples are often only obtainable in small amounts, reducing the
sample volume requirements for these spectroscopies is a key objective. Examples
of where this has been achieved in recent work at the University of Warwick are:
the development of a micro-volume Couette flow cell, which enables linear dichroism
spectra to be recorded using samples volumes as low as 25 µL [5]; and an extruded
quartz capillary sample holder for circular dichroism, which only requires 3 µL of
sample to record a spectrum [6].
The work of this thesis continues with the theme of lowering the sample volume
requirements by developing a methodology for obtaining much of the information
that can be gained from linear dichroism, through detecting the fluorescence
emissions of a sample. This is because fluorescence measurements are intrinsically
more sensitive than absorbance measurements, providing that a fluorophore is
present [7]. An additional advantage of fluorescence detection is that only
chromophores that are also fluorophores are detected, which can greatly enhance
the selectivity of measurements.
This chapter provides a general introduction to the work of this thesis. Fuller
introductions to each topic are given at the beginning of each chapter.
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1.1 Linear dichroism and fluorescence detected
linear dichroism
The spectroscopic technique linear dichroism (LD) is used to examine the physical
orientation of highly anisotropic systems by measuring diﬀerences in the absorption
of light polarised parallel (Ak) and perpendicular (A?) to the sample’s orientation
axis, as stated in Equation 1.1. This technique is well known and its application
requires that the sample contains suitable chromophores, in addition to an eﬃcient
alignment on the macromolecular level — the two most common orientation methods
currently being Couette flow [5,8, 9] and mechanical stretching [10,11].
LD = Ak   A? (1.1)
Historically, the main biomolecular applications of LD were studies of
deoxyribonucleic acid (DNA) and DNA-drug systems [12]; however, more recent
reports include the structural and kinetic characterisation of lipid vesicles and
proteins bound to lipid membranes [13], in addition to steady-state kinetic studies
of fibrous protein polymerisation [14]. In these instances, the technique relies on
the characteristic absorbance regions of the protein under investigation. In the
mid-ultraviolet region, the ⇡⇤  ⇡ and ⇡⇤  n transitions of the ubiquitous peptide
bond dominate [15]. This is not an ideal chromophore for an orientationally sensitive
technique, as the large number of residues in a typical protein means that the
ensemble average of these transitions does not necessarily possess a high degree
of preferential alignment. Proteins with tryptophan residues can be investigated
using the intrinsic absorbance of the indole chromophore, although in some cases
this can be complicated by external, overlapping absorbance signals (e.g. from the
nucleotides whose hydrolysis commonly initiates and drives protein polymerisation).
Measuring fluorescence emissions eliminates this problem by limiting what is
detected to the light emerging from fluorophores.
Coupling LD with other analytical techniques was first proposed in 1972 by Akiyoshi
Wada [16], however, there have been very few reports on coupled LD until recently.
The development of a capillary micro-volume Couette flow accessory for LD has
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allowed the first measured fluorescence detected flow linear dichroism spectra, thus
opening the door for biological applications [5].
We define fluorescence detected linear dichroism (FDLD) as measuring the
diﬀerence in the fluorescence emission intensity, following excitation with incident
light polarised parallel and perpendicular to the sample’s orientation axis. This is
stated in Equation 1.2.
FDLD = Fk   F? (1.2)
The method we have developed for measuring FDLD uses commercial instruments,
which have been adapted for LD. The development process required a full
understanding of what the instrument output was from an LD measurement, and
how to calculate FDLD from the collected data. Full experimental and theoretical
descriptions of both LD and the FDLD developed here are given in Chapter 2.
Our FDLD experiments were first performed using a simple test system of small
fluorescent molecules, oriented on a stretched oxidised polyethylene film. This
allowed us to optimise the experimental setup to achieve the best quality data.
The molecules we selected for this were: anthracene, 1,6-diphenyl-1,3,5-hexatriene
(DPH), and 4-methylphenyl benzoate (MPB). The results of these experiments, and
a discussion of what they show, is given in Chapter 3.
From the FDLD of small molecules on polyethylene films we moved on to
experiments of DNA-dye complexes, oriented in solution using micro-volume Couette
flow. Developing a system whereby the relative orientation of chromophores in a
biological sample can be examined, with an enhanced sensitivity when compared
with conventional LD, is the primary aim of this study, and so these experiments
would really determine whether this aim has been achieved. A comparative analysis
of the LD and FDLD of these systems is given in Chapter 4, as well as those of an
additional biological sample: M13 bacteriophage in solution.
Information on the rates at which some proteins polymerise to form fibres in solution
— and therefore factors such as the preferred pH or salt concentration for the process
to occur — can be obtained by monitoring the LD of the polymerising protein in
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Couette flow [17]. We had hoped to emulate this using FDLD, where we would
be able to take advantage of the techniques increased measurement sensitivity and
selectivity. However, in the end we were unable to collect any FDLD data from the
model protein we selected: the Escherichia coli actin homologue MreB. Although
we did express and purify the protein using a number of techniques from molecular
biology, and the results we did collect are presented in Chapter 5 .
1.2 Molecular biology
Molecular biology is the study of the intracellular processes and molecular
interactions that come together to produce a functioning organism [18]. Several
key discoveries from the middle of the 20th century gave rise to molecular biology
as a recognised field in its own right, where previously such studies may have been
considered as part of biochemistry or genetics. Among the earliest of these works
was the 1944 publication by Avery et al., who showed that DNA is responsible for
the transmission of one phenotype of an organism to another through transformation
[19]. A short while later, and most famously, Crick and Watson proposed the double
helical structure of DNA [20], though Crick’s later publication ‘Central dogma of
molecular biology’ was just as important for molecular biology [21].
The central dogma describes the mechanism by which the genetic information stored
in DNA is used to form a functioning organism. An overview of this mechanism is
that sections of DNA known as genes are copied into ribonucleic acid (RNA) by
a process called transcription [22]. The sequence of bases in the RNA are then
translated into proteins, which perform a huge number of the functions vital to an
organism’s survival [21].
For the purpose of copying a gene, and producing enough replicate DNA fragments
of the gene to transform them into a cell, a significant advance was the invention of
the polymerase chain reaction (PCR) by Kary B. Mullis in 1983 [23]. PCR is used
to amplify a given sequence of DNA using a small amount of genomic DNA, two
short DNA primers that are complementary to opposite ends of the target sequence,
and a DNA polymerase that is able to withstand high temperatures, such as the Taq
5
1.3. WALL SHEAR STRESS Chapter 1
polymerase found in the bacterium Thermus aquaticus [24]. Combing the ability to
produce large quantities of a desired DNA fragment with the ability for DNA ligase
to join fractions of DNA together — a discovery made by Weiss and Richardson in
1967 [25] — made it possible to introduce a new gene into a cell, as well as control
its expression with additional DNA sequences.
A common method used to control the expression of a gene that has been
transformed into a new cell is the negative control mechanism of the Lac repressor,
first isolated by Gilbert and Müller-Hill in 1966 [26]. We also used this system to
control the expression of MreB.
These key techniques of molecular biology allowed us to obtain MreB from E. coli.
We then were able to analyse its structure using circular dichroism. A full description
of the methods we used to obtain the protein, in addition to its structural analysis
is given in Chapter 5.
1.3 Wall shear stress
The final results chapter of this thesis, Chapter 6, describes a novel method for
detecting the wall shear stress (WSS) exerted on a surface by a fluid flowing over it.
In particular it describes in detail the methods of image analysis and data processing
that were used in the publication: ‘Direct detection and measurement of wall shear
stress using a filamentous bio-nanoparticle’ [2].
Developing a method to accurately measure WSS is highly important in a number
of fields, such as micro-fluidics [27] and lab-on-a-chip technologies [28]. However, it
is of particular importance in medicine, where abnormal WSS in the vasculature is
associated with diseases such as atherosclerosis [29], and it also plays a key role in
molecular transportation in the microvasculature [30–32]. A problem with existing
methods is that they average many of the WSS dynamics over a surface. The method
given in Chapter 6 calculates the WSS at a given point on a surface, allowing greater
resolution of how it varies across a surface.
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CHAPTER 2
The development of a fluorescence
detection methodology for linear dichroism
spectroscopy
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2.1 Introduction
Our fluorescence detection methodology for linear dichroism spectroscopy was
applied to a number of spectrometers during the course of this PhD. The basic
setup was the same for all of them, with a long pass edge filter in place before the
photomultiplier tube detector, which faces the propagation direction of the incident
light. The key diﬀerences, and where the technique needed to be optimised, lay
in the software settings of the detector and the subsequent data processing. This
chapter begins with an in-depth discussion of the two spectroscopic techniques that
have been combined — linear dichroism and fluorescence excitation spectroscopy —
which is followed by a practical and theoretical explanation of fluorescence detected
linear dichroism (FDLD).
2.2 Spectroscopy in the ultra-violet to visible region
Spectroscopy may be defined as the study of the interaction between radiated energy
and matter. The form this interaction takes is widely varied, and largely depends
on the frequency of the radiated energy used. In the ultraviolet (UV) to visible
region, the electric field generated by photons may have suﬃcient energy to change
the electron distributions in molecules — for one or more electrons to be excited
from the ground state to an excited state. For such an electronic transition to take
place, the energy of the incoming light must equal the energy gap between the two
states (i.e. h⌫ = Ef   Ei, where h is Plank’s constant, ⌫ is the frequency of the
light, and Ei and Ef are the energies of the initial and excited states, respectively)
and the transition dipole moment between the states must be non-zero:
µfi =
Z
 ⇤fµ id⌧ 6= 0 (2.1)
µ =  er (2.2)
where  f and  i are the wavefunctions of the final and initial states, respectively, the
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⇤ denotes that the complex conjugate is being used, and d⌧ is the volume element.
The electric dipole moment operator, µ, is the distance between the centres of
positive and negative charges in a molecule (r) multiplied by the magnitude of
these charges. The transition dipole moment is a measure of the degree to which
an electron in state i is polarised by incoming incident light, such that its spatial
distribution is similar to that of state f . In short: an oscillating electric field interacts
with a molecule through its dipole moment. The energy of this interaction, H(t),
can be described as:
H(t) = µ ·E(t) (2.3)
where E(t)= E0 cos(!t) — ! represents the angular frequency of the light, t denotes
time and E0 is a uniform electric field. Both the electric dipole and the electric field
are vector properties, and their dot product can be zero even if their magnitudes
are not. A simple example of this is when the instantaneous electric dipole of the
molecule is polarised perfectly along some Z axis and the electric field is polarised
on the Y axis of the same coordinate system. In this instance, H(t) would be equal
to zero. Conversely, the value of H(t) will be maximised when the polarisation
of the incident light is exactly aligned with the polarisation of the electric dipole
moment for a transition, and so will simply be equal to µE(t). Equation 2.1 states
that µfi is the dipole moment associated with a transition between two states, and
that it is a vector property (as in Cartesian coordinates, there will be an element
associated with the x, y and z directions). The scalar quantity |µfi|2 is proportional
to the transition probability, and so by maximising the interaction energy we are also
maximising the probability that a given transition between two states will occur.
Using simple unit vectors to describe the polarisation states, Figure 2.1 illustrates
the eﬀect of rotating the electric field 90  in the Y Z plane, whilst fixing the electric
dipole along a Z axis. It is this dependency on the relative orientations of the
electronic transition dipole moment and the electric field vector of the incident light
that gives rise the property of dichroism.
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Figure 2.1: The figure shows the dot product between two unit vectors, one of which
is being rotated 90  relative to the other. This illustrates the eﬀect rotating the
axis of the electric field vector relative to the polarisation direction of a molecule’s
electric transition dipole moment has on |µfi|2, and therefore, on the probability of
a transition.
2.2.1 Linear dichroism
As discussed above, the probability of a molecule absorbing a photon of light is
dependent on the extent to which the electric field vector aligns with the molecule’s
electric dipole transition moment. This principle enables the measurement of a linear
dichroism (LD) spectrum, as in an anisotropically oriented sample there will be a
diﬀerence in the absorbance spectra when using incident light polarised parallel to
the sample’s orientation axis, compared with when light polarised perpendicular to
this axis is used (with the rare exception of cases where the transition angles are at
an average of the magic angle (⇠ 54.7 ) to the orientation axis) 1. With reference
to Figure 2.2, LD may be defined as:
1Here and throughout this section we are considering only the ideal case where a sample
has a single chromophore per absorption band, with each of the chromophores having an equal
probability of being oriented by the orientation apparatus. Overlapping chromophore absorbances,
chromophores stereochemically fixed with respect to each other, or anisotropic light scattering, may
distort a measured LD spectrum.
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LD = AZ   AY (2.4)
X
Z
Y
µ
 
↵
Figure 2.2: The orientation of an electric dipole transition moment (µ) in
a Cartesian coordinate system, where Z is the orientation axis and X is the
propagation direction of the incident light. The angle between µ and the molecular
orientation axis is denoted ↵, and the angle it makes with the propagation direction
of the incident light is  .
From Equation 2.4 we can derive the more familiar LD equation [33]:
LD =
3
2
AisoS(3 cos
2 ↵  1) (2.5)
where ↵ is the angle between the transition’s polarisation and the orientation axis;
Aiso is the isotropic absorbance of the sample; and S is an orientation factor, which
equals 1 for a perfectly oriented sample and 0 if the sample is isotropic [34].
A key part of an LD measurement is the method used to induce a preferential
alignment in a sample. Small molecules may be oriented on untreated commercial
polyethylene (PE) films or oxidised polyethylene (PEOX) — see Chapter 3 for details
of preparation — that are further stretched along the manufacture stretch direction.
The mechanical stretching apparatus used in this work consists of two parallel
double-ended dowel screws, which span the length of a metal frame. Each screw is
attached to a cog at each end of the frame, which are both controlled synchronously
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by a central cog. Set perpendicularly onto the screws, and at an equal distance from
the central dowel, are two parallel clamps that move apart or together upon turning
the central cog. To align a sample, a segment of PEOX film is clamped between the
jaws of the stretcher, and the cogs are turned to evenly stretch the film. Following
the measurement of a baseline spectrum, typically 40 µL of sample was deposited
onto the film, and the solvent allowed to evaporate. Molecules tend to preferentially
align with their long axis along the stretching direction of the film. A photograph
of a mechanical stretcher is given in Figure 2.3.
Figure 2.3: Mechanical stretcher used to orient small molecules for LD
measurements. This figure is reproduced from reference [35].
For biological molecules, the most appropriate method to induce a preferential
alignment in a sample is generally micro-volume Couette flow [5]. Using this
experimental setup, the sample is held between two coaxial cylinders: a rotating
outer quartz capillary, and a stationary inner quartz rod. The sample is subject
to a viscous drag force, which at rotation velocities below that which initiates
turbulent flow, causes the sample to orient in the plane perpendicular to the long
axis of the rod. The orientational distribution of a sample aligned in this way is
highly dependent on the distribution of aspect ratios of its component molecules,
with higher aspect ratios orienting better. This property comes with a number of
advantages, such as: the LD of a PCR mixture only detects the PCR product,
since neither the primers nor the unpolymerised bases orient [36]; recording the LD
of a DNA binding molecule in the presence of DNA exclusively detects the bound
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molecules and DNA, as the free molecules will be isotropically oriented; and the
kinetics of the formation of long chain polymers can be followed, as the LD value
will increase as the molecules polymerise to form structures with increasing aspect
ratios.
The instrument we use to record LD for this work is the Jasco J-815 circular
dichroism (CD) spectropolarimeter (Jasco UK), which is illustrated schematically
in Figure 2.4.
D
PEM
FL
LS
M0
M1
SH S1
M2
M3
M4
M5
P1
P2
S2
O-ray
E-ray S3
Figure 2.4: A schematic of the Jasco J-815 CD spectrometer, redrawn from the user
manual [37]. LS stands for light source, M for mirror, S for slit, P for prism, L for
lens, F for polariser, PEM for photoelastic modulator, and D for detector. These
components are discussed in the main text. E-ray and O-ray denote the extraordinary
ray and ordinary ray, respectively.
With reference to Figure 2.4, the Jasco J-815 CD spectrometer uses a xenon arc lamp
light source (LS), which emits broad-spectrum radiation. This light then — either
directly or by reflection from mirrors (M0 and M1) — travels through a system of two
monochromators. A monochromator essentially has two components: a dispersing
element (either a prism or a diﬀraction grating) and an exit slit, whose position
relative to the dispersing element determines which wavelength passes through to
the sample. Jasco instruments use crystal prisms (P1 and P2) to separate the
incident light according to wavelength. A second eﬀect of the prism monochromators
is that their crystal axis orientations have been set such that the light exiting the
third slit (S3) is to a good degree linearly polarised. To clean this up into linearly
polarised light, the beam passes through a focussing lens (L) to a linear polariser
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(F), which is necessary before the light passes through the photoelastic modulator
(PEM) (Figure 2.4).
After the incident radiation passes through a sample, it reaches a photomultiplier
tube (PMT) detector (D). The sequence of components making up a PMT begin
with a photocathode, which emits electrons (or photoelectrons) when struck by
light. These are directed towards a series of ‘electron multiplier’ dynodes via a
focusing electrode [38]. It is through a series of secondary emissions from these
dynodes that the gain on the original signal is achieved. This occurs in three
stages: primary electrons, with energy of around a few hundred electron volts, are
absorbed by the dynode and impart their energy to the electrons in its material; the
energised electrons then diﬀuse through the material; and at the surface, electrons
with suﬃcient energy are able to escape into the vacuum, on route to the next
dynode. The multiplied electrons are finally collected by an anode, which generates
the output signal [38]. Integrated over the time frame that the PMT is irradiated by
each wavelength of incident light, this flow of electrons is proportional to the photon
flux reaching the photocathode. If we had a similar detection system recording the
photon flux of the incident beam prior to the sample, we could easily calculate the
sample’s absorbance spectrum using the Beer-Lambert law. However, as we want
to calculate the diﬀerence of two absorbances, this spectrometer has a slightly more
elaborate detection system. Before looking into how this calculation is achieved, it
is important to first consider the output of a photoelastic modulator.
A photoelastic modulator (PEM) is a dynamic polarisation device — as opposed to
the static polariser, F, mentioned above — and (for UV-visible radiation) consists of
a silica bar, which is fused to a piezoelectric transducer [39]. Piezoelectric materials
generate mechanical stress upon the application of an electric field, and silica is a
photoelastic material, meaning its birefringence is altered upon the application of
stress [40]. By setting the voltage applied to the piezoelectric material to be such
that it vibrates at the natural resonance frequency of the silica bar (which in our
case is set at 50 kHz), the birefringence of the bar is modulated. Considering the
linearly polarised input beam, polarised at 45  to the stress axis of the bar, as the
supposition of two, in-phase beams, the PEM will aﬀect one of these components
diﬀerently, in the time-dependent retardation ( ):
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  =  0 sin(!t) (2.6)
where  0 is the peak retardation (i.e.  /2 — the drive voltage of the modulator must
be altered at each wavelength ( )), !/2⇡ is the modulation frequency (50 kHz); and
t is time [41]. Therefore, the output of the PEM is an electromagnetic field, whose
polarisation is alternating (continuously between the states) in a time dependent
manner. It has been shown that the intensity of light transmitted by a sample is
then [40]:
I =
I0
2
⇥
(e ak + e a?) + (e ak   e a?) cos( )⇤ (2.7)
where I0 is the intensity of light incident on the PEM and a? and ak are the
sample’s absorbance of perpendicular (Y axis) and parallel (Z axis) polarised light,
respectively [40]. We can use Equation 2.6 to expand the last term of Equation 2.7
in a Fourier-Bessel series:
cos( 0 sin(!t)) = J0( 0) + 2J2( 0) cos(2!t) (2.8)
where Jn( 0) are Bessel functions of the first kind. Equation 2.8 allows us to split
Equation 2.7 into static (I(0)) and dynamic (I(2!)) components:
I(0) =
I0
2
⇥
(e ak + e a?) + (e ak   e a?)J0( 0)
⇤
(2.9)
and, at twice the modulation frequency:
I(2!) = I0J2( 0)(e
 a?   e ak)
= J2( 0)(I?   Ik)
(2.10)
Our instrument is configured such that J0( 0) = 0, therefore Equation 2.9 may
simply be written:
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I(0) =
I0
2
(e ak + e a?)
= (Ik + I?)/2
(2.11)
Equation 2.11 shows that the I(0) component is not a function of time, and so the
current this will generate at the PMT will be continuous at each wavelength, i.e.
a direct current (DC) is generated. When there is no sample between the PEM
and the PMT, this is all the detector will see [42]. This is not true for the I(2!)
component, shown in Equation 2.10, which when an aligned sample is present, has
intensity that varies sinusoidally at absorbing wavelengths, and so will generate
an alternating current (AC) [43]. Therefore, when an aligned sample is in place,
the output signal detected at the PMT anode consists of an AC component (/
(I?   Ik)), produced by the diﬀerential absorbance of a sample, coupled to a DC
component (12(Ik + I?)), which is proportional to the average photon flux reaching
the PMT. These two components are separated into two channels. The AC channel
contains an amplifier followed by a lock-in amplifier, which is phase-locked to twice
the modulation frequency of the PEM (for LD measurements), and outputs a voltage
that contains information on the diﬀerential absorbance of a sample. The signal in
the DC channel passes through an operational amplifier that also outputs a voltage,
this time being proportional to the mean beam intensity [42,43].
The instrument then calculates the diﬀerential absorbance of the sample (the AC
component) with respect to the average light throughput at each wavelength (the
DC component) by taking their ratio [37]:
LD = log10
I?
Ik
= log10
1 + AC/2DC
1  AC/2DC (2.12)
The log10
I?
Ik
term in Equation 2.12 can be shown to equal Ak   A? by using the
Beer-Lambert law:
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LD = Ak   A?
=   log10
Ik
I0,k
+ log10
I?
I0,?
= log10
I?/I0,?
Ik/I0,k
= log10
I?
Ik
(2.13)
where I0,? = I0,k are the incident intensities of perpendicular and parallel light,
respectively. As the AC component is much smaller than the DC component in
Equation 2.12, LD can be approximated as [37]:
LD = k
AC
DC
log10 e (2.14)
where k is a machine constant. In normal operation, Equation 2.14 is simplified by
amplifying or attenuating the AC and DC outputs simultaneously, such that the
DC output is maintained at a constant value. This is achieved by calculating the
diﬀerence between the DC value at time t, and the set value, which in our case is 1:
DCe = DCt   1 (2.15)
The variation or error from the value of 1 in theDC output,DCe, is then used to vary
the potential (or the high tension voltage) across the PMT via a servomechanism,
to reduce its value to zero [37]. Equation 2.14 may then simply be expressed as:
LD = k0AC (2.16)
2.2.2 Fluorescence excitation spectroscopy
Once an electron has absorbed the energy of an incoming photon in the ultraviolet
or visible region, and is occupying one of the vibrational energy levels of an excited
state, it immediately begins a process which will see it return to the ground state.
In most chromophores, this is achieved through a non-radiative process, such as
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vibrational decay or collisional quenching, however, in some cases, the electron
releases energy by emitting a photon. Where there is no intersystem crossing from
a singlet to a triplet state, this occurrence is termed fluorescence. Figure 2.5 is a
Jabłoński diagram, which illustrates the processes through which an electron can
return to the ground state.
Figure 2.5: Jabłoński diagram [44] illustrating the processes that occur following the
absorption of a photon. Through absorption, an electron in one of the vibrational
levels of the singlet ground state (S0i) is excited to a first (S1) or second (S2) singlet
state. It is most likely that it then decays down to the S10 state, from where it can
release its energy radiatively and drop down to the S0. An electron in the S1 may
also go through spin conversion to a triplet state (Ti), in a process called intersystem
crossing. Radiative decay from a triplet state to the S0 (phosphorescence) is spin
forbidden, and occurs over a much longer time frame. This figure was adapted from
a TikZ template on www.TEXample.net.
From Figure 2.5 one can easily see that fluorescence emissions are lower in energy
than the light that was absorbed. This energy diﬀerence is called the ‘Stokes shift’,
after Sir G. G. Stokes who first observed the phenomenon [45]. It is less obvious from
Figure 2.5, though generally true, that the energy of the emitted light is independent
of the energy of the excitation light used; a phenomenon eponymously named:
‘Kasha’s’ rule [46]. These features of fluorescence mean that one can relatively easily
distinguish between fluorescence emissions and transmitted or Rayleigh scattered
incident light; and also, one can measure variations in the fluorescence emissions
18
2.2. SPECTROSCOPY IN THE UV-VISIBLE REGION Chapter 2
over a range of excitation wavelengths with little (or no) alterations to the detection
system.
A schematic representation of a typical spectrofluorometer is given in Figure 2.6.
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Figure 2.6: Schematic of spectrofluorimeter. Many of the optical elements can be
the same as in the CD spectrometer given in Figure 2.4. The diﬀerent components
are the beamsplitter (BS), which directs light towards a reference detector (rD) so
that the incident light intensity can be recorded. This figure was drawn in Microsoft
PowerPoint.
Recording the variation in fluorescence intensity with the wavelength of exciting light
gives a fluorescence excitation spectrum [47]. In an ideal case, where the detection
eﬃciency of the instruments is exactly the same at all wavelengths and its wavelength
calibration is accurate, a fluorescence excitation spectrum should be superposable
onto an absorbance spectrum, when using a sample containing only a single
chromophore, which is also a fluorophore [48]. However, an advantage of fluorescence
measurements over absorbance methods is that they are intrinsically more sensitive,
as they depend only on the incident light intensity and the instrument’s ability to
detect low light levels, and not its ability to diﬀerentiate between two, nearly equal
signals from the incident and transmitted light beams (as shown in Equation 2.18).
When measuring a spectrum of a sample containing multiple chromophores,
fluorescence detection can also be much more selective than detecting the absorbance
directly, as in most cases only one of the chromophores will fluoresce. Though
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with samples such as these (containing multiple chromophores with only a single
fluorophore) one has to be cautious of the inner-filter eﬀect, where the spectrum is
distorted by the emitted light being reabsorbed before reaching the detector. The
inner filter eﬀect is usually not too much of a problem, as fluorescence detection
permits the use of highly dilute samples.
2.3 Fluorescence detected linear dichroism
Our motivation for developing a fluorescence detection methodology for linear
dichroism spectroscopy was to enable us to obtain information on the relative
orientation of chromophores in a sample, with increased measurement sensitivity
and chromophore selectivity than is possible with conventional absorbance linear
dichroism. We begun by defining fluorescence detected linear dichorism (FDLD) as
the diﬀerence in the intensity of fluorescence emissions after excitation by parallel
(Fk) and perpendicularly (F?) polarised light:
FDLD = Fk   F?. (2.17)
The following sections detail the development of FDLD’s experimental
configuration, and the theoretical basis of the experiment.
2.3.1 Experimental procedure
In their work on fluorescence detected circular dichroism (FDCD), Muto et al.
used the Stoke’s shift of fluorescence emissions to separate them from transmitted
incident light by placing 100 mm of saturated NaNO3 solution between the sample
and the detector [49]. We use similar reasoning in our FDLD experiments, where
we use long-pass edge filters with a high optical density through their attenuated
wavelengths and as high a cut-oﬀ gradient as possible, to maintain the PMT facing
the propagation direction of the incident light. The initial motivation for this was
that when using a mechanical stretcher to orient a sample (Figure 2.3), it is not
possible to detect a signal at 90  as it is blocked by the apparatus, however, we
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have found that it also gives better results when using solution samples oriented by
Couette flow.
When selecting a long-pass filter, the first thing that needs to be considered is the
sample’s excitation and emission wavelength maxima. These can be measured using
standard absorbance and fluorescence spectrophotometers. The cut-oﬀ wavelength
of the long-pass filter is selected to lie between these maxima. It is preferable that
the Stoke’s shift of the fluorophore is large, so that that there is no overlap between
the excitation and emission peaks. This is generally the case when the fluorophore
is excited into the S2 state (Figure 2.5), although it is less common when exciting
into S1. When there is overlap between the excitation and emission spectra, a
trade-oﬀ has to be made between the wavelength range of the measured spectrum
and its signal intensity. Selecting a filter with a steep cut-oﬀ gradient reduces the
sacrifice of both these parameters. The long-pass filters used in this work are given
in Table 2.1.
Table 2.1: Long-pass filters used for fluorescence detected linear dichroism
Filter Cut-oﬀ Wavelength (nm)
SCHOTT OG570 570
ThorLabs FEL0400 400
ThorLabs FELH0450 450
ThorLabs FEL0500 500
ThorLabs FEL0550 550
Semrock FF01-300/LP-25 300
Semrock FF01-341/LP-25 341
Semrock FF02-409/LP-25 409
Semrock LP02-568RU-25 568
In Table 2.1, the SCHOTT OG570 filter is included as an example of the coloured
glass filters we used. This type of filter performs very poorly in our setup, as
they transmit too much light through their attenuated wavelengths, and so spectra
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measured using these are a mixture of LD and FDLD. All of the ThorLabs filters
listed performed very well, with their maximum transmission intensity through their
attenuated wavelengths being 0.01% (optical density (OD) 4). These filters blocked
light over a large wavelength range, though their cut-oﬀ gradient was found to be
quite shallow, with ⇠15 nm between their maximum transmission and rejection
regions.
The steepest cut-oﬀ gradient filter in Table 2.1 is the Semrock Razor Edge
LP02-568RU-25, with only 3 nm between its maximum transmission and rejection
regions. This filter, however, is designed for Raman spectroscopy and has a poor
range of blocked wavelengths. Much better performers in this respect are the other
Semrock filters, which are all from the BrightLine series. They have the range of
blocked light achieved by the ThorLabs filters (with an increased blocking eﬃciency
of OD 5-7), with only a 6 nm cut-oﬀ gradient. On occasions when an individual
filter’s blocking range did not cover the region we wished to measure, it was found
to be very eﬀective to ‘piggyback’ one filter on top of another, such that the incident
light hit the filter with the longest cut-oﬀ wavelength first. This technique was used
frequently throughout this work.
Once an appropriate long-pass filter has been selected, it needs to be fitted directly
in front of the detector. As the filters given in Table 2.1 require that they are set
at exactly 90  to the incident light to transmit all polarisations of light equally, we
custom made a holder that fit them into a Jasco J-815 spectrometer. A diagram of
the filter holder is given in Figure 2.7.
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Figure 2.7: Drawing of the custom made long-pass filter holder used to fit filters into
a Jasco J-815 spectrometer. Once the  25 mm filter was placed in the mouth of the
fitting, a rubber o-ring was used to hold it in place. All dimensions shown are in
millimetres.
Once the filter and sample are in place, the other adjustments are made using the
instrument’s software. So that transmitted light is not recorded, the wavelength
range must start before the cut-oﬀ wavelength of the long-pass filter that is in place
in the instrument — the minimum number of wavelengths before depends on the
steepness of its cut-oﬀ gradient — and the stop wavelength is set at the shortest
wavelength of the range. Channel two of the instrument is set to record either
the high tension voltage (HT) or the DC output from the PMT, depending on
whether the DC is set to be constant (using Equation 2.15) or the HT is set at a
constant value (normally 600 V), respectively. In either case, it is obvious from the
trace of this channel whether the filters being used block transmitted light over the
selected wavelength range, as regions where they transmit light will be seen as a
sharp decrease in the HT value or a sharp increase in the DC output.
Whether to set the instrument to measure in fixed HT or fixed DC mode depends
on the sample one is using. The reason for this, and an introduction to the theory
of FDLD is given below.
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2.3.2 Theoretical introduction
Fluorescence emission may be defined as the absorbance of a sample, multiplied by
the quantum yield of the fluorophore [50]:
F =  
⇥
I0(1  e a)
⇤
(2.18)
where   is the quantum yield, I0 is the intensity of the incident light, and a is the
Eulerian absorbance of the sample. Assuming the long pass filter is 100% eﬀective,
  is the same for both polarisations of exciting light, and that the fluorescence
lifetime of the fluorophore is much shorter than the reciprocal of the frequency of
the PEM [51], with reference to Equation 2.17, FDLD may be described as follows.
In our experiment, we must expand Equation 2.18, in terms of the incident intensity
of the two linear light polarisations, I0,k and I0,?, and their respective sample
absorbance, ak and a?:
F =  
⇥
I0,k(1  e ak) + I0,?(1  e a?)
⇤
(2.19)
As ak/? = a¯± aLD2 , where a¯ is the average absorbance of the two light polarisations,
and aLD is their diﬀerence, i.e.  aLD = ak a?, we can write Equation 2.19 as [52]:
F =  
⇥
I0,k(1  e (a¯+
 aLD
2 )) + I0,?(1  e (a¯ 
 aLD
2 ))
⇤
(2.20)
We again know that the incident intensity of each light polarisation on a sample is
a time varying function of the phase shift,  , produced by the PEM (Equation 2.7),
where I0,k/0,? =
I0
2
(1± cos  ) [52]. And so Equation 2.20 becomes:
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F =  
⇥I0
2
(1 + cos  )(1  e (a¯+ aLD2 )) + I0
2
(1  cos  )(1  e (a¯  aLD2 ))⇤
=
 I0
2
⇥
(1 + cos  )(1  e (a¯+ aLD2 )) + (1  cos  )(1  e (a¯  aLD2 ))⇤
=
 I0
2
⇥
2  e (a¯+ aLD2 )   e (a¯  aLD2 )   (e (a¯+ aLD2 )   e (a¯  aLD2 )) cos  ⇤
=
 I0
2
⇥
2  e a¯((e aLD2 + e  aLD2 )  (e aLD2   e  aLD2 )) cos  ⇤
=
 I0
2
⇥
2  e a¯(2  aLD cos  )
⇤
(2.21)
Using Equation 2.8 to expand cos  , and remembering that our instrument is
configured such that J0( 0) = 0, we get:
F (0) =
 I0
2
⇥
2  e a¯(2  aLDJ0( 0)
⇤
=  I0
⇥
1  e a¯⇤ (2.22)
and
F (2!) =
 I0
2
⇥
2e a¯ aLDJ2( 0)
⇤
=  I0e
 a¯J2( 0) aLD
(2.23)
Here, as for linear dichroism, we again have the measured AC (F (2!)) and DC
(F (0)) components of the instrument output. The DC term is the average of
the fluorescence emission intensity following excitation by the two orthogonal light
polarisations. The AC term is proportional to the diﬀerential absorbance,  aLD,
and so is also proportional to LD (as  aLD = ln(10)LD). We divide the AC signal
by the DC, which removes the incident light intensity term, I0, which is unknown
in our measurement. In this study, the sign of the FDLD spectra has been changed
so that signals are of the same sign as LD, and so measurements using the two
techniques can be more easily compared.
FDLD =  AC
DC
(2.24)
In order to record a spectrum in fixed DC mode, using the mechanism described
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in Equation 2.15, the AC signal should be much smaller than the DC output,
or the average fluorescence intensity. Where the oriented sample fluorophore only
weakly fluoresces, the DC output could be increased by including a non-interacting,
unaligned fluorophore into the sample, which, if its concentration is low enough to
avoid the inner filter eﬀect, would increase the signal to noise ratio of the sample
without eﬀecting its sign or magnitude. This would only be possible for samples
oriented in the solution phase, where small fluorescent molecules would not have a
high enough aspect ratio to orient in flow — the mechanical stretching apparatus
used for solid samples would orient all small molecules. For this reason, it was
generally found to be better to fix the HT for solid samples, oriented on stretched
polyethylene films, and to fix the DC for solution samples oriented in Couette flow.
In fixed DC mode, FDLD spectra are simply calculated using Equation 2.25.
FDLD =  AC (2.25)
2.4 Methods summary
FDLD was designed to combine the sensitivity and selectivity of a fluorescence
excitation measurement, with the sensitivity to the relative orientation of
chromophores in a sample, obtainable through LD. To perform an FDLD
measurement on a commercial LD instrument, a long-pass edge filter must be
selected, which has a cut-oﬀ threshold wavelength that lies between the excitation
and emission wavelengths of the fluorophore in the sample. As fluorescence emissions
are longer in wavelength than the excitation light used (Stoke’s shifted), this means
that only the fluorescent light will reach the PMT and be detected.
Within the software settings of the instruments, it is possible to record a spectrum
in two modes: one where the HT voltage is fixed and the varying DC trace is
recorded; and in the other mode the DC output is fixed at 1, and one only needs to
invert the trace from the AC channel to provide the FDLD spectrum, as defined
in Equation 2.17. If the spectrum is recorded using a fixed HT, then the both
the AC and DC traces need to be used to calculate the FDLD spectrum using
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Equation 2.24.
2.5 Conclusions
In this chapter we have reviewed the theory behind LD, and how an instrument
translates the currents generated in its PMT detector during a measurement into
an LD signal. We then described our FDLD experimental configuration — where
the PMT is kept facing the propagation direction of the incident light and a high
quality long-pass edge filter is placed in front of it, to block transmitted incident
light, whilst allowing longer wavelength fluorescence emissions to pass freely —
and defined FDLD as the diﬀerence in fluorescence emission intensity following
excitation with incident light polarised parallel and perpendicular to the orientation
axis of a sample, respectively. The chapter closes with a method we propose will
allow the calculation of FDLD spectra from the currents generated in a PMT, much
like is done in LD.
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CHAPTER 3
Fluorescence detected linear dichroism of
small molecules oriented on polyethylene
film
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3.1 Introduction
As stated in Equation 2.17, we define FDLD as the diﬀerence in the fluorescence
emission intensity from a sample, following excitation with light polarised parallel
to the molecular orientation axis and light polarised perpendicular to that axis,
respectively. Our initial proof of concept FDLD experiments focussed on recording
the spectra of small fluorescent organic molecules, oriented on stretched oxidised
polyethylene films (PEOX) [35]. Orienting molecules on stretched polymer films
has been used for decades as a means to determine the polarisation directions of
their electronic transitions, and the recent development of PEOX has meant that
this simple technique can be used for a wider range of compounds [35]. Anthracene
(Figure 3.1A) is a molecule which has been well studied using LD [10, 35, 53–55],
and so recording its FDLD spectrum was an ideal starting point. It possesses
two allowed transitions in the ultraviolet region: a long wavelength 1La band at
379 nm and a short wavelength 1Bb band at 254 nm — and following both of
these excitations, some molecules return to the ground state through a radiative
process [56].
O
O
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C
Figure 3.1: Small fluorescent molecules used in stretched film FDLD experiments.
A: anthracene, B: trans-1,6-diphenyl-1,3,5-hexatriene (DPH), C: 4-methylphenyl
benzoate (MPB).
A representation of trans-1,6-diphenyl-1,3,5-hexatriene (DPH) is given in
Figure 3.1B. DPH is another well studied molecule, particularly because of its use
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as a fluorescent probe [57–60], but also because it is the smallest member of a class
of linear diphenyl polyenes, which have intriguing spectroscopic properties [61, 62],
and are used as model compunds for vitamin A [63]. The ground singlet state (S0)
and the first excited state (S1) of DPH both have Ag symmetry, and so an S1  S0
transition is forbidden by the Laporte selection rule — that transitions must be
accompanied by a change in parity [64]. The S2 of DPH has Bu symmetry, and so
an S2  S0 transition is allowed, and it is this band that is seen in a UV-visible
absorption spectrum of the molecule. On the return to the ground state things are
more complex. Fluorescence directly from the S2 has been reported, as the S0  S2
transition is allowed, though generally it is the S1  S2 transition that occurs
quickly through internal conversion [65]. As the S1 and S2 states are very close in
energy, vibronic coupling between them allows the transition from the S1  S0 via
the S2 [66]. For these reasons DPH was also selected as an interesting molecule to
investigate with FDLD.
Significantly less attention has been given to 4-methylphenyl benzoate (MPB,
Figure 3.1C) in the literature, when compared with anthracene and DPH. It
is reported to be an eﬀective benzoate ester when used in Friedel-Crafts Fries
rearrangement reactions [67], though there is next to nothing about its spectroscopy,
which, as is demonstrated below, is quite interesting.
In this chapter we show the potential of fluorescence detected linear dichroism
(FDLD) to be performed using a commercial linear dichroism (LD) instrument,
by illustrating the information that can be extracted from spectra collected with
stretched PEOX and an appropriate long-pass edge filter.
3.2 Materials and methods
3.2.1 Materials
All chemicals were purchased from Sigma-Aldrich (Sigma-Aldrich Company Ltd.,
Dorset, UK) and used without further purification. The solvents used were
chloroform (spectrophotometric grade, Sigma-Aldrich) and methanol (laboratory
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grade, Fisher Chemicals).
3.2.2 Preparation of PEOX films
3 ⇥ 5 cm2 sections of polyethylene were cut from Glad® Snap Lock® bags, and
oxidised in an Emitech K1050X Plasma Asher connected to an oxygen gas supply
for 1 min at 50 W to generate PEOX [35].
3.2.3 Spectroscopic techniques
Prior to measuring a spectrum, a section of PEOX was clamped between the jaws of
a mechanical stretcher (Figure 2.3), which were set to be 2.5 cm apart. The central
cog of the stretcher was then turned to stretch the film 1.8⇥, so that the final
distance between the jaws was 4.5 cm. To swell the film, 40 µL of solvent (without
sample) was pipetted onto its surface and allowed to evaporate. The mechanical
stretcher was then placed into a Jasco J-815 spectropolarimeter, and a baseline LD
or FDLD measurement was recorded using the parameters given in Table 3.1.
A range of high tension voltage (HT) values were tried for initial FDLD
measurements, and a value of 600 V was generally found to produce spectra with the
best signal to noise ratio when using the molecules given in Figure 3.1 as analytes.
Therefore, this value was used for all fixed HT FDLD measurements in this thesis.
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Table 3.1: Parameters used for film LD and FDLD measurements
Parameter LD FDLD
D.I.T. 1 s 1 s
Bandwidth 1 nm 1 nm
Data Pitch 0.2 nm 0.2 nm
Scanning Mode Continuous Continuous
Scanning Speed 100 nm/min 100 nm/min
Accumulations 3 8
DC Output Constant Variable
HT Voltage Variable 600 V
Following a baseline measurement, 40 µL of sample solution was deposited on to the
film surface and the solvent was allowed to evaporate. The sample spectrum was
then measured using the same parameters as was used for the baseline measurement.
In cases where the sample molecule being used is not prone to photobleaching, it
was found to be better to pipette additional sample solution onto the first film
when recording a series of spectra with increasing analyte, instead of preparing fresh
solutions of increasing concentration. This is because LD and FDLD signals are not
only proportional to the concentration of chromophore, but also to its alignment,
and each sample aligns slightly diﬀerently on diﬀerent films.
For LD measurements, where a variable HT voltage was used (Table 3.1), the
baseline trace was simply subtracted from the sample trace to produce the final
spectrum. As the FDLD measurements were recorded using a fixed HT voltage,
the baseline and raw sample spectra were calculated separately from the alternating
current (AC) and direct current (DC) output of the instrument, using Equation 2.24.
The resulting baseline traces were then subtracted from the sample traces to give
the final FDLD spectra, which are plotted in Section 3.3.
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3.3 Results and discussion
The results of the LD and FDLD spectroscopic measurements, recorded from
small molecules oriented on stretched oxidised polyethylene (PEOX), are given
below. Unpolarised ultraviolet (UV)-visible and fluorescence emission spectra are
also given, to illustrate how the choice of long-pass edge filter was made for FDLD
measurements.
3.3.1 Anthracene
Anthracene is a good test compound as its lowest energy short-axis polarised
transition has overlaid vibronic progressions and significant intensity ‘borrowed’
from the 254 nm long-axis polarised transition [68]. It also shows diﬀerent LD
spectra (diﬀering in both peak wavelength and sign) for oligomeric structures [35].
Anthracene’s window between absorbance and emission is small, and so the long-pass
edge filter had to be chosen carefully for FDLD measurements.
Figure 3.2 shows the UV-visible absorbance and fluorescence emission spectra of
anthracene deposited on a stretched PEOX film, with the emission spectra being
measured using an excitation wavelength of 254 nm. The bandwidths of the
excitation and emission monochromators were both set at 1 nm.
The dashed grey line in Figure 3.2 indicates the cut-oﬀ wavelength of the Semrock
409 nm long-pass edge filter (Table 2.1). As can be seen from the figure, there is a
slight overlap in the excitation and emission bands of the molecule. This filter was
selected for FDLD measurements to obtain a complete excitation spectrum, which
in this case comes at the expense of some of the emission intensity that reaches the
detector.
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Figure 3.2: Absorbance (blue) and fluorescence emission (red) spectra of 40 µL of
1 mg/mL anthracene solution (0.224 µmol) deposited on a stretched PEOX film.
The excitation wavelength for the emission spectrum was 254 nm. The dashed grey
line shows the cut-oﬀ wavelength of the long-pass filter selected for recording FDLD
spectra.
Figure 3.3 shows the LD and FDLD spectra of monomeric anthracene. A Semrock
long-pass edge filter 409 nm was placed in front of the photomultiplier tube (PMT)
detector when measuring the FDLD spectra. The instrument parameters given
in Table 3.1 were used for recording all LD and FDLD spectra in the figure. As
anthracene is not prone to photobleaching, each set of spectra were recorded on the
same section of PEOX , with additional 40 µL aliquots of stock solution being added
to the film prior to each spectrum being measured.
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Figure 3.3: LD (top) and FDLD (bottom) spectra of monomeric anthracene,
oriented on stretched PEOX films. The numbers given for each spectrum indicate
the number of 40 µL aliquots of anthracene stock solution that was added to the
film. For LD measurements a 10 µg/mL stock solution was used (following solvent
evaporation, one 40 µL addition would leave 2.24 nmol of anthracene on the film),
and for FDLD measurements a 100 ng/mL stock solution was used (leaving 22.44
pmol following solvent evaporation). Both LD and FDLD were measured using the
settings given in Table 3.1, with the Semrock 409 nm long-pass edge filter being used
for FDLD measurements.
Figure 3.3 shows that in the region of the long axis transition (⇠254 nm), the general
shape of the FDLD spectra of anthracene is in good agreement with that of the LD
spectra of monomeric anthracene, which is given in the same figure, and featured
in a previous work by Razmkhah et al. [35]. However, as the figure shows, the
concentrations of the stock solutions used diﬀer by a factor of 100. This is because
it was not possible to obtain FDLD spectra resembling the monomeric LD spectra
when using equal concentrations.
A consequence of the low sample amount used for the FDLD measurements in
35
3.3. RESULTS AND DISCUSSION Chapter 3
Figure 3.3 is that the spectra have a poor signal to noise ratio in the region of the
short axis transition. This is improved when higher sample amounts are added to
the film. An example of this is the LD and FDLD spectra given in Figure 3.4.
Here, 40 µL aliquots of a 10 µg/mL stock solution of anthracene in chloroform and
methanol (CHCl3(20):CH3OH(80)) were deposited onto the PEOX for each set of
measurements.
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Figure 3.4: LD (top) and FDLD (bottom) spectra of anthracene. For both sets
of measurements, a 10 µg/mL stock solution in chloroform and methanol (20:80)
was used to deposit anthracene on the PEOX . The numbers in both figure legends
indicate the number of 40 µL aliquots that were added to the film (leaving 2.24 nmol
after solvent evaporation). These are the only film FDLD spectra presented in this
work that were recorded using a variable HT voltage (fixed DC output). This was
done to increase the dynamic range of the experiment, and in this case did not cause
saturation (flattening) of the bands.
From Figure 3.4, the 254 nm LD intensity is significantly larger than its FDLD, but
the 379 nm FDLD is larger than its LD reflecting the higher fluorescence quantum
yield of the longer wavelength transition. Thus, in this example, FDLD enhances
the sensitivity of the weak long wavelength transition. Most noticeable from the
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spectra, however, is the diﬀerence in the spectral shape of the short wavelength
band when using the two techniques. It has been shown previously that when high
sample amounts are deposited on the surface of PEOX , an inversion of the 254 nm
peak occurs due to layers of anthracene adopting higher order structures, such as
dimers or trimers, and orienting diﬀerently on the film [35]. However, at these
concentrations the inversion of the 1Bb band peak at 254 nm begins to appear in the
first of the FDLD spectra, when only 2.24 nmol of anthracene had been deposited
on the film. It is also apparent from the FDLD spectra, that with increasing
anthracene amounts, a shorter wavelength negative peak emerges at 248 nm, and a
strong positive peak at 240 nm appears.
The long wavelength 1La band of anthracene has a clear vibronic progression, which
can be seen in both LD and FDLD as illustrated in Figure 3.5. The fact we
can see it in FDLD also, with a good signal to noise ratio, is significant, as it
may open the door to viewing such progressions when overlapping signals from
non-fluorescent chromophores obscure them when using absorption methods. This
may make it possible to see in greater detail how electronic states are eﬀected by
their environment.
The sign change of the near-UV short axis transition is a further interesting feature
of anthracene’s spectroscopy, and it can be clearly seen in both spectra in Figure 3.5.
It arises as the 1La band in anthracene is coupled to the strong 1Bb band in
the spectrum [54]. As the energy of the vibronic components of the 1La band’s
progression increase, and become closer in energy to the 1Bb band’s excitation, the
coupling becomes stronger [69], and the sign of the LD and FDLD spectra changes
around 340 nm.
37
3.3. RESULTS AND DISCUSSION Chapter 3
0.
00
0.
05
0.
10
0.
15
L
D
-0
.0
01
5
0.
00
00
0.
00
15
200 250 300 350
-0
.0
2
0.
00
0.
02
Wavelength / nm
F
D
L
D
Wavelength / nm
Figure 3.5: The LD (top) and FDLD (bottom) spectra of anthracene after five 40 µL
additions of a 10 µg/mL stock solution. These data are reproduced from Figure 3.4,
with the addition of dashed lines to highlight the 1400 cm 1 vibronic progression at
379 nm, 361 nm, 342 nm, 325.5 nm and 311 nm.
3.3.2 1,6-Diphenyl-1,3,5-hexatriene
The UV-visible absorbance and fluorescence emission spectra of
1,6-diphenyl-1,3,5-hexatriene (DPH) deposited on a stretched PEOX film are
given in Figure 3.6.
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Figure 3.6: Absorbance (blue) and fluorescence emission (red) spectra of 40 µL of a
1 mg/mL 1,6-diphenyl-1,3,5-hexatriene solution deposited on a stretched PEOX film.
The excitation wavelength used for the emission spectrum was 379 nm.
The fluorescence emission spectrum in Figure 3.6 was measured using an excitation
wavelength of 379 nm, and the bandwidths of the excitation and emission
monochromators were set at 3 nm and 1 nm, respectively. The dashed grey line in
the figure again represents the cut-oﬀ wavelength of the Semrock 409 nm long-pass
edge filter, which was also selected for the FDLD measurements of this molecule.
In this case, there is a greater Stoke’s shift when compared with anthracene, and so
a full DPH excitation spectrum can be recorded with very little emission intensity
being blocked by the filter.
DPH is a molecule with a particularly high quantum yield, so the stretched-film
FDLD data were able to be collected using pmol amounts, while the LD required
nmol quantities to give a reasonable signal, showing the advantage of FDLD for
eﬃcient fluorophores. The DPH spectra using both these techniques are given in
Figure 3.7.
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Figure 3.7: The LD (top) and FDLD (bottom) spectra of DPH. The numbers in both
figure legends indicate the number of 40 µL aliquots of stock solution that were added
to the film. For LD measurements a 10 µg/mL stock solution was used (leaving
1.72 nmol after solvent evaporation) and for FDLD measurements a 10 ng/mL
stock solution was used (1.72 pmol DPH after solvent evaporation). All spectra were
recorded with the measurement parameters given in Table 3.1.
The diﬀerent vibronic components of the 300⇠400 nm DPH transition illustrate
features of FDLD that need to be considered. The measured LD and FDLD in
Figure 3.7 look similar for the lowest three vibronic components of DPH, however,
the highest component in the two sets of spectra is quite diﬀerent. The underlying
reason for this diﬀerence lies with the complex emission spectroscopy of DPH
mentioned in the introduction to this chapter. DPH has at least two excited
electronic states of similar energy (the lower state of 1Ag symmetry whose transition
to the ground state is forbidden and the higher 1Bu state which is allowed) [61].
Non-radiative transfer between the states is possible resulting in diﬀerent vibronic
states having diﬀerent quantum yields [70].
A further noticeable diﬀerence between the sets of spectra in Figure 3.7 is that the
peak at 256.5 nm in the FDLD, which is also present in the unpolarised UV-visible
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spectrum of Figure 3.6, appears to be completely absent from the LD spectra.
Interestingly, this is in the region of the 0-0 transition of phenylethene (styrene),
which is reported to be at 250 nm [71]. However, as styrene’s emission is around
308 nm, and emissions of this wavelength would be blocked by the long-pass filter,
it is unlikely that styrene contamination is what we are seeing here. It may be that
this peak emerges due to DPH aggregates being formed on the film, which, as was
observed with anthracene, FDLD has increased sensitivity towards.
3.3.3 4-Methylphenyl benzoate
The UV-visible absorbance and fluorescence emission spectra of 4-methylphenyl
benzoate (MPB) deposited on a stretched PEOX film are presented in Figure 3.8.
The figure also contains two dashed grey lines: one at the cut-oﬀ wavelength of the
Semrock 300 nm long-pass edge filter and a second at the cut-oﬀ wavelength of the
Semrock 341 nm long-pass edge filter. This is an example of when one has to think
carefully about choosing a long-pass filter to use for FDLD measurements. When
using the 341 nm filter for MPB FDLD, it is possible to obtain a full excitation
spectrum, however, it would seem from Figure 3.8 that a lot of the emission intensity
is being blocked by the filter, in addition to transmitted incident light. Although
in this case quality FDLD spectra are still obtained using this filter, as is shown
below.
It is also possible to collect MPB FDLD spectra using a long-pass edge filter with
a 300 nm cut-oﬀ wavelength. As is illustrated in Figure 3.8, this allows us to collect
much more of the emission intensity of the fluorophore, however, we are unable to
collect a spectrum over the full excitation range. FDLD spectra of MPB recorded
using this filter are also given below, where we found that we were able to collect
data using much smaller amounts of sample.
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Figure 3.8: Absorbance (blue) and fluorescence emission (red) spectra of 40 µL of 1
mg/mL 4-methyl phenylbenzoate solution deposited on a stretched PEOX film. The
excitation wavelength for the emission spectrum was 274 nm.
The LD and FDLD spectra of MPB are presented in Figure 3.9. A Semrock 341
nm long-pass edge filter was used to collect the FDLD spectra displayed in this
figure, and the parameters given in Table 3.1 were used for both LD and FDLD
measurements.
MPB is another extremely eﬃcient fluorophore. Its FDLD spectrum shows a greatly
enhanced signal magnitude for its long wavelength transitions when compared with
LD, further illustrating the potential increased sensitivity of FDLD measurements.
The enhancement for the shorter wavelength band is less but still significant.
42
3.3. RESULTS AND DISCUSSION Chapter 3
-0
.0
05
0.
00
5
0.
01
5
0.
02
5
L
D
1
2
3
4
180 200 220 240 260 280 300
-0
.0
5
0.
05
0.
15
0.
25
F
D
L
D
1
2
3
4
Wavelength / nm
Figure 3.9: The LD (top) and FDLD (bottom) spectra of MPB. The legend numbers
indicate the number of 40 µL aliquots of MPB stock solution were pipetted into the
surface of the PEOX film. A 10 µg/mL stock solution was used for both sets of
measurements, which, after solvent evaporation, left 1.88 nmol of MPB. All spectra
were measured using the parameters given in Table 3.1. A Semrock 341 nm long-pass
edge filter was used for FDLD measurements.
The quantities of MPB used for the experiments in Figure 3.9 were chosen to be
the same for both LD and FDLD to better compare the two techniques, and to
demonstrate the increased measurement sensitivity of FDLD. However, though a
greater amount of structure can be seen in the FDLD spectra, it is also clear that
the detection system is beginning to be saturated and the bands are flattened.
The FDLD spectra of MPB were measured at lower concentrations to avoid the
problem of absorption flattening, and the result is given in Figure 3.10. Here, the
Semrock 341 nm long-pass edge filter was again used for the measurements.
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Figure 3.10: FDLD spectra of MPB recorded using a Semrock 341 nm long-pass
edge filter. For each measurement 40 µL of 500 ng/mL MPB solution in methanol
was added to the surface of the film and allowed to evaporate (leaving 94.23 pmol of
MPB) before recording a spectrum. The numbers in the legend indicate the number of
aliquots that were added. All spectra were measured using the FDLD measurement
parameters given in Table 3.1. The dashed lines at 289.5 nm, 278.5 nm, 267.5 nm,
256.5 nm and 245 nm indicate a 1457 cm 1 vibronic progression and referred to in
Table 3.2.
Figure 3.10 shows the FDLD spectra of MPB at lower amounts than were used
for the spectra in Figure 3.9. The improved resolution of the vibronic structure
within the bands compared with LD is striking, and we are able to pick out a 1457
cm 1 progression from the 289.5 nm maximum. The measured progression slightly
diﬀers from a theoretical one originating from that position, which is illustrated in
Table 3.2. However, the clarity with which such vibronic detail can be obtained when
using FDLD compared with absorption methods shows the potential advantage of
using the technique to provide additional information about a molecule.
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Table 3.2: Comparison of the observed positions of the vibronic progression shown
in Figure 3.10 with theoretical values assuming a 1457 cm 1 progression from the
band with maximum at 289.5 nm.
Calculated position of 1457 nm 1
vibronic components
Observed position
289.5 nm 289.5 nm
277.78 nm 278.5 nm
266.98 nm 267.5 nm
256.98 nm 256.5 nm
247.71 nm 245 nm
A further point about the spectroscopy of MPB deposited on stretched polymer
films, is that its fluorescence excitation spectra show a hypsochromic shift in the 297
nm monomer peak to 280 nm with additional amounts of MPB. This is illustrated
using the conventional unpolarised fluorescence excitation spectra in Figure 3.11.
The spectrum was recorded on a Jasco FP-6500 fluorescence spectrophotometer.
The emission wavelength for the measurement was fixed at 330 nm, and the
bandwidth of both the excitation and emission monochromators was set to 3 nm.
The blue shift in the monomer peak of MPB is possibly due to the formation
of H-aggregates on the film. H-aggregates are formed when the arrangement to
molecules in a sample is such that the coupling between their dipoles leads to a
blue shift in the absorption band [72]. Similarly, J-aggregates are formed when the
molecules are stacked so that their transition dipoles are parallel, which causes a
red (bathochromic) shift in their absorbance spectrum [72]. The fluorescence from
H-aggregates is often strongly self-quenched, however, a number of reports show
that this is not always the case, particularly when the sample is on film [73,74].
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Figure 3.11: Fluorescence excitation spectra of MPB on stretched PEOX film. The
legend numbers indicate the number of 40 µL aliquots of 10 µg/mL MPB stock
solution was added to the film. The bandwidths of both the excitation and emission
monochromators was set to 3 nm. The emission wavelength was set at 330 nm.
The dashed lines illustrate the hypsochromic shift of the 297 nm monomer peak with
increasing amounts of MPB.
A final example of FDLD spectra measured using MPB is given in Figure 3.12.
These spectra were recorded using a Semrock 300 nm long-pass edge filter, instead
of the 341 nm filter that was used in the above FDLD measurements. As in this
case much more of the emission intensity of the fluorophore is reaching the detector,
we were able to use a lower amount of sample deposited on the film surface, with
each 40 µL deposit of 10 ng/mL MPB solution leaving 1.88 pmol behind following
solvent evaporation.
Figure 3.12 shows that the relative magnitude of peaks in these spectra are quite
diﬀerent to when higher amounts of MPB are deposited on the film. Although we
are not able to see the longer wavelength maximum of the monomer peak, at 297
nm in Figure 3.11, it would appear that the 256.5 nm peak from Figure 3.10 is
also from the monomer, as here it has an increased magnitude when compared with
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the 280 nm aggregate peak. It may also indicate that the 280 nm peak may have
an overlaid contribution from a red-shift of the 256.5 nm peak due to J-aggregates
also being formed on the film. This is a further illustration of the significant eﬀect
that the stacking of MPB molecules deposited on a film has on its spectroscopy,
and of the increased insight that an be obtained when using a fluorescence detection
methodology.
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Figure 3.12: FDLD spectra of MPB recorded using a Semrock 300 nm long-pass
edge filter. For each measurement 40 µL of 10 ng/mL MPB solution in methanol
was added to the surface of the film and allowed to evaporate (leaving 1.88 pmol of
MPB) before recording a spectrum. The numbers in the legend indicate the number of
aliquots that were added. All spectra were measured using the FDLD measurement
parameters given in Table 3.1.
3.4 Conclusions
Building on the theory detailed in Chapter 2, the results given in this section
show that we can actually record FDLD spectra using a commercial instrument,
adapted for LD spectroscopy. The FDLD spectra of a number of small organic
molecules, deposited on stretched PEOX films, were the starting point for our
development of the method, due to the simplicity with which the mechanical
stretching apparatus can orient a sample containing multiple copies of a single
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molecule. We have confirmed that FDLD spectra may be calculated from the
AC and DC components of the instrument output, when recording with a fixed
HT voltage using Equation 2.24. We have also shown that FDLD spectra can
be obtained using a variable HT voltage, as was done for the anthracene FDLD
spectra in Figure 3.4. Varying the HT voltage increases the dynamic range of the
experiment, and so one does not have to lower it manually to record regions of high
fluorescence emission that may otherwise flood the detector.
As demonstrated above, FDLD can give similar information to that obtained from
LD, often with only a fraction of the amount of sample. For all of the molecules used
in the experiments in this section, their FDLD spectra showed a large enhancement
in signal magnitude compared with their LD spectra. The two most striking
examples of this were: DPH, where we could see a similar signal magnitude with
1 ⇥ 10 3 of the amount of sample; and MPB, where comparing Figures 3.9 and
3.12 shows we can achieve similar signal magnitudes with 1⇥ 10 4 of the amount of
sample.
In some cases, however, FDLD spectra show diﬀerences when compared with LD
spectra. FDLD spectra seem to show an increased resolution of the vibrational
structure of molecule, as is very apparent in the MPB spectra, and also has
an increased sensitivity to oligomeric species, as we observed in the anthracene
measurements. In the anthracene spectra, we can record the monomer spectrum
using both LD and FDLD, which is demonstrated in Figure 3.3. It is only when
⇠2.24 µmol of anthracene has been deposited on the film we begin to see the
oligomeric species in LD. However, the anthracene FDLD spectra show oligomeric
species with much lower sample amounts.
Comparing the two sets of spectra of MPB, the increased ability to detect small
signals when using FDLD is very apparent. The LD spectra have poor resolution
within the absorption bands, and seem to show only aggregate peaks, even when
small amounts of sample are deposited on the film. In contrast, the FDLD spectra
show additional fine structure within the bands, even when we used the same sample
as we used to record the LD spectra. The sensitivity of FDLD then allows even
smaller sample amounts to be recorded, which, as is shown is Figures 3.10 and 3.12,
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reveals bands that are not observed in the absorption spectra, which we propose
originates from the excitation of the monomer.
These measurements recorded using polymer films to orient a sample acted as a
valuable tool for optimising our FDLD methodology. They were key to working out
the long-pass filters that should be selected, which software settings should be used
for a given measurement, and how the information gained from FDLD compares
with that obtained from conventional LD. As the ultimate goal is for FDLD to
be used with biological systems, and a more useful alignment technique for these
is Couette flow, the next chapter describes the use of this alignment method to
record the FDLD spectra of biological systems: deoxyribonucleic acid (DNA) with
fluorescent probes and M13 bacteriophage.
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CHAPTER 4
Couette flow fluorescence detected linear
dichroism of DNA binding dyes
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4.1 Introduction
The information for creating the fundamental components that combine to form all
living things are encrypted into DNA. A scientific understanding of every aspect
of this molecule, and its interactions with its environment, is therefore crucial to
our understanding of the processes of life. In the field of medicine, the number of
drugs approved for therapeutic use is growing at an exponential rate, and in the
US the number reached 1453 by December 2013 [75]. It is therefore also crucial to
our understanding of the eﬃcacy and safety of these drugs that we understand the
ways in which they interact with DNA and eﬀect its function. In this chapter, some
of the insights linear dichroism has provided to this subject are reviewed, and we
show that in some cases fluorescence detected linear dichroism enhances our ability
to obtain such information.
Aside from molecules that bind covalently to DNA, such as the well known
chemotherapeutic cisplatin and the nerve gas alkylating agents, small molecules bind
non-covalently to DNA through three established mechanisms: intercalation, groove
binding, and external binding [76]. Intercalation — a mechanism first proposed by
Lerman in his study of acridines in 1961 [77] — occurs when planar molecules insert
between adjacent bases of the DNA chain, without breaking any hydrogen bonds of
the Watson-Crick base pairs. Therefore, intercalated molecules stack perpendicular
to the backbone of the DNA. Due to the geometry of the base pairs, the interhelical
spaces between the two strands that form the backbone are of unequal size. The
smaller of the two measures approximately 12 Å in B-DNA, and is called the minor
groove. The larger, at approximately 22 Å, is called the major groove. Molecules
binding to either of these sites are angled more in line with the DNA’s major axis,
with their long axis transition moments tending to lie between 35  and 45  from
it [78]. Molecules may also bind electrostatically to external sites of DNA, however,
this mode of binding is generally random and will not be considered further is this
study.
Linear dichroism has a long history of being used to investigate the way in which
small molecules interact with double stranded DNA [79–81]. Its sensitivity to the
relative orientations of chromophores in a sample mean that molecules that are
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intercalated into DNA, with their molecular long axis perpendicular to the DNA’s
orientation axis, are easily distinguishable from those that are groove bound, lying
with their long axes less than 45  from this axis. The latter gives rise to positive
LD signals for their long axis polarised transition, whereas the former results in a
negative signals for the same transition.
Figure 4.1: Two of the modes in which small molecules can bind to double stranded
DNA: A shows a molecule intercalated between adjacent base pairs, and B shows
a molecule bound to the minor groove. These images were generated by Dr Shirin
Jamshidi, King’s College London, and have not previously been published.
B-form DNA has its own intrinsic absorbance at 260 nm, mainly due to the
⇡⇤  ⇡ transitions of the bases that lie perpendicular to the DNA’s molecular
long axis (their combination giving an apparent transition dipole moment angle of
86 ) [82]. LD spectra in this region are dominated by this absorption band, and the
ultra-violet spectral features of bound small molecules are often overwhelmed, or
obscured by its presence. As DNA is not a fluorescent molecule, in cases where
the bound small molecules are fluorophores, these features may be unveiled by
FDLD. As mentioned in Chapter 2, this increased measurement selectivity was
one of the major motivations in our decision to develop this technique, along
with the potential for increased measurement sensitivity, which is intrinsic to
fluorescence measurements when compared with absorption methods. These eﬀects
are illustrated below using four fluorescent molecules (ethidium bromide, propidium
iodide, 4’,6-diamidino-2-phenyindole, and Hoechst 33258) bound to DNA.
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This chapter closes with a proposed novel application of FDLD to detect pathogenic
bacteria using wild-type M13 bacteriophage as a bio-sensor, where the intrinsic
fluorescence of the tryptophan residues on the pVIII capsid proteins give rise to
strong FDLD signals.
4.1.1 Fluorescent molecules
The fluorescent DNA stains used in this work are shown in Figure 4.2. Ethidium
bromide was first synthesised by Watkins and Woolfe of the Boots company in 1952,
as an enhancement on the trypanocidal activity of dimidium bromide in animals [83].
Since then, it has become one of the most widely used and extensively studied
fluorescent DNA probes on the market. It binds to DNA through intercalation, as
described above, and this action produces a striking enhancement of its fluorescence
quantum yield due the ethidium ions being less exposed to solvent molecules [84].
Similarly, propidium iodide also binds to DNA through intercalation, which is
accompanied by an increase in fluorescence intensity.
4’,6-diamidino-2-phenyindole (DAPI) was first synthesised in 1971, once again for its
enhanced trypanocidal activity [85]. The compound Hoechst 33258 was synthesised
by the Hoechst AG company, and both it and DAPI are also very commonly used
as fluorescent DNA stains.
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Figure 4.2: Structures of Small Molecules. A: Ethidium Bromide B: Propidium
Iodide C: DAPI D: Hoechst
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4.1.2 Couette flow orientation
M. Couette published the first experimental investigation of the flow of a liquid held
between two rotating, concentric cylinders in 1887, and the rheological technique
still bears his name today [86]. It is extremely useful for orienting biological
macromolecules in solution, due to the relatively small sample volumes required
when compared with other methods, such as flow-through channels. It was first
used in the context of flow linear dichroism by A. Wada in 1964. In this setup,
the annular gap between the outer and inner cylinders was 0.7 mm, and 2.6 mL of
sample was required for a single experiment [87]. The more recent innovation by
Marrington et al., here at the University of Warwick, of the micro-volume Couette
flow cell significantly reduced the sample volume requirement to 60 µL [5]. This
made it possible for LD to probe the structure of protein fibres, which are often
obtained in such small amounts that 2.6 mL would not be easily obtained. It is this
Couette flow setup that is used in all experiments described in this work.
4.2 Materials and methods
This section gives the details of all of the chemicals and solvents that were used
to prepare the samples for spectroscopic analysis, in addition to the instruments,
materials and settings used for all measurements.
4.2.1 Materials
Deoxyribonucleic acid (DNA) sodium salt from salmon testes was purchased from
Sigma-Aldrich and used for all DNA experiments. Stock solutions were prepared
by weighing out approximately 10 mg of DNA, and leaving it to reconstitute in 10
mL of filtered and deionised water (18.2 M⌦·cm, Millipore Direct-QTM) overnight
at 4 C. The final concentration of the stock solution was then measured using a
Jasco V-660 UV-visible spectrometer, using the extinction coeﬃcient: "260 = 6600
M 1cm 1 [88].
The molecules ethidium bromide (EtBr), propidium iodide (PI),
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4,6-diamidino-2-phenyindole (DAPI) and Hoechst 33258 were purchased from
Sigma-Aldrich and used as received. Stock solutions were made by dissolving
the powders in filtered and deionised water, and their concentrations were again
determined spectrophotometrically using extinction coeﬃcients of: "480 = 5680
M 1cm 1 (EtBr, [89]), "494 = 5900 M 1cm 1 (PI, [90]), "340 = 27000 M 1cm 1
(DAPI, [91]), and "338 = 42000 M 1cm 1 (Hoechst 33258, [92]).
Samples of M13 bacteriophage were a gift from Professor Tim Daﬀorn at the
University of Birmingham.
4.2.2 Spectroscopic techniques
All UV-visible absorption measurements were recorded using a Jasco V-660
spectrophotometer. Samples of stated concentrations were prepared in 1.5 mL
Eppendorf tubes, before being transferred to a 0.1 cm quartz cuvette and
placed in the spectrometer. Baseline measurements were always taken separately,
and subsequently subtracted, so to eliminate the possibility of an error due to
baseline data propagating through the sample spectra, which may happen if the
baseline solution is contaminated and the machine is set to subtract its spectrum
automatically. Table 4.1 provides the measurement parameters for the UV-visible
measurements conducted in this work.
Table 4.1: Parameters used for UV-visible absorbance measurements
Parameters
D.I.T. 1 s
Bandwidth 1 nm
Data Pitch 0.2 nm
Scanning Mode Continuous
Scanning Speed 100 nm/min
Accumulations 1
LD and FDLD measurements were made on a Jasco J-815 following the procedure
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outlined in Chapter 2, using a fixed DC output. The parameter settings of the
instrument are given in Table 4.2. For FDLD measurements of DNA-EtBr and
DNA-PI, a Semrock 568 nm long-pass filter was piggy-backed on top of a Thorlabs
550 nm long-pass filter and placed in front of the PMT using the holder illustrated
in Figure 2.7. FDLD measurements of DAPI and Hoechst 33258 were performed
in a similar way, using Semrock 409 nm and Thorlabs 400 nm long-pass filters.
Equation 2.25 was used to convert the instrument output to FDLD spectra.
Table 4.2: Parameters used for LD and FDLD measurements
Parameter LD FDLD
D.I.T. 1 s 1 s
Bandwidth 1 nm 1 nm
Data Pitch 0.2 nm 0.2 nm
Scanning Mode Continuous Continuous
Scanning Speed 100 nm/min 100 nm/min
Accumulations 3 8
DC Output Constant Constant
HT Voltage Variable Variable
4.3 Results and discussion
Presented below are the results of the spectroscopic measurements recorded using
DNA-dye complexes and samples of M13 bacteriophage, in addition to a discussion
of what they show, and in particular, how using FDLD adds to the information
that is obtainable using other techniques.
4.3.1 Ethidium bromide and propidium iodide
The UV-visible spectra of 50 µM EtBr with a range of DNA concentrations are
given in the top left panel of Figure 4.3. It is clear that the addition of DNA has
a dramatic eﬀect on both the short and long wavelength absorption bands, with
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a large decrease in absorption in the near-UV and a slight increase along with a
bathochromic shift in the visible region. These are common characteristics of DNA
intercalators [93]. The top right panel of Figure 4.3 tracks the absorbance at 480
and 526 nm, illustrating the red shift in the absorbance maximum in this region.
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Figure 4.3: UV-visible absorbance and fluorescence emission spectra of 50 µM
Ethidium Bromide and a range of concentrations of salmon sperm DNA. Top left:
UV-visible absorbance spectra. Top right: Plot of the peak values at 480 and 526
nm, showing the bathochromic shift of the EtBr peak upon binding DNA. Bottom
left: Fluorescence emission spectra, recorded using an excitation wavelength of 506
nm. Bottom right: Plot showing the change in fluorescence intensity with DNA
concentration, highlighting the increase in quantum yield when EtBr is bound to
DNA.
The bottom panels of Figure 4.3 show the fluorescence emission spectra of 50 µM
EtBr with increasing concentrations of DNA. All of the spectra were measured using
the same samples as were prepared for the UV-visible absorption spectra. They
illustrate the approximately 25-fold increase in the fluorescence emission intensity
from EtBr following the addition of DNA, which has been shown previously [94].
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The reason for this increase in the quantum yield of the fluorophore is that when it
is intercalated between the base pairs of DNA, there is a reduction in proton transfer
to solvents molecules, which occurs rapidly when the free dye is dissolved in a protic
solvent [84].
Figure 4.4 shows the UV-visible Couette flow LD spectra of 200 µM DNA with
increasing concentrations of EtBr. This result is in agreement with LD spectra
of DNA-EtBr complexes found in the literature [5, 95]. The DNA-only spectrum,
shown in red in the figure, has a strong negative signal at 260 nm, reflecting the
⇡⇤  ⇡ transitions of the DNA bases, which are oriented at 86  from the long axis
of the molecule [82]. With increasing EtBr concentration, the negative signal in
this region increases, due to the contribution of the long axis polarised transition
of the eithidium ion. The sign of this signal in the LD spectra is evidence of the
intercalating mode of binding that the ethidium cation adopts in the complex.
It is also apparent from Figure 4.4, however, that it is very diﬃcult to separate
the signals coming from the DNA absorbance from those coming from EtBr, as
they overlap one another in the UV region of the spectra. As the EtBr changes
the orientation parameter (S in Equation 2.5), the DNA signal can not simply be
subtracted. This lack of selectivity is a common problem with many spectroscopic
techniques. Whilst in nuclear magnetic resonance (NMR) spectroscopy it is possible
to reduce selectivity problems by taking actions such as substituting to a deuterated
solvent, this is not achievable using absorbance methods. Numerical methods
for resolving overlapping bands in absorbance spectra have been proposed by a
number of investigators, which generally involve fitting either Gaussian or Lorentzian
distribution to the band shapes [96–99]. However, these methods contain an error
that can be large, especially if an inappropriate distribution is selected for the band
shape [97]. Simply using a more selective technique would avoid this issue.
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Figure 4.4: Linear dichroism spectra of 200 µM DNA with increasing concentrations
of ethidium bromide. All measurements were recorded using the parameters given in
Table 4.2. Concentrations are as indicated in the figure legend.
As DNA is not fluorescent and ethidium ions are, it is possible to record a spectrum
from the ethidium alone by changing the detection system to detect fluorescence
emissions only, as is done in FDLD. The Couette flow FDLD spectra of DNA-EtBr
complexes are given in Figure 4.5.
An immediately noticeable diﬀerence between Figures 4.4 and 4.5 is that the FDLD
spectra appear much noisier than LD, or indeed the film FDLD spectra shown in
Chapter 3. This is because in the Couette flow setup, the sample is farther away
from the PMT and so the solid angle of the detector is reduced, and therefore fewer
photons are collected than when measuring film FDLD spectra. This has also
been shown to be the case when measuring fluorescence detected circular dichroism
(FDCD) [100]. However, it is still clear from the FDLD spectra in Figure 4.5
that the molecule has adopted an intercalating binding mode by the sign of peaks,
and that FDLD signals have an increased magnitude when compared with the LD
peaks at equal sample concentrations. These factors would be highly beneficial when
investigating the binding mode of a fluorescence molecule whose absorbance signals
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are completely obscured by the DNA or other bound compounds.
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Figure 4.5: Fluorescence detected linear dichroism spectra of 200 µM DNA with
increasing concentrations of ethidium bromide. All measurements were recorded
using the parameters given in Table 4.2.
The propidium ion has a similar structure to that of the ethidium ion, as illustrated
in Figure 4.2, and it also binds to DNA through intercalation. This is demonstrated
in both the LD and FDLD spectra of DNA-PI complexes, which are given in
Figures 4.6 and Figure 4.7, respectively.
A further interesting diﬀerence between the LD and FDLD spectra is the relative
intensity of the long and short wavelength absorbance bands. In LD spectra of both
EtBr and PI it is clear that the short wavelength absorption bands are much more
intense than the long wavelength bands, which is visible even with the presence of
the DNA signal. There is not such a diﬀerence in the relative magnitude of either of
the sets of FDLD spectra. This is because in the short wavelength transition we are
exciting into the S2 of the molecules, and fewer of the electrons decay to the ground
state via a radiative process than in the S0  S1 decay of the long wavelength band,
i.e. the short wavelength band has a lower fluorescence quantum yield than the long
wavelength band.
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Figure 4.6: Linear dichroism spectra of 200 µM DNA with increasing concentrations
of propidium iodide bromide. All measurements were recorded using the parameters
given in Table 4.2.
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Figure 4.7: Fluorescence detected linear dichroism spectra of 200 µM DNA with
increasing concentrations of propidium iodide. All measurements were recorded using
the parameters given in Table 4.2.
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4.3.2 DAPI and hoechst 33258
The UV-visible absorbance and fluorescence emission spectra of 20 µM of DAPI
with increasing concentrations of DNA are given in Figure 4.8.
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Figure 4.8: UV-visible absorbance and fluorescence emission spectra of 20 µM DAPI
and a range of concentrations of salmon sperm DNA. Top left: UV-visible absorbance
spectra. Top right: Plot of the peak values at 341 and 370 nm, showing the
bathochromic shift of the DAPI peak upon binding DNA. Bottom left: Fluorescence
emission spectra, recorded using an excitation wavelength of 342 nm. Bottom right:
Plot showing the change in fluorescence intensity with DNA concentration.
Figure 4.8 shows that in the visible region, the DAPI maximum at 341 nm undergoes
a large red (bathochromic) shift upon the addition of DNA. However, it is the very
large increase in fluorescence emission intensity that is most apparent from the figure.
This increase in sensitivity demonstrates the advantage of detecting fluorescence
emissions for some DNA probes at low concentrations.
DAPI has been shown to be a groove binding dye from its LD spectra, which binds
preferentially to AT rich regions of DNA [101]. The binding mode DAPI adopts
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is illustrated in the LD spectra we have recorded, of 200 µM DNA and increasing
concentrations of DAPI, which given in Figure 4.9.
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Figure 4.9: Linear dichroism spectra of 200 µM DNA with increasing concentrations
of DAPI. All measurements were recorded using the parameters given in Table 4.2.
From Figure 4.9 we can see that at these concentration ratios, the DAPI signal is
barely visible. Though a weak positive band around 370 nm can be seen, which is
evidence of the groove binding mode adopted by DAPI. It is certainly not possible
to observe any additional signals within the absorption band of the DNA itself.
This is in contrast to the FDLD spectra of the same samples, which are given in
Figure 4.10.
With the exception of the red spectrum in Figure 4.10, which is of DNA only, all
of the spectra show a strong positive peak with maximum at 370 nm. This clearly
shows that the DAPI molecule has bound to a groove of the DNA, and is a further
illustration of the increased measurement sensitivity of FDLD. In addition, it is
also possible to observe smaller, negative bands in the FDLD spectra, which were
obscured by the DNA absorption in the LD spectra. The transition moment of the
absorption band in this region has been shown to lie at 26  from the transition at
370 nm [35], and the fact that is gives a negative FDLD signal shows that it is
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angled towards the orientation direction of the DNA in flow.
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Figure 4.10: Fluorescence detected linear dichroism spectra of 200 µM DNA with
increasing concentrations of DAPI. All measurements were recorded using the
parameters given in Table 4.2.
Hoechst 33258 is another groove binding DNA probe and, like DAPI, it binds
preferentially to AT-rich regions of DNA [102]. The UV-visible absorption and
fluorescence emission spectra of Hoechst 33258 with increasing concentrations of
DNA are given in Figure 4.11.
The UV-visible absorption spectra once again show a red shift in the long wavelength
transition upon the addition of DNA, though Hoechst 33258 absorbs more strongly
than DAPI in this region. From the bottom panels of Figure 4.11, it can be seen that
the introduction of our DNA into the sample causes a large increase in fluorescence
intensity. This is in agreement with what is in the literature [103,104].
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Figure 4.11: UV-visible absorbance and fluorescence emission spectra of 20 µM
Hoechst 33258 and a range of concentrations of salmon sperm DNA. Top left:
UV-visible absorbance spectra. Top right: Plot of the peak values at 336 and 370 nm,
demonstrating the bathochromic shift of the Hoechst 33258 peak upon binding DNA.
Bottom left: Fluorescence emission spectra, recorded using an excitation wavelength
of 346 nm. The sharp peak just below 700 nm in the spectra in from scattered
incident light, and not from Hoechst 33258. Bottom right: Plot showing the change
in fluorescence intensity with DNA concentration.
The LD spectra of 200 µM DNA with increasing concentrations of Hoechst 33258 is
given in Figure 4.12. This result is in agreement with previously published spectra
of DNA-Hoechst 33258 complexes [5]. The positive signal in the near-UV region of
the spectra shows that Hoechst 33258 is bound to a groove of the DNA. Relative to
the DNA absorbance band, the signal magnitude from the dye here is slightly larger
when compared with the DAPI-DNA complexes given in Figure 4.9, owing to the
Hoechst 33258’s stronger absorbance in this region. However, it is apparent that we
would not be able to reduce the Hoechst 33258 concentration much further without
losing the signal, and we cannot see any of the bands within the absorbance region
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of the DNA, which we know are there from Figure 4.11.
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Figure 4.12: Linear dichroism spectra of 200 µM DNA with increasing concentrations
of Hoechst 33258. All measurements were recorded using the parameters given in
Table 4.2.
As a second illustration of results obtained from a DNA groove binding fluorescent
probe, the FDLD spectra of 200 µM DNA with a range of concentrations of Hoechst
33258 is given in Figure 4.13. Like DAPI, the FDLD spectra of Hoechst 33258 show
a large positive peak from the long-axis transition, centred around 370 nm, which
is visible at dye concentrations in the 100s of nano-moles.
In Figure 4.13, however, the spectra have a slightly poorer signal to noise ratio
compared with previous examples, possibly due to the lower dye concentrations used,
which makes it diﬃcult to pick out the vibrational structure within the absorbance
band. Nevertheless, two dips in the spectra at 405.5 nm and 397 nm are visible in
the spectra of the highest three concentrations of Hoechst 33258. Assuming these
are from a 528 cm 1 progression, dashed grey lines have been overlaid to pick out
other peaks with the same energy gap, that are barely visible above the noise.
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Figure 4.13: Fluorescence detected linear dichroism spectra of 200 µM DNA with
increasing concentrations of Hoechst 33258. The dashed grey lines at: 405.5 nm, 397
nm, 388.85 nm, 381 nm, 373.5 nm, and 366.3 nm highlight possible peaks from a
528 cm 1 vibronic progression. All measurements were recorded using the parameters
given in Table 4.2.
Figure 4.13 also shows that there is a relatively large negative peak around 260 nm
in the FDLD spectra of Hoechst 33258, which is obscured by the DNA’s absorbance
signal were we measuring LD spectra. This peak is visible in the Hoechst 33258-only
absorbance spectrum in the top left panel of Figure 4.11. This transition has been
shown previously to be oriented at 23  from the long axis of the molecule, and the
fact that it gives a negative FDLD signal shows that it is oriented towards the long
axis of the DNA when bound to the molecule, enabling us to detect which way the
Hoechst inserts in the groove [105].
Latt and Wohlleb made observations of the 260 nm transition of Hoechst 33258
when the molecule was bound to DNA and when it was on its own [106]. They used
UV-visible absorbance spectroscopy, and by subtracting the spectrum of the Hoechst
33258-DNA complex from that of Hoechst 33258 on its own, found that when bound
to DNA this absorbance maximum is blue shifted to 245 nm. We do not observe
this shift in our FDLD results in Figure 4.13, which may emphasise the benefit of
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using a fluorescence detection system to selectively observe one fluorescent species
in a sample, instead of having to obtain selective data through a more convoluted
method.
4.3.3 Potential use to detect pathogenic bacteria
As is discussed in Chapter 5, finding new ways to detect pathogenic bacteria, either
in the environment or in a living organism, is vital to reducing the amount of
antibiotics we use and arresting the development of antimicrobial resistance. In
2012, Pacheco-Gómez et al. published their work towards developing an assay that
detects the diﬀerence in the LD signal of an M13 bacteriophage-antibody complex in
the presence or absence of pathogenic bacteria [107]. This assay was patented by Prof
Timothy Daﬀorn and Dr Matthew Hicks prior to this publication [108]. Figure 4.14
illustrates the principle behind the detection system designed by Daﬀorn and Hicks.
Figure 4.14: Illustration of the LD assay to detect pathogens in solution. A: In the
absence of any pathogen target, the M13 bacteriophage aligns very well, and hence
gives a strong LD signal. B: Where a target bacterium is present (textured red),
the M13 complexes bind to it and lose much of their freedom to align in the flow
direction. Therefore, presence of a pathogen will be seen as a loss in LD signal.
Figure 4.14 shows the outer pVIII proteins (green) and the end pIII proteins (yellow)
endogenous to the M13 bacteriophage. Attached to the pIII proteins is an antibody
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and secondary antibody complex (both grouped in solid red), which are selected to
be specific to a pathogenic target. One may wish to use fluorophores attached to the
pVIII proteins (orange) although these are not strictly necessary for the experiment,
since aligned M13 has its own LD signal. Clearly, the assay is heavily reliant on
the ability to detect an oriented M13 bacteriophage LD signal, and its sensitivity
to relatively small concentrations of pathogens in solution is highly dependent on
the ability of the detection system to measure small losses in M13 alignment. An
example LD spectrum of 100 µg/mL of M13 bacteriophage, oriented in Couette
flow, is given in Figure 4.15.
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Figure 4.15: LD spectrum of a 100 µg/mL sample of M13 bacteriophage, oriented in
micro-volume Couette flow. The dashed grey line shows where LD is equal to zero.
This spectrum was recorded using the instrument parameters given in Table 4.2.
The largest peak in the LD spectrum of M13 bacteriophage, given in Figure 4.15,
is in the far-UV region and comes from the ⇡⇤  ⇡ and ⇡⇤  n transitions of the
peptide backbone [15]. In the near-UV region of the spectrum, the broad, shallow
peak is from the absorbance of the aromatic amino acids, tryptophan and tyrosine.
Like many biological samples, M13 bacteriophage is produced and purified in buﬀers
that contain salts [107], which absorb light in the far-UV and can distort signals
from the chromophore of interest. The sample used to record the LD spectrum in
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Figure 4.15 was diluted down to 100 µg/mL from a 18 mg/mL stock solution with
water, and so the eﬀect of the salts in the buﬀer are negligible. However, when using
high concentration buﬀers it would generally be preferable to use the signals in the
near-UV to track changes in alignment.
As has been demonstrated in the spectra of the DNA binding fluorescent probes
above, FDLD has the potential to be used to detect a fluorophore at much
lower concentrations than can be achieved when using absorbance methods. M13
bacteriophage contains one tryptophan and two tyrosines per PVIII protein, and
each bacteriophage contains approximately 2,700 copies of this protein along its
shaft [109]. As both of these amino acids are fluorescent we predicted we should be
able to detect M13 bacteriophage alignment using FDLD. This is indeed the case,
as illustrated in the FDLD spectra given in Figure 4.16.
Figure 4.16 shows the FDLD spectra of a range of concentrations of M13
bacteriophage. It is clear from the figure that it is possible to detect down to a
concentration of 50 µg/mL, with a very good signal to noise ratio. This is despite
using the same experimental setup as was used for the FDLD measurements of
the DNA-dye complexes. The reduced noise in this example may be due to the
choice of long-pass filter collecting more of the emitted photons. Comparing the
100 µg/mL sample with the LD spectrum, given in Figure 4.15, we see that 17.5
times the signal magnitude in the aromatic region is obtained when using FDLD
(LD280 = 0.00184646, FDLD280 = 0.0323457). This shows that FDLD could add
a great deal to the eﬃciency of the detection of pathogenic bacteria assay described
above.
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Figure 4.16: FDLD spectra of a range of concentrations of M13 bacteriophage,
oriented in micro-volume Couette flow. All spectra were recorded using the
parameters given in Table 4.2, with a variable HT voltage. A Semrock 300 nm
long-pass edge filter was used to block transmitted incident light in each measurement.
It is also interesting to see the high resolution of the signature 1La and 1Lb bands
of the tryptophan’s indole chromophore around the 280 nm region of the spectra
in Figure 4.16 [110]. Similar to the FDLD spectra of small molecules oriented on
stretched PEOX , given in Chapter 3, this is a further example of the increased ability
of FDLD to resolve the individual contributions to an absorption band.
We know that each of the M13 bacteriophage particles possesses two fluorophores,
tryptophan and tyrosine, however, we do not know the degree to which each was
contributing to the FDLD spectra. To try and gain insight into this, we measured
the intensity of fluorescence emissions over a range of excitation and emission
wavelengths. The result is illustrated in Figure 4.17.
The fluorescence properties of the two fluorescent amino acids are well known —
tryptophan possesses excitation and emission maxima at 280 nm and 350 nm,
respectively [111], and tyrosine’s excitation and emission maxima are at 275 nm
and 303 nm [112]. Although tryptophan’s emission wavelength is highly dependent
on its surroundings, and in a hydrophobic environment can be 330 nm or lower [113].
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From Figure 4.17 we can see that at both the excitation maxima in the phage FDLD
spectrum, the emission maxima are around 330 nm, which suggests the signal is
predominately coming from the tryptophan residues, in hydrophobic environments.
Figure 4.17: 3D plot showing the change in fluorescence emission intensity
with excitation wavelength. This measurement was made on a Jasco FP-6500
spectrofluorimeter.
A further confirmation of the fact that the signals present in the M13 bacteriophage
FDLD spectra originate from tryptophan, is that tyrosine fluorescence is reduced
significantly by the presence of tryptophan and the peptide bonds in proteins, and
so tyrosine will most likely have a lower quantum yield in the environment of
our measurement than tryptophan [114]. Tyrosine fluorescence is also significantly
eﬀected by pH [115]. These factors are important in our discussion of the bacterial
actin homologue MreB (Chapter 5), which contains five tyrosine and zero tryptophan
residues.
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4.4 Conclusions
In this section we have shown the utility of LD for determining the binding mode
that small molecules adopt when bound to DNA. On observing any LD signal from
the molecules we know that they are bound, as they are too small to orient in Couette
flow on their own, and from the sign of the signal we can determine whether they
are intercalated between the base pairs of the DNA (giving a negative LD signal) or
bound to the major or minor groove of the molecule (giving a positive LD signal).
We have also shown that in cases where the bound molecule is a fluorophore, it is
possible to record a micro-volume Couette flow FDLD spectrum of the sample. Due
to the distance of the oriented sample from the detector in the current Couette flow
cell, these spectra have a decreased signal to noise ratio than the LD spectra of the
same samples. However, they give signals of much higher magnitude in the examples
given above, due to the inherent increased sensitivity of fluorescence detection, and
a new design of Couette flow cell where the sample chamber is closer to the detector
would increase the signal to noise ratio.
A further advantage of fluorescence detection is in the selectivity of the measurement
when dealing with samples of complex mixtures, which is also clearly demonstrated
in the FDLD spectra given above. In the examples of the intercalating dyes
ethidium bromide and propidium iodide, it is possible to see the the sign of the bands
overlapping with the DNA’s absorbance from their LD spectra, however, FDLD
reveals the full dye spectral shape, absorption maxima and the relative magnitude
of peaks throughout this region.
The FDLD spectra of the minor-groove binding dyes DAPI and Hoechst 33258
bound to DNA show a large increase in signal magnitude for their near-UV
transitions, when compared to their LD spectra. Additionally, in both cases the
transitions in the middle-UV region can also be observed in their FDLD spectra —
transitions that are completely obscured by the DNA’s absorbance signal in the LD
measurements. The negative sign of these peaks provides additional insight into the
orientation of the bound dye.
Finally, we looked at the LD and FDLD spectra of M13 bacteriophage solutions,
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oriented by Couette flow. The FDLD spectra showed a large enhancement of signal
in the aromatic region of the spectra, which we argue would add significantly to
the ability of a previously devised LD assay used to detect pathogenic bacteria
in solution [107]. The FDLD spectra also show highly resolved bands of the
tryptophan residues, which further demonstates the additional information that can
be obtained when using the technique.
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Expression and characterisation of the E.
coli actin homologue MreB
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5.1 Introduction
It is well known that antimicrobial resistance (AMR) is a serious threat to
global public health. There have been numerous reports from the World Health
Organisation that have emphasised the current — and not just future — danger
of AMR [116]. The first World Antibiotic Awareness Week begun on the 16th
November 2015, and the UK government has recently published its own five year
strategy to tackle the problem [117]. The problem of AMR increased with the use of
antimicrobial drugs [118]. These drugs, whilst creating an environment too hostile
for most bacteria to survive, promotes the survival of pathogenic bacteria which
have a mutation that makes them drug resistant. In the absence of any antibiotic
it may be that mutant populations are less fit for survival, and so one strategy to
help reduce AMR is to use fewer antibiotics [1].
Reducing the amount of antibiotics we use is critical to combatting AMR, and there
is a global drive to increase awareness of the risks associated with the overuse of
antibiotics. One example here in the UK is the Treat Yourself Better Campaign
(www.treatyourselfbetter.co.uk). The need to use fewer antibiotics, however, will
only serve as an afterthought to a dairy farmer whose livelihood may be jeopardised
through mastitis in his herd, or a mother whose child may have a bacterial infection.
In cases such as these, the real work must be done in the development of better
diagnostics, so as to eliminate any doubt about whether or not the use of antibiotics
is required. One way in which fluorescence detected linear dichroism may help
achieve this goal is discussed in Chapter 4.3.3.
A second solution to the problem of AMR is to discover new drug targets and develop
new antibiotics that function in a novel way [1]. With a large body a drugs that all
kill pathogenic bacteria by a unique mechanism, it would be possible to cycle their
use so that bacteria are less likely to evolve to become resistant to any one. The
focus of this chapter is the expression, purification, and structural analysis of one
such potential target: the bacterial actin homologue MreB (MreB). What follows is
an introduction to this protein, our methods for obtaining it, and the results and
conclusions of this work.
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5.1.1 MreB
Bacterial cell morphology is determined by the peptidoglycan cell wall: a meshwork
of glycan strands, which are cross-linked by peptide bridges [119]. This network
of covalently bonded molecules makes the cell wall extremely strong, and resistant
to the interior turgor pressure of the cell [120]. The biosynthesis of peptidoglycan
begins in the cytoplasm, with the generation of soluble cell wall precursors, as is
illustrated in Figure 5.1 [121].
Figure 5.1: Uridine diphosphate (UDP)-N-acetylglucosamine is converted into
UDP-N-acetylmuramic acid, in reactions catalysed by the enzymes MurA and MurB.
In a sequence of reactions catalysed by the other Mur enzymes: MurC, MurD,
MurE and MurF; this goes on to form UDP-N-acetylmuramic acid pentapeptide.
On the inner face of the cytoplasmic membrane, the membrane protein MraY then
catalyses the formation of Lipid I from UDP-N-acetylmuramic acid pentapeptide.
Subsequently, a UDP-N-acetylglucosamine molecule is ligated to Lipid I by MurG,
to form Lipid II. Lipid II is then transported into the periplasm, where a group of
enzymes called penicillin binding proteins insert it into the pre-existing cell wall.
This figure is reproduced from reference [121].
Bacterial cell morphogenesis is directly dependent on the proteins involved in
peptidoglycan synthesis, such as the penicillin binding proteins (PBPs). PBPs are
the target for  -lactam antibiotics, and fall into two classes: those of high molecular
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weight, which can perform both the functions of assembling glycan chains and
forming peptide links; and those of lower molecular weight, that solely function to
form peptide bridges [122,123]. However, it is also indirectly dependent on cell-shape
determining proteins, such as the bacterial-actin homologue MreB, which is found
in most rod and spiral shaped bacteria [124]. This has been demonstrated by MreB
depletions in: Caulobacter crescentus, where the phenotype of the mutation was the
formation of lemon-shaped cells; Bacillus subtillus, where MreB-depleted mutants
showed defects in chromosome segregation, followed by cell shape defects; and E.
coli, where disruptions to mreB were found to promote the growth of rounded,
inflated cells [122,125,126].
Fluorescence microscopy images of C. crescentus have shown that MreB has a
very similar localisation pattern to the peptidoglycan synthesising enzyme MurG,
in addition to PBP2 [119, 127]. These experiments suggest that MreB may act
to spatially organise peptidoglycan synthesis. In their 2010 paper, White et al.
looked to confirm this by testing whether any other C. crescentus peptidoglycan
synthesising enzymes localise in a similar fashion to MreB [121]. To do this they
tagged the C-teminal of the cytosolic proteins MurB, MurC, MurD, MurE and MurF,
in addition to the integral membrane protein MraY, with the fluorescent protein
mCherry. Using fluorescence microscopy they were able to confirm that all of these
proteins did indeed exhibit similar localisation patterns to MreB.
White et al. used their result to construct a cellular model of MreB and its role
in peptidoglycan synthesis, which is shown in Figure 5.2. They did not conduct
experiments themselves on the cytosolic structure of MreB polymers, but used
information from previously published reports, such as experiments performed by
Shih et al. on E. coli MreB [128]. As will be discussed below, the cytoplasmic
structure of MreB is currently a matter of debate in the literature.
It was thought that MreB dynamics were driven by its own polymerisation, however,
the process was poorly understood. In their 2011 paper, van Teeﬀelen et al.
attempted to investigate this by inhibiting peptidoglycan synthesis in E. coli
[129]. They first tested mutants that cannot synthesise diaminopimelic acid, an
intermediate in the biosynthetic pathway leading to the pentapeptide component
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Figure 5.2: Model of interactions between the bacterial morphogenetic proteins and
the cell wall synthesising enzymes. MreB is shown to act to spatially organise the
enzymes involved in synthesising peptidoglycan precursors in the cytoplasm, and
through the integral membrane protein MreD, it also acts to position MreC, which
positions peptidoglycan assembly in the periplasm. This figure is reproduced from
reference [121]
lysine [120]; they then used antibiotics such as fosfomycin, which targets the
peptidoglycan synthesising enzyme MurA. Their epifluorescence microscopy images
showed both of these treatments had the eﬀect of reducing the intracellular motility
of the short, membrane-associated MreB filaments — these are often referred to as
‘patches’ in the literature, as the filaments are too small to be properly resolved
by light microscopy — and furthermore this occurred well before any eﬀect on
cell morphology was observed. This indicates that the cellular motion of MreB
is dependent on the availability of peptidoglycan subunits [129].
Garner et al. went on to test this further by depleting three components of the
B. subtilis peptidoglycan elongation machinery: RodA, RodZ and Pbp2A [130].
Over time these depletions resulted in the gradual cessation of MreB patch motility.
They then introduced antibiotics that target peptidoglycan synthesis, which also
halted MreB movement. Most notably, the minimum inhibitory concentrations that
stopped MreB motion mirrored those that stopped cell growth. They therefore
79
5.1. INTRODUCTION Chapter 5
concluded that MreB motion was driven by peptidoglycan synthesis.
Garner et al. also used single particle tracking to investigate the existence of a long
range MreB cytoskeleton. It was found that there was no correlation in the motion
of individual MreB complexes. Distinct patches were observed to pause or reverse
direction, in a manner that was completely independent of its neighbour. These
findings are inconsistent with the idea of a long, filamentous MreB cytoskeleton.
Domínguez-Escobar et al. used total internal reflection fluorescence (TIRF)
microscopy to image GFP-tagged isoforms of MreB in B. subtilis [131]. They
again showed that MreB complexes rotate perpendicular to the long axis of the
cell in ‘patches’ during exponential growth. They suggested that the previously
shown helical structure may have been a result of the increased depth of field of
epifluorescence microscopy. The experiments were repeated using the Gram negative
bacteria E. coli and C. crescentus, and these yielded the same results.
Domínguez-Escobar et al. then looked at the same question addressed by van
Teeﬀelen et al.: What drives MreB patch motion? Fluorescence recovery after
photobleaching (FRAP) experiments suggested that treadmilling was unlikely to
be the dominant force, as the patches moved position with little change in their
molecular composition. An example of one of their experiments is given in Figure 5.3.
Figure 5.3: An inverse FRAP experiment, showing the location of green fluorescent
protein (GFP) labelled Mbl (an isoform of MreB in B. subtillus) on the cell wall.
The region outlined in the first frame was bleached, leaving a single GFP-Mbl patch.
The kymograph on the far right shows that the patch has moved, with no loss of
fluorescence. This figure is reproduced from reference [131]
Further work on the cellular structure of MreB was published in 2012 by Swulius
et al. [132]. They used cryo-electron microscopy to visualise E. coli cells that
over-expressed MreB with an N-terminal yellow fluorescent protein (YFP) tag,
a strain that has commonly been used to show the extended cytoskeletal helix
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formed by MreB. They confirmed previous results, however, when they repeated
the experiment with other strains — such as FB76, where the chromosomal MreB
gene was replaced with MreB-RFPSW , and the resulting tag is positioned in an
internal loop of the protein — they could not find any extended helical structures.
They thus concluded that the proposed helical MreB cytoskeleton in E. coli is an
artefact of using an N-terminal fluorescent tag [132].
Reimold et al., using two super-resolution fluorescence microscopy techniques
conclude that MreB forms “a discontinuous structure that is highly dynamic,
including filaments as long as 3.4 µm” [133]. This is a compromise between the
two extremes: the long range cytoskeleton similar to that formed by its eucharyotic
counterpart and the short filaments that are too small to be resolved by light
microscopy. So it would seem that much more work is required to understand
the cytosolic structure of MreB, and its implications for the longitudinal growth of
bacteria. Though what is clear, is that MreB is a key actor in the formation of the
bacterial cell wall, and therefore, a good target for new antimicrobial compounds.
In the following sections the methods used to clone, express and purify MreB are
described in detail. The structure of the MreB protein we obtained was then
analysed using circular dichroism (CD) and fluorescence.
5.2 Materials and Methods
5.2.1 Molecular cloning
Molecular cloning techniques are used to obtain recombinant plasmid DNA, which
is the template for expressing a desired protein when induced in a suitable host
cell. A basic outline of this process may be given in four fundamental steps: firstly,
one must obtain a fragment of DNA that contains the gene of interest, flanked
by the recognition sequences of two restriction endonucleases; then, an appropriate
expression vector must be selected that possesses these same recognition sequences;
following this, both the gene and the plasmid are treated with the restriction
endonucleases, so that the products possess short, complementary ‘sticky ends’;
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and finally the two are covalently bound together with the use of a DNA ligase.
5.2.1.1 PCR amplification of MreB gene (mreB)
Nurse et al. have shown that E. coli MreB is capable of forming filamentous bundles
in vitro, however, a precondition for this is that the first 20 residues of the protein
must be removed [134]. This is because an N-terminal amphipathic helix that binds
the protein to the E. coli inner membrane causes MreB to aggregate in vitro. We
therefore started the sequence of the upstream primer from the ATG beginning 61
bases from the start of the E. coli MreB gene. The oligonucleotide primers used
in the polymerase chain reaction (PCR) are given in Table 5.1. The recognition
sequences of NcoI and XhoI are underlined in the upstream and downstream primers
respectively. The E. coli MreB primary sequence from the twenty-first residue begins
methionine–leucine; however, due to the NcoI recognition sequence encoding two
guanines following the start codon, it was necessary to mutate the second residue
from a leucine to a valine.
Table 5.1: Primers used to amplify the mreB gene using restriction enzymes
Primer Sequence
Upsteam
5’ - TTTGCGCCATGGTGAAAAAATTTCGTGGC
ATGTTTTCCAATGACTTG
Downstream
5’ -TTTGCGCTCGAGCTCTTCGCTGAACAGGTC
GATC
The complete reaction mixture used for the PCR is given in Table 5.2. The DNA
polymerase is added last, immediately prior to initiating the reaction, so to avoid
the degradation of the primers due to the polymerases 3’ to 5’ exonuclease activity.
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Table 5.2: Reaction Mixture (200 µL)
Reagent Concentration Volume (µL)
Phusion Reaction
Buﬀer
5 ⇥ 40
dNTPs 10 mM 4
Forward Primer 10 mM 10
Reverse Primer 10 mM 10
E. coli Genomic DNA 45.9 ng/µL 2.26
Nuclease-free H2O - 141.74
Phusion HF DNA
polymerase
2 U/µL 2
The mixture was divided up between 8 PCR tubes (20 µL in each) and placed in
the DNA Engine Tetrad 2 Peltier Thermal Cycler (BioRad). The reaction was set
to proceed as described in Table 5.3.
Table 5.3: Conditions used for the PCR amplification of E. coli MreB. The initial
denaturation step breaks the hydrogen bonds between the complementary strands
on DNA. The temperature is then lowered, allowing the oligonucleotide primers to
anneal to the sites they complement on the genomic DNA. Finally, the temperature
is raised to 72 C to optimise the 5’ to 3’ polymerase activity of the enzyme. The
process repeated a further 34 times to increase the amplicon concentration.
Step Temperature ( C) Time (s)
Initial Denaturation 98 30
98 10
35 cycles 66 30
72 45
Final Extension 72 600
Hold 4 1
Following the procedure outlined in Appendix B.1, the DNA fragments in the PCR
products were separated according to their size using gel electrophoresis.
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Figure 5.4: Gel electrophoresis run using the PCR products. The length of our E.
coli MreB is 1044 base pairs. All of our samples show a intense dark band just above
the 1000 base pair marker, which most likely signals our desired product.
From the result shown in Figure 5.4 it is clear that each of the samples contains a
DNA fragment of approximately the size of the MreB gene. Therefore we could safely
pool the samples together and remove any impurities, such as unreacted primers,
using a PCR purification kit.
5.2.1.2 Expression vector
Our choice of expression vector was one of the pET System: pET28b. Genes cloned
in to these vectors are under the control of bacteriophage T7 transcription [135].
T7 RNA polymerase is extremely selective, and when fully induced in bacterial
cells, which have been engineered to express the bacteriophage polymerase, a large
portion of resources are focussed on the expression of the target gene. The T7lac
promoter included in pET28b uses the additional control of the lac operon. This
measure means that its expression is negatively regulated by the binding of the lac
repressor (LacI) to the lac operator, just upstream from where the mreB gene is
to be inserted. The subsequent addition of isopropyl  -D-1-thiogalactopyranoside
(IPTG) induces transcription by forming a complex with LacI, inhibiting its binding
to the lac operator. This function could also be performed by lactose, however,
IPTG is preferred as it is not broken down by  -galactosidase, and so its cellular
concentration remains high [136].
The lac operon is part of a system that regulates the diauxic growth pattern of
bacteria, in which they utilise metabolites sequentially, rather than in parallel [137].
Glucose is the preferred energy source, however, when its concentration is depleted
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in the cell, the aﬃnity of LacI for the operator is reduced, and lactose becomes the
primary energy source. There is another upstream regulatory element in the lac
operon, which binds a catabolite activator protein–cyclic adenosine monophosphate
(CAP–cAMP) complex, and promotes transcription [138]. In the presence of glucose,
cellular cAMP levels are low, thus transcription is once again inhibited by its
presence. Therefore, including additional glucose to the medium in which the cells
are being grown will maximally inhibit basal protein expression prior to the addition
of IPTG, minimising its interference with the normal functioning of the cell [139].
The pET28b vector also contains a kanamycin resistance cassette, so that the
bacterial cells it has been successfully transformed into may be selected for on an
LB agar plate containing 50 µg/mL kanamycin. The full vector map showing all
these sites, in addition to the multiple cloning site, is given in Figure 5.5.
Figure 5.5: Vector map of pET-28b
5.2.1.3 Restriction digests
Restriction endonucleases are enzymes produced by bacteria to cleave DNA at
specific sites, protecting the organisms from infection by bacteriophages. Once
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isolated these enzymes can be used in the laboratory to cleave plasmid DNA, so
that specific genes encoding a target protein may be inserted. To this end, the
downstream restriction site we used was that of the enzyme XhoI, which after
digestion leaves a 5’ sticky end with sequence TCGA. Upstream from where the gene
is to be inserted is the recognition sequence for the enzyme NcoI. This restriction
enzyme leaves a 5’ sticky end with sequence CATG following digestion, which like
that left by XhoI, is an inverted repeat. Under certain conditions NcoI exhibits ‘Star
Activity’, where the enzyme’s specificity is relaxed, and cuts are made at a number
of regions of DNA that are similar to the recognition sequence. For this reason we
opted to use the high fidelity NcoI-HF enzyme (New England Biolabs) which has
been engineered to reduce such eﬀects.
The composition of the reaction mixture used to digest the PCR product, creating
the 5’ sticky ends on the amplicon, is given in Table 5.4. Bovine serum albumin
(BSA) was added to the reaction to stabilise the enzymes and reduce enzyme loss
due to attachment to the interior of the Eppendorf tube or pipette tip; this is
particularly important when using XhoI.
Table 5.4: Digestion of PCR Product. Some concentrations are given in terms of
units of activity (U).
Reagent Concentration Volume (µL)
Purified PCR Product - 39.5
NEBuﬀer 4 10⇥ 5
BSA 10 mg/mL 0.5
XhoI 20 U/µL 2.5
NcoI-HF 20 U/µL 2.5
The digestion of the expression vector proceeded with mixture detailed in Table 5.5.
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Table 5.5: Digestion of pET-28b Vector DNA
Reagent Concentration Volume (µL)
Plasmid DNA 235.8 ng/µL 31.8 (7.5 µg)
NEBuﬀer 4 10⇥ 5
BSA 10 mg/mL 0.5
H2O - 7.7
XhoI 20 U/µL 2.5
NcoI-HF 20 U/µL 2.5
The two restriction reactions are left at 37 C overnight. When the digestions are
complete, the digested PCR product is placed on ice and the digested plasmid DNA
is dephosphorylated with shrimp alkaline phosphatase (SAP). The 5’ ends of the
digested vector possess phosphate groups that are required for ligation. Removing
these groups with SAP reduces the probability that self-ligation will occur, therefore
reducing the number of background non-recombinants. The dephosphorylation
reaction was performed by adding the mix given in Table 5.6 to the reaction and
incubating at 37 C for a further 30 minutes.
Table 5.6: Dephosphorylation of Digested pET-28b Vector DNA
Reagent Concentration Volume (µL)
Dephosphorylation
Buﬀer
10⇥ 5
Shrimp Alkaline
Phosphatase
1 Unit/µL 5
H2O - 40
A PCR purification kit can then be used to remove impurities, such as the restriction
enzymes, from both digestions; this leaves only the DNA in a low salt buﬀer. In the
case of the digested expression vector, however, the small fragment cut out between
the two restrictions sites — XhoI (158)! NcoI (295) — is greater than 100 kb, and
87
5.2. MATERIALS AND METHODS Chapter 5
so will also stick to the silica membrane assembly in the spin column. Therefore one
may wish to separate the fragments using gel electrophoresis, and extract the larger
of two from the gel. The number of background non-recombinants will consequently
be lowered further. However, this benefit comes at the expense of linearised plasmid
DNA concentration. We decided that this would be too costly for our purposes, and
so proceeded having used only the PCR purification.
5.2.1.4 Ligation
DNA ligases fuse strands of DNA together by catalysing the formation of
phosphodiester bonds between the 3’-hydroxyl and the 5’-phosphate ends of two
nucleotides. For this to occur it is essential that the appropriate ends of the DNA
fragments align, and are engaged long enough for the DNA ligase to act to bind
them. To aid this, the ligation mixtures — which are displayed in Table 5.7 — are
left to incubate overnight at 16 C instead of 37 C. The lower temperature slows
down the molecules in the sample, and stabilises the hydrogen bonds between the
complementary overhangs on the treated plasmid and gene insert.
Table 5.7: Composition of ligation mixtures
Reagent 1:1 1:2 1:3
Vector
Only
Control
Insert
Only
Control
Treated Plasmid (45.2
ng/µL)
2.21 µL 2.21 µL 2.21 µL 2.21 µL -
Treated PCR Product
(31.9 ng/µL)
3.13 µL 6.27 µL 9.40 µL - 3.13 µL
10⇥ T4 DNA Ligase
Buﬀer
2 µL 2 µL 2 µL 2 µL 2 µL
Sterile Water 11.66 µL 8.52 µL 5.39 µL 14.79 µL 13.87 µL
NEB T4 DNA Ligase 1 µL 1 µL 1 µL 1 µL 1 µL
Following the ligation reaction, 5 µL was taken from each reaction mixture and
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used to transform E. coli Top10 competent cells. Transformants are selected for by
growing the small cultures on LB agar plates containing 50 µg/mL kanamycin. A
selection of colonies were picked from each of the plates (with the exception of the
controls) and grown overnight at 37 C, as outlined in Appendix B.4. The plasmid
was subsequently extracted from each culture by mini-preparation and sequenced
using the T7 promotor and terminator primers. A number of these sequences
matched the MreB sequence, which is given in Appendix A.
5.2.2 Expression and purification
After obtaining the plasmid containing the gene of the protein we wish to express,
we must over-express the gene in a suitable cell line, and then lyse the cells and
separate our protein from the rest of mix. The following sections detail how this
was achieved for the E. coli MreB used in this work.
5.2.2.1 Expression trial
The cell line we selected as an expression host was the E. coli strain C41(DE3).
The C41(DE3) and C43(DE3) strains are derived from the BL21(DE3) strain, and
are commonly used to overcome the eﬀects of over-expressing toxic proteins. It has
been shown empirically that the C43(DE3) strain is generally preferred in these
cases [140], however, we found that this cell line over-expressed MreB to such a
degree that it formed insoluble aggregates. Our recombinant pET28b-mreB DNA,
in addition to ‘empty’ pET28b DNA, was transformed into the expression host cells,
and successful transformants were again selected on LB agar antibiotic plates. A
single colony was picked from each of the plates, and used to grow up overnight
cultures, with the addition of glucose (see Appendix B.4). Two 100 µL aliquots
of each of the overnight cultures were used to inoculate the solutions in 4 Falcon
tubes, which each contained the following: 10 mL of LB media, 10 µL of 50 mg/mL
kanamycin, and 40 µL of 50% w/v sterile glucose solution. All of the samples were
then placed in a 37 C incubator, and shaken at 180 rpm until an optical density at
600 nm (OD600) of ⇠0.6 was reached. At this point IPTG was added to each culture
to a final concentration of 1 mM.
89
5.2. MATERIALS AND METHODS Chapter 5
One culture containing the recombinant DNA and one culture containing the empty
vector were then placed in a 16 C incubator, and shaken at 180 rpm for 24 hours.
The remaining two cultures were placed back in the 37 C incubator for four hours
after the addition of IPTG.
When the cultures had reached the end of their respective incubation periods, they
were centrifuged at 10,000 ⇥g for 15 minutes to pellet the cells. The pellets were
resuspended in 1 mL of Buﬀer A (see Appendix B.5), and the cells were sonicated.
The sample concentrations were measured using the BioRad assay, and the volume of
each corresponding to 20 µg of protein was pipetted into labelled 500 µL Eppendorf
tubes.
What remained in each culture was then centrifuged for a further 20 minutes at
10,000 ⇥g, to pellet the cell debris and other impurities. The BioRad assay was
again used to measure the concentrations of soluble protein left in the supernatant,
and the volume corresponding to 20 µg was pipetted into a further four labeled
500 µL Eppendorf tubes. The contents of the eight Eppendorfs were used to run
a sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) gel, the
result of which is given in Figure 5.6.
Figure 5.6: SDS-PAGE gels of small scale expression. The lanes from left to right
are as follows: whole cell fraction of C41(DE3) cells transformed with pET28b; whole
cell fraction of C41(DE3) cells transformed with pET28b-mreB; soluble fraction
of C41(DE3) cells transformed with pET28b; soluble fraction of C41(DE3) cells
transformed with pET28b-mreB. The red arrow indicates the approximate distance
a protein of the size of MreB (⇠37 kDa) would travel on the gel, which is also the
location of the dark bands on each of the cultures where our recombinant DNA was
used.
The expression trial indicated that the best conditions to express MreB in E. coli
C41(DE3) cells is to grow at 37 C for 4 hours after induction with IPTG. Therefore,
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it was with these conditions that we moved on to larger scale expression.
5.2.2.2 Large scale expression and purification
One litre cultures were grown using the procedure described above. Figure 5.7
shows an SDS-PAGE gel, which was run using the product of one of these cultures.
The whole cell fractions, which are marked WC, show very intense bands at
approximately 37 kDa. It is clear from these lanes that there is a large concentration
of MreB being expressed in the cell. The two lanes marked ⇥10K and ⇥50K are
the protein that remains in the supernatant, after the culture has been centrifuged
for 15 minutes at 10,000 ⇥g and 30 minutes at 50,000 ⇥g, respectively. Although
these show a good deal of soluble protein remains, the quantity putative MreB has
depleted when compared with the whole cell fractions, most likely due to a small
portion forming inclusion bodies. The next three lanes, marked HTin, FT and HT,
are related to the HisTrap column used to purify the MreB, and denote the sample
used to load the HisTrap column, the flow-through from the column, and the sample
eluted from the column, respectively. The HisTrap purification is discussed further
below.
Figure 5.7: SDS-PAGE gel of large scale expression of E. coli MreB in strain
C41(DE3). The lanes from left to right are as follows: the protein markers (at 97
kDa, 66 kDa, 45 kDa, 30 kDa, 20 kDa and 14 kDa) the whole cell fraction following
sonication of the culture; the soluble protein left after the cultures were centrifuged
for 15 minutes at 10,000 ⇥g; the residual protein after the culture was centrifuged
for a further 30 minutes at 50,000 ⇥g; the sample use to load the HisTrap column;
the flow-through from the HisTrap column; and finally the sample eluted from the
HisTrap column.
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As mentioned above, the MreB protein was expressed with a His-tag, so it can
be purified using a HisTrap HP (5 mL, GE Life Sciences) column, which came
pre-packed with nickel sepharose. After flushing through 100 mL of Buﬀer A, the
protein was loaded onto the column on the bench, using a bench top peristaltic
pump (Pharmacia LKB Pump P-1). The loaded column was then fitted to an ÄKTA
Pure chromatography system, and eluted from the column in 1.5 mL fractions with
an increasing gradient of Buﬀer B (Appendix B.5) flowing through the column.
Figure 5.8 shows the result of the HisTrap elution.
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Figure 5.8: Resulting chromatogram from the HisTrap elution of the MreB following
its over-expression in the C41(DE3) cell line. The red line shows the absorbance
of the eluted solution, and the grey box highlights the region where MreB is present.
The blue line illustrates the percentage concentration of the high imidazole containing
Buﬀer B. The figure shows that MreB comes elutes at a Buﬀer B concentration of
⇠70-80%.
The fractions from the region covered by the grey box in Figure 5.8 were collected
and used to run an SDS-PAGE gel to confirm that MreB was present and check its
purity, which is shown in Figure 5.7. It was found that MreB was present, but there
were a number of other lighter bands on the gel, indicating that it was not absolutely
pure. It was thought that these may be proteins that have a natural aﬃnity to the
HisTrap column, and so we next used TEV protease to cleave the His-tag from the
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protein, and again run the protein through the HisTrap column using a bench top
peristaltic pump. The TEV protease we used also contained a His-tag, and so it,
in addition to the protein impurities, should stick to the column, whilst the flow
through should contain only the pure MreB. However, a further SDS-PAGE gel
was run using the flow through and some of the lighter bands were still present.
This could be due to some additional proteins interacting with MreB itself, and not
simply binding to the column. In an attempt to separate these impurities from the
MreB in our sample, we used the ÄKTA Pure chromatography system with a gel
filtration column to further purify the sample. The result of this is illustrated in
Figure 5.9.
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Figure 5.9: Example chromatogram of the gel filtration of MreB. The column used
was a HiPrep Sephacryl S-300 HR (GE Healthcare), which was equilibrated with 3
volumes of Buﬀer C (Appendix B.5) prior to use. A flow rate of 1 mL/min was
used for this measurement.
Figure 5.9 shows the result of the gel filtration of the MreB sample. The small band
with maximum at 193 mL is the region where MreB came oﬀ the column. However,
it was found that a number of impurities also came oﬀ here, and so to minimise
their presence in the final sample, only the fractions within the grey region of the
chromatogram were pooled. An SDS-PAGE gel was run of these pooled fractions,
in addition to the fraction taken from the large peak at around 100 mL on the
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chromatogram, and the result is given in Figure 5.10.
Figure 5.10 shows that the MreB protein is of high purity following gel filtration.
Therefore the sample was concentrated using a VivaSpin® 20 sample concentrator
with centrifugation at 3,200⇥g at 4 C. A small volume of dilute MreB solution was
left following this method, which was suﬃcient for structural analysis using circular
dichroism (CD).
Figure 5.10: Result of SDS-PAGE run on a 15% resolving gel. The lane on the far
left are the protein markers (their sizes from top to bottom are: 97 kDa, 66 kDa,
45 kDa, 30 kDa, 20 kDa and 14 kDa). The lane in the middle is from the pooled
fractions around the 100 mL region of Figure 5.9. The lane on the right is from the
fractions within the grey region of Figure 5.9
5.3 Results and Discussion
5.3.1 Circular dichroism and MreB secondary structure
Circular dichroism is the diﬀerence in the absorption of right (AL) and left (AR)
circularly polarised light by an optically active material, as stated in Equation 5.1
[141].
CD = AL   AR (5.1)
Samples of chiral molecules, where one enantiomer is in excess, are optically active
— a fact that was first demonstrated by Pasteur in his observations of optical
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activity in the two enantiomers of tartaric acid [142]. Proteins are made up of
amino acids, which, with the exception on glycine, are chiral molecules, and only
their L- enantiomer is produced by cells to make proteins. However, it is not only
the components of proteins that are chiral, but also the regular structures they
form when folded, known as secondary structure. The most common examples of
secondary structure are ↵-helix,  -sheet and  -turn, and each of these elements
produce distinct features in a far-UV CD spectrum. A CD spectrum of MreB is
given in Figure 5.11.
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Figure 5.11: Circular dichroism spectrum of E. coli MreB (with 20 residues
omitted). This measurement was taken using the concentrated sample used to run the
SDS-PAGE gel in Figure 5.10 in a 0.1 cm quartz cuvette. A Jasco J-1500 circular
dichroism spectropolarimeter was used for the measurement. The concentration of
the sample of 0.55 µM, which was determined using an extinction coeﬃcient of "280
= 7450 M 1cm 1
Figure 5.11 shows that the protein appears to have a large amount of ↵-helix, as
the large positive peak at 190 nm, in addition to the negative peaks to 208 and 222
nm, are signature spectral features of this structure [143]. To analyse the spectrum
further, we used the online tool DichroWeb, developed by Whitmore and Wallace
of the University of London [144].
DichroWeb allows users to predict the secondary structure elements of a protein
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from its CD spectrum using one of five analysis algorithms: SELCON3 [145, 146];
CONTINLL [147,148], K2D [149]; CDSSTR and VARSLC [150–152]. A number of
reference data sets are also used in the analysis [152–155]. Figure 5.12 shows the
results of the analysis of the MreB CD spectrum given in Figure 5.11, using the
SELCON3, CONTINLL, CDSSTR and K2D algorithms. Reference set 7 was used
for all with the exception of K2D, which is preprogrammed with its own reference
set [155].
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Figure 5.12: Figure showing the output of DichroWeb using four of its algorithms:
SELCON3 (top left), CONTINLL (top right), CDSSTR (bottom left) and K2D
(bottom right). In each of the four panels the experimental input data are plotted
along with the reconstructed data produced using the analysis algorithm. The figure
also shows the diﬀerence between the experimental and reconstructed data.
From Figure 5.12 it is apparent that the analysis algorithms provide a good spectral
fit to the experimental data, with only the fit using the SELCON3 algorithm having
any significant error in the far-UV of the spectrum. From these results we can be
confident in the other output of DichroWeb, which are the predicted proportions of
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secondary structure elements within the protein. These are given in Table 5.8, along
with the normalised root mean square deviation (NRMSD) fit parameter [156].
Table 5.8: Secondary structure composition of MreB calculated using a range of
algorithms in the online web server DichroWeb. The spectrum given in Figure 5.11
was used as input data. The far right column of the table contains the NRMSD
parameter, which indicates the goodness of fit between the experimental and
calculated spectra.
Analysis ↵-Helix  -Sheet  -Turn Other Total
Spectral
NRMSD
SELCON3 0.36 0.17 0.19 0.28 1.00 0.11
CONTIN 0.34 0.18 0.19 0.29 1.00 0.02
CDSSTR 0.38 0.16 0.19 0.27 1.00 0.01
K2D 0.32 0.18 - 0.50 1.00 0.07
The crystal structure of C. crescentus MreB has been published previously by van
den Ent et al. [157]. The secondary structure reported in the protein data bank
(PDB entry: 4czi) from the crystal structure the authors submitted — calculated
using the DSSP hydrogen bond estimation algorithm [158] — contains 36% ↵-helix
and 27%  -sheet. This is in reasonable agreement with the secondary structure
composition of MreB calculated in DichroWeb, particularly the ↵-helix content. It
is to be expected that the MreB measured here would have less ordered structure,
as it was recorded in solution, whereas the C. crescentus MreB measured by van
den Ent et al. was from crystal structure, which is an inherently more ordered and
restricted environment.
The  -sheet content derived from our calculated MreB spectra is significantly lower
than that reported in the literature for C. crescentus MreB [157]. Although the fact
that our measurement was conducted in the solution phase will partially account for
this discrepancy, a further reason in that 5.2% of the  -sheet content of the published
structure comes from the structure within the first 20 residues of the protein, which
we have excluded when expressing our E. coli MreB.
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5.3.2 MreB fluorescence
Using the same sample as was used to record the CD spectrum in Figure 5.11,
the fluorescence excitation and emission spectra of MreB were recorded on a Jasco
FP-6500 spectrofluorometer. The result is given in Figure 5.13.
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Figure 5.13: Fluorescence excitation (blue) and emission (red) spectra of MreB,
measured on a Jasco FP-6500 spectrofluorometer. For the excitation spectrum, the
emission wavelength was set to 320 nm, and the excitation and emission bandwidths
were set to 3 nm and of 10 nm, respectively. For the emission spectrum, the
excitation wavelength was set to 280 nm, and the excitation and emission bandwidths
were set to 5 nm and 3 nm, respectively.
MreB does not contain any tryptophan residues, and so its fluorescence comes from
its 5 tyrosine residues. As mentioned in Section 4.3.3, tyrosine is a poor fluorophore
in proteins, and the measurements here were recorded with large excitation and
emission bandwidths, and the PMT detector sensitivity set to high, giving it a high
HT voltage. With these settings, we can see that good fluorescence spectra can be
collected from the protein.
The spectra given in Figure 5.13 show that it may be possible to collect FDLD
spectra of MreB if the protein can be oriented. We had attempted unsuccessfully a
number of times to collect FDLD spectra of another protein that only contains a
single tyrosine residue, FtsZ — a bacterial tubulin homologue whose LD spectrum
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has been recorded and published [159] — but this result shows that MreB may be
a more suitable candidate. Unfortunately, we were unable to adapt the purification
protocol of MreB to obtain enough sample to develop a polymerisation kinetics assay
using FDLD.
5.4 Conclusions
Here we have shown a method for the cloning, expression and purification of E. coli
MreB with a cleavable poly-histidine tag. Its purity has been confirmed through
SDS-PAGE, where a strong band was observed just below the 37 kDa marker — the
molecular weight of our MreB is 36938.3 Da — with very few, faint bands appearing
from contaminants. The structure of the purified MreB sample was analysed using
CD, along with the online analysis tool DichroWeb, and it was found that the
structure of our sample from E. coli was in good agreement with a previously
published structure of MreB from C. crescentus [157].
We have also shown that a good fluorescence signal can be collected from
MreB, despite tyrosine being its only fluorophore, which may indicate that its
polymerisation kinetics could be studied using our FDLD method. Unfortunately
we were not able to optimise our method for purifying our product to obtain a
high enough quantity of MreB to be able to develop this FDLD assay during this
project. The problems we had were in maintaining a high amount of soluble protein
after lysing the cells, and then separating the soluble MreB from a large number of
contaminants, even after HisTrap elution and gel filtration.
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CHAPTER 6
Direct detection and measurement of wall
shear stress using a filamentous
bio-nanoparticle — M13 bacteriophage
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6.1 Introduction
This chapter details the data processing and analysis contribution to a project that
aimed to calculate the wall shear stress (WSS) a fluid exerts on a surface, which
was published in the October 2015 issue of Nano Research [2]. WSS is a measure
of the tangential component of the force exerted on a surface by a fluid flowing over
it [160]. Abnormal WSS in the vasculature is associated with a number of medical
conditions, such as atherogenesis [161], and aneurysms [162]. Therefore, our ability
to accurately measure the WSS stress within the vasculature is highly valuable to
diagnostic, and even preventative medicine.
Currently, the WSS within the vasculature is most commonly measured using
bulk measurement techniques, such as particle image velocimetry (PIV) or particle
tracking velocimetry (PTV) techniques [163, 164]. There have been a number of
reported problems with these techniques for investigating WSS, one of which is their
inherent bias, due to the concentrations of tracer particles decreasing as the surface
boundary is approached [165]. Secondly, they make the assumption that both the
flow and the surface over which the fluid is passing, is uniform. This means that
the measured WSS is an average over that surface, and some of the information
on the WSS dynamics critical to understanding diseases of the vasculature may be
obscured.
This work uses fluorescently labelled M13-bacteriophage, with a surface binding
agent attached to the end pIII proteins, as a nanosensor. The M13 bacteriophage
complexes were attached to flow slides coated with either collagen IV or cultured
human conditionally immortalised endothelial cells (GEnCs), and their response to
a range of flow velocities allowed us to calculate the WSS at the point of attachment.
The work was undertaken as part of a large collaborative project. The contribution
of the author of this thesis to the work focussed around analysis of the fluorescence
signals, which is the main content of this chapter.
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6.2 Methods
This section presents an overview of all the methods used to determine the WSS
exerted on a specific point of a surface by a fluid flowing over it. The focus of this
chapter is data processing and analysis, and so these sections contain much more
detailed information.
6.2.1 Experimental methods
All experimental procedures were carried out by Daniela P. Lobo, however, a
brief outline of the experiment is presented here to help with understanding the
subsequent data analysis.
Cultures of M13 bacteriophage were grown, purified, and fluorescently labelled with
tetramethylrhodamine isothiocyanate (TRITC), as described by Pacheco-Gómez et
al. [107], and subsequently derivatized with a protein anchor attached to the pIII
protein, as illustrated in Figure 6.1. The protein anchors used were anti-collagen IV
(aCol) and wheat germ aglutinnin (WGA) to be used in the collagen IV and GEnCs
coated flow slide experiments, respectively.
Microchannel flow slides, coated with collagen IV were purchased from Ibidi,
Munich, and human conditionally immortalized glomerular endothelial cells
(GEnCs) were grown using a literature protocol [107, 166]. The completed
M13-aCol-TRITC and M13-WGA-TRITC constructs were bound to a flow slide,
coated in either collagen IV or GEnCs, and the slides were placed in a spinning
disk confocal microscope. A pump was then attached to the slides to control the
flow rate, and all fluorescent images were recorded using a nominal WSS of 0-3.5
dyn·cm2.
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Figure 6.1: Illustration of the derivatized M13-aCol-TRITC bacteriophage. The
pVIII proteins (green) were labeled with the fluorescent dye TRITC (orange). The
pIII proteins (yellow) were labelled with the anti-body anchor (red), which attached
the whole complex onto a surface. The figure also shows how the particle responds
to flow in the ‘positive’ and ‘negative’ directions.
6.2.2 Phage orientation function
Microscopy experiments of two kinds were undertaken. Five image stacks recording
the response to flow of M13-aCol-TRITC attached to collagen IV coated slides were
obtained. Only one image stack for M13-WGA-TRITC attached to a GEnCs coated
flow slide was collected. These image stacks were converted to AVI files using the
program Fiji [167]. All subsequent data processing was performed in MATLAB
(MATLAB R2014b, The MathWorks Inc., Natick, MA) with code written for the
purpose.
The first step was to read in to MATLAB the .avi file containing the microscopy
image stack. Following this, the number of frames and the frame rate was retrieved
from the file, from which the time parameter was calculated.
cellObj = VideoReader(’PhageMicroscopyMovie.avi’);
vidFrames = read(cellObj);
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numFrames = get(cellObj, ’NumberOfFrames’);
frameRate = get(cellObj, ’FrameRate’);
Time = ((1:numFrames)/frameRate)’;
The method used to distinguish the M13 bacteriophage particles from the
background is thresholding, where the image is segmented based on the fact that
regions where the M13 is present have considerably higher pixel intensity than where
it is absent [168]. To perform this action, the RGB images (from the RGB colour
model) need to be converted to grayscale, and MATLAB requires the image intensity
values to be converted to double precision format.
for k = 1 : numFrames
img(k).gray = rgb2gray(vidFrames(:,:,:,k));
end
for k = 1 : numFrames
img(k).double = im2double(img(k).gray);
end
To display an example image from the greyscale stack, the ‘imshow’ command is
used. An example of this is given in Figure 6.2 to show one greyscale image of
a fluorescent M13-aCol-TRITC particle. This frame of the image stack is used
throughout this section to show the eﬀect of the image processing commands.
figure(1)
imshow(img(45).gray, ’InitialMagnification’, ’fit’)
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Figure 6.2: Example of a greyscale image produced after reading a microcopy image
stack in to MATLAB. This image shows a M13-aCol-TRITC particle, anchored to
a collagen IV coated flow slide.
The next step was to compute threshold values that will be used to convert the
greyscale images to binary images. MATLAB has a global function for this, based
on Otsu’s method [169]. Once the threshold value was computed, it was used to
binarise the images, so that pixels with an original value greater than the threshold
were assigned a value of one, and those below are set a value of zero. A duplicate
binary image stack was also created to be used for background subtraction.
level=zeros(numFrames,1);
for k=1:numFrames
level(k)=graythresh(img(k).double);
end
for k = 1 : numFrames
img(k).binary = im2bw(img(k).double,level(k));
end
for k = 1 : numFrames
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img(k).binary1 = img(k).binary;
end
After thresholding, the frame of the image stack shown above is now displayed in
Figure 6.3.
figure(2)
imshow(img(45).binary1, ’InitialMagnification’,’fit’)
Figure 6.3: The figure shows a product of the thresholding process, using the same
image as is shown in Figure 6.2. The white region has a uniform pixel intensity of
one, and all other pixels have a value of zero.
At this point the images were binary, with the main region of ones being the M13
bacteriophage complex. This region was then defined as the region of interest by
finding and grouping the connected ones in the image. To clean up any residual
background regions of ones that made it through the thresholding process, the largest
region (the M13) was deleted from the first image stack, and then this whole stack
was subtracted from the duplicate made above.
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for k = 1 : numFrames
regions(k) = bwconncomp(img(k).binary);
end
for k = 1 : numFrames
numPixels = cellfun(@numel,regions(k).PixelIdxList);
[biggest,idx] = max(numPixels);
img(k).binary(regions(k).PixelIdxListidx) = 0;
end
for k = 1 : numFrames
img(k).subtracted = imsubtract(img(k).binary1,img(k).binary);
end
The final piece of image processing that was performed was to find the convex hull of
the region, which fits a convex polygon within the M13 bacteriophage region of the
binary image. This was included to deal with the potential problem of a group of
pixels within the phage body having a pixel intensity below the threshold value (and
hence would now have a intensity of zero), and also to help smooth the edges of the
phage, as both of these issues may distort the information on the phage orientation
and length.
for k = 1 : numFrames
img(k).convhull = bwconvhull(img(k).subtracted);
end
An example image from the final processed image stack is given in Figure 6.4.
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figure(3)
imshow(img(45).convhull,’InitialMagnification’,’fit’)
Figure 6.4: The figure displays and example of the processed images used to obtain
orientation and major axis length data. It is once again the same image as was used
in Figure 6.2, however this a convex polygon has been fit within the boundaries of
this particle, and so the edges are considerably smoother.
The function ‘regionprops’ was used to obtain the M13-aCol-TRITC and
M13-WGA-TRITC orientation and major axis length from each image in the stack.
The function was used to find the major axis of the M13 complexes by finding
the longest straight line that can be drawn within the region of interest, in pixels.
The function is then used to find the particle’s orientation by calculating the angle
between the major axis and the horizontal, or x axis of the image, in degrees.
for k = 1 : numFrames
Orientation(k).Orientation=regionprops(img(k).convhull,’Orientation’);
end
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for k = 1 : numFrames
Majoraxis(k).Majoraxis=regionprops(img(k).convhull,’MajorAxisLength’);
end
At this point, all of the processed data were stored in structure arrays. To use
the data for subsequent calculations more easily, and also to plot it, the relevant
data needed to be extracted into vectors. This was done using the ‘extractfield’
commands. Here, the M13 length data was also converted from pixels to µm, which
in this case required multiplication by 0.0693.
Angle=zeros(numFrames,1);
for k = 1 : numFrames
Angle(k)=extractfield(Orientation(k).Orientation,’Orientation’);
end
Length=zeros(numFrames,1);
for k = 1 : numFrames
Length(k)=extractfield(Majoraxis(k).Majoraxis,’MajorAxisLength’);
end
LengthNM = Length*0.0693;
The next problem that must be dealt with was to find a way of defining the times
at which the flow was applied to the M13-aCol-TRITC, and when it was turned
oﬀ. The defining characteristic of the flow being on is that the movement of the
particle is restricted, and the variance in its angle relative to the horizontal axis is
reduced. It is this property that we used to distinguish between the flow being on
or oﬀ. First, a moving standard deviation of the orientation data was calculated.
The minima of this vector corresponds to the times at which flow was applied. The
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’findpeaks’ function finds the local maxima of a vector, and so we simply calculated
the inverse of the moving standard deviation vector and used this function to find
the times at when flow is applied. These data were also smoothed prior to using the
findpeaks function to ensure the maxima were found precisely.
MovStanDev = movingstd(Angle,51,’c’);
InverseSmooth=-1*MovStanDev;
SmoothedData = smooth(InverseSmooth,0.1,’rloess’);
findthepeaks=findpeaks(SmoothedData, ’MINPEAKHEIGHT’, -30);
for k=1:length(findthepeaks)
indvalues(k)=find(SmoothedData==findthepeaks(k));
end
The smoothed moving standard deviation data is displayed in Figure 6.5. It shows
that there are nine peaks, and the modulus of their maximum values are trending
to an increased magnitude as time increases, which tells us that the flow rates being
applied are getting progressively weaker.
figure(4);
plot(Time, SmoothedData)
xlabel(’Time / s’)
ylabel(’Smoothed Data’)
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Figure 6.5: The inverse moving standard deviation of the orientation data, obtained
from one of the microscopy data sets using M13-aCol-TRITC bound to a collagen IV
coated flow slide. The data has been smoothed so that the maxima are better defined.
The maxima values from Figure 6.5 were then used to set a time frame over which
flow was applied. Twenty seconds after the maxima and ten seconds prior was
selected, so to allow the M13 bacteriophage complexes some time to settle following
the application of shear flow. The average orientation and major axis length of the
M13 particles over these time frames were calculated, in addition to the standard
deviation of these properties.
LOW=49;
HIGH=101;
indvalues=[indvalues, numFrames-(HIGH+5)];
for k=1:length(indvalues)
StdAngle(k) = std(Angle(indvalues(k)-LOW:indvalues(k)+HIGH));
end
for k=1:length(indvalues)
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StdLength(k) = std(LengthNM(indvalues(k)-LOW:indvalues(k)+HIGH));
end
for k=1:length(indvalues)
Average_Angle(k) = mean(Angle(indvalues(k)-LOW:indvalues(k)+HIGH));
end
for k=1:length(indvalues)
Average_Length(k) = mean(LengthNM(indvalues(k)-LOW:indvalues(k)+HIGH));
end
for k=1:length(indvalues)
TimeBars(k)=Time(ceil((indvalues(k)-LOW+indvalues(k)+HIGH)/2));
end
findthepeaks=findpeaks(SmoothedData, ’MINPEAKHEIGHT’, -30);
for k=1:length(findthepeaks)
indvalues(k)=find(SmoothedData==findthepeaks(k));
end
Finally, the processed data were grouped and exported to text files, so that they
can be analysed and plotted in R [170].
DataMatrix=cat(2,Time,Angle,LengthNM);
header = ’Time’, ’Angle’, ’Length’;
RawDataOut = dataset(DataMatrix,header:);
export(RawDataOut,’file’,’RawDataOut.txt’,’Delimiter’,’,’)
% To export ’raw’ data to a text file
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DataMatrix=cat(2,TimeBars’,Average_Angle’,StdAngle’,Average_Length’,...
StdLength’);
ProHeader = (’TimeBars’,’AverageAngle’,’StdAngle’,’AverageLength’,...
’StdLength’);
ProDataOut = dataset(DataMatrix,ProHeader:);
export(ProDataOut,’file’,’ProDataOut.txt’,’Delimiter’,’,’)
% To export ’processed’ data to a text file
6.2.3 Mathematical model
David J. Smith wrote a probability model for the orientation of the tethered
bacteriophage particle in flow, which is presented in detail in the SI of our publication
[171]. It begins by postulating a partial diﬀerential function — based on a random
walk model, with additional parameters to account for the viscous restoring force of
the fluid — and then uses a set of assumptions to present the ordinary diﬀerential
equation:
D
d2p
d 2
+
d(  p)
d 
= 0 (6.1)
where D is the diﬀusion coeﬃcient;  is the orientation of the particle;   is a
positive constant that relates to the shear rate of the fluid; and p = p( ), which
is the probability of finding the particle in a given orientation. The key part for
the experimental analysis is that one solution of this ODE is a normal distribution,
where the mean equals zero and the standard deviation ( ) equals D  :
p = A exp(
   2
2D
) (6.2)
From here, as shown in the SI of the paper [2], we can say that:
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ln( ) =  0.5 ln(WSS)  1.5 ln(L) + k (6.3)
where L the length of the particle and k is a constant, and:
1
 2
/ Nominal WSS (6.4)
Therefore, the model predicts that a plot of ln( ) vs. ln(WSS) will have a slope of
-0.5 and that the nominal WSS is proportional to the inverse square of the standard
deviation of the particle’s adopted orientations at a given flow rate.
6.3 Results and discussion
6.3.1 Collagen IV coated flow slides
The experiments where the M13-aCol-TRITC was attached to a collagen IV coated
slide were used as a simple model system, to show that the WSS can be predicted
from the behaviour of the particle in flow, using the mathematical model described in
Section 6.2.3 above. To confirm that the collagen IV coated slide results agree with
the model, we first checked that the orientation data of M13-aCol-TRITC followed
a normal distribution, at each flow rate, as predicted by Equation 6.2. To do this
we used the Shapiro-Wilks test using the function shapiro.test(x) in R, and also the
Anderson-Darling test, using the function ad.test(x) in the nortest package [172,173].
An example set of results from one of the image stacks is given in Table 6.1.
114
6.3. RESULTS AND DISCUSSION Chapter 6
Table 6.1: Results of the Shapiro-Wilks and Anderson-Darling tests for the normality
orientation data from one of the image stacks. The null hypothesis in the
Shapiro-Wilks test is that the data is from a normal distribution, and so a p-value >
0.05 indicates that the data is normally distributed. Likewise, the null hypothesis of
the Anderson-Darling test is that the data is normally distributed, and so a p-value
> 0.05 would indicate that this is the case.
Nominal WSS
(dyn.cm 2)
p-value
Shapiro-Wilks Test
Anderson-Darling
Test
3.5 0.2606 0.05826
-3.5 0.2672 0.2321
2.5 0.4731 0.3933
-2.5 0.146 0.2865
1.5 0.9939 0.9953
-1.5 0.07569 0.06401
1.0 0.7106 0.5338
-1.0 0.6047 0.4769
0.5 0.1486 0.09329
0 2.321e-05 2.492e-05
Table 6.1 shows that when a shear flow is applied, all of the data agree with the
null hypothesis of both tests: that the data comes from a normal distribution. This
is a good indication that the mathematical model is correct. The extremely small
p-values shown at a nominal WSS of 0 dyn.cm 2 shows that the orientation data is
not normally distributed when no flow is applied, which was expected.
In the collagen IV coated slide experiments, the motion of a M13-aCol-TRITC
particle was unhindered in all directions, and so it was equally likely to adopt any
orientation relative to the horizontal axis of the image (in the range -90  to 90 ) in
either the positive or negative flow directions. Figure 6.6 illustrates this symmetrical
response to flow direction.
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Figure 6.6: Scatter plot of the orientations adopted by the M13-aCol-TRITC particle
bound to a collagen coated flow slide at varying nominal WSS values. The red errors
span ±  around the mean value.
Figure 6.6 shows that when no flow is applied, the phage particle freely adopts any
orientation between  90  and +90 , moving only under the influence of Brownian
motion. It also shows that increasing the flow rate restricts the orientation of a
particle, and the higher the flow rate the smaller the variance in particle orientation.
So by observing the variance in the orientation of a particle at a given flow rate, we
have a means of measuring the strength of that flow rate.
It is also apparent from Figure 6.6 that there is symmetry in the eﬀect that the
positive and negative flow rates have on the phage particle’s orientation. As the
particle responds the same way, irrespective of flow direction, we can group the
orientation data based on the modulus of the nominal WSS values. These data were
then used to calculate the frequency distribution of angles of the M13 particle in 3 
bins, which was normalised to the number data points within each nominal WSS
data set, as illustrated in Figure 6.7.
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Figure 6.7: (a) Example of the variation in angle of the M13-aCol-TRITC particle
bound to a collagen IV coated flow with time when a shear flow is applied. The
nominal WSS is indicated at the top in dyn.cm 2. (b) Normalised frequency
distribution of the orientation adopted by an M13 bacteriophage particle, tethered
to a collagen IV coated slide, subject to a range of nominal WSS. (c) ln( ) vs.
ln(Nominal WSS) for the 5 image stacks of M13-aCol-TRITC bound to collagen
IV coated flow slides used in this work. The regression line is calculated from the
combination of all of the data from the image stacks.
Figure 6.7 A and B show that at higher nominal WSS, the distribution is much
narrower around 0 , and as the WSS is relaxed, the distribution broadens as the M13
particle is less restricted. Figure 6.7 C shows that the data are in good agreement
with the model shown in Equation 6.3, which allowed us to look at data where the
particle was not on a uniform surface, and flow direction mattered.
6.3.2 Endothelial cell coated slides
The movie recorded of the M13-WGA-TRITC bacteriophage bound to a GEnCs
coated flow slide was analysed in the same way as the above. The diﬀerence in this
case was that the surface of the slide is not uniformly flat, and so depending on
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the location on the GEnCs that the phage is bound to, its movement may be more
restricted when subjected to flow in one direction than the opposite flow direction.
The particle in our movie exhibits this behaviour, which is illustrated in Figure 6.8.
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Figure 6.8: Illustration of the asymmetrical response of the particle to flow direction.
The points show the orientations adopted by the M13-WGA-TRITC particle bound
to a GEnC coated flow slide at varying nominal WSS values and the red errors span
±  around the mean value.
Figure 6.8 shows that in the negative flow direction, the average orientation adopted
by the M13-WGA-TRITC particle was ⇠ 0, whereas in the positive flow direction
the average angle is higher and reduces with increasing nominal WSS. This shows
that the particle’s movement is restricted due to the position that it has bound
to the cell. It can also be seen that the variance in the orientation of the particle
is reduced when flow is applied in the positive direction. From Equation 6.4 this
suggests that for equal flow rates in both directions, the positive flow direction would
exert a higher WSS at the point where the particle is attached.
To assess the eﬀect of the non-uniform surface on the exerted WSS more
quantitatively, we can plot the ln( ) vs. ln(Nominal WSS), as we did for the collagen
coated slides in Figure 6.7 C. The result is given in Figure 6.9.
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Figure 6.9: ln( ) vs. ln(Nominal WSS) for the of M13-WGA-TRITC bound to
GEnCs coated flow slides under shear flow in the positive and negative directions.
Figure 6.9 shows the ln( ) vs. ln(Nominal WSS) data for the M13-WGA-TRITC
bacteriophage particle bound to a GEnCs coated flow slide, and the gradient of
the calculated regression lines. Although the slopes of the regression lines appear
smaller than the predicted value of  0.5 from Equation 6.3, they are in reasonable
agreement within the large error of the experiment. More image stacks from these
experiments would have reduced the error and allowed us to produce better statistics,
which would have been preferable.
From Equation 6.4 we know that the nominal WSS is proportional to the inverse
variance of the phage’s orientation. To better illustrate the eﬀect the GEnCs are
having on the WSS, we can plot 1/ 2 versus the nominal WSS for both the collagen
and GEnCs data. This is given in Figure 6.10.
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Figure 6.10: Plot of the inverse variance (1/ 2) versus nominal WSS from
Figures 6.7 C and 6.9. The labelled points highlight the values at a nominal WSS of
3.5.
From Figure 6.10 it is apparent that the presence of the GEnCs are having a large
eﬀect on the WSS at the point that the phage particle is attached, and also that the
eﬀect varies depending on the direction the fluid is flowing over it. As already shown
by Barbee et al., the presence of the endothelial cell significantly increases the WSS
due to the shape of the protruding cell [174]. These results were corroborated by
Pozrikidis, who mathematically modelled flow over protuberances in a plane surface
in [175].
The eﬀect of flow direction is also interesting. We can see that the WSS exerted is
significantly higher when the flow is in the positive direction than when the flow is
in the negative direction. We can see from Figure 6.8 that the particle is much more
restricted in the orientation it can adopt when the flow is in the positive direction.
This also give us an indication of where on the cell that the M13-WGA-TRITC
particle may be bound, and shows that the WSS exerted in a surface by a fluid
flowing over it is not uniform over that surface.
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6.4 Conclusion
This work shows a method of measuring the WSS exerted on a surface by a
fluid flowing over it with vastly increased spatial resolution than other commonly
used methods, such as PIV and PTV. The method was calibrated using a simple
model system of M13-aCol-TRITC particles bound to a collagen coated flow
slides, where the WSS was calculated from the particle’s flow behaviour using a
mathematical model. This method was then applied to an irregular surface —
M13-WGA-TRITC particles bound to GEnCs coated flow slides — and we showed
that it is possible to measure the local WSS at the point of the particle’s attachment.
This experiment also highlights the deficiency in other methods that average over
local WSS dynamics, by showing that the WSS exerted can be very diﬀerent across
a non-uniform surface.
This chapter was particularly focussed on the data processing and analysis elements
of this work. The image stacks, which were collected on a Nikon Eclipse inverted
microscope, were analysed using a custom made algorithm that was written in
MATLAB. The images were binarised using a thresholding technique, and the
background noise was subtracted from our region of interest (ROI). A convex
polygon was then fit into the ROI to smooth its edges, and remove any dark pixels
within it. The length and angle of the ROI was then tracked throughout each image
stack, and a code was implemented to determine times where a shear flow had
been applied. This process provided the data required to test the predicted phage
behaviour using our mathematical model, and show the diﬀerences in WSS exerted
on a surface by a constant shear rate, which depend on the uniformity of surface
and the direction of the flow.
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Conclusions and future work
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The aim of this work was to develop experimental and analytical methods, which
enhance our ability to study samples of anisotropically oriented fluorophores. The
primary development here is the novel fluorescence detection method for linear
dichroism spectroscopy. Using this technique, we have shown that information on
the relative orientation of chromophores in a sample can be obtained with increased
sensitivity and selectivity than is achievable when using absorption LD. A particular
motivation for this was to make LD more suitable for studying biological systems,
which are often obtained in small quantities, in solutions that contain complex
mixtures of molecules. We also explained whether flow fluorescence methods could
be used more generally. To this end a new production method for MreB is
reported, and the analysis of fluorescence data for tethered M13 bacteriophage is
also presented.
The theory behind our FDLD experiment, with a particular focus on how to
produce an FDLD spectrum from the currents generated in the PMT detector of a
commercial CD spectropolarimeter, is derived in Chapter 2. The first experimental
results of small molecules oriented on stretched PEOX films is presented in Chapter 3,
and in all of these experiments we demonstrated the large increase in sensitivity of
FDLD, showing that signals of similar magnitude or larger were attainable with
only a fraction of the amount of sample. Interestingly, some of the FDLD spectra
given in this chapter also showed an increased resolution of the vibronic components
within an absorption band, illustrating that in some cases more information about
a molecule may be obtained by using FDLD.
The LD and FDLD spectra of complexes of DNA and ethidium bromide, propidium
iodide, 4’,6-diamidino-2-phenyindole (DAPI), and Hoechst 33258 are compared in
Chapter 4. Here, we again showed the increased sensitivity of FDLD, though in
this case the signal to noise of the spectra was poorer due to the distance between
the sample in the Couette flow cell and the detector. However, we also demonstrated
the increased selectivity of the measurement, as we were detecting signals from the
fluorescent dyes only, and not the DNA, which often dominates the middle-UV region
of LD spectra. In doing so, we were able to see in greater detail the sign and relative
magnitude of the dye signals within this region, which adds to the information we
know about how the molecules are bound to DNA.
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In Chapter 4 we also gave the LD and FDLD spectra of M13 bacteriophage
oriented in Couette flow, where in addition to simply being able to detect tryptophan
signals at lower M13 concentrations when using FDLD, we again showed the higher
resolution of the diﬀerent absorption bands of the indole chromophore attained
when using FDLD. We propose that these properties would improve the detection
capabilities of an LD assay designed to detect pathogenic bacteria in solution
[107,108].
We developed a protocol for the cloning, expression and purification of the E.
coli actin homologue MreB, which is given in Chapter 5. We demonstrated that
our product was pure using SDS-PAGE, and analysed its structure using circular
dichroism and the online analysis tool: DichroWeb. We found that the structure
of our protein was in good agreement with the published crystal structure of C.
crescentus MreB, though ours showed slightly less ordered secondary structure,
which would be expected as our measurement was performed in solution. Although
we were not able to obtain MreB in a high enough quantity to develop an FDLD
assay to study its in vitro polymerisation kinetics, we did show that a good
fluorescence signal can to obtained from the protein, indicating that this may be
achievable.
We were also involved in a work which showed that the WSS could be calculated
at a specific point by attaching a fluorescently labelled M13 bacteriophage to the
surface, and gave the full details in Chapter 6. Our focus was primarily on the
data processing and image analysis, and so these sections are given in greater detail.
We showed that by using a global thresholding process in MATLAB, a background
subtracted microcopy image stack containing a particle of interest can be binarised,
and the particle’s size and orientation can be tracked throughout the image stack.
The data obtained using this algorithm were then used to calculate the WSS at
the point of the particle’s attachment, and clearly showed that it varied when the
surface is not uniform. Future work using this method will involve the analysis of
images obtained from a labelled particle bound to the wall of the vasculature in
vivo. The ability to observe the eﬀect of vascular surface dynamics should increase
our understanding of diseases related to WSS.
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Following on from the work of this thesis, the development of a new flow cell for
micro-volume Couette flow FDLD would greatly improve the signal to noise ratio
of the measurement. The new design would have the sample chamber closer to
the detector, with focussing lenses directing a higher proportion of the fluorescence
emissions towards the detector. Although we were not able to achieve it during
the course of this work, an area of high potential for FDLD lies in observing the
polymerisation process of proteins, and other monomers, to form long chain fibres.
Using FDLD one would be able to test the eﬀect of a range of conditions, such
as temperature, pH, or concentration, on the polymerisation of such a sample. To
this end, an FDLD Couette flow cell would also greatly benefit from including an
injection system, so that reaction initiators (or terminators) could be introduced
during the course of the measurement, and one could observe the propagation of the
reaction in full.
A key measure of the usefulness of an analytical technique is how readily one can
obtain information about a sample or a process of interest when using it. For
investigations into the relative orientation of chromophores in complexes that possess
a high aspect ratio, or when seeking to find the optimum conditions for molecules to
polymerise to form fibres, Couette flow LD possesses a degree of selectivity, as only
information on chromophores with a macroscopic alignment is obtained. Including
the additional selectivity of fluorescence detection to the experiment broadens its
utility, as data from samples of complex mixtures can more easily be recorded. This
is also true of microscopy based experiments, such as our method for detecting
WSS. By using a fluorescently labelled particle we were able to selectively detect
its response to an applied shear flow, to the exclusion of all other particles carried
in the solution, which would have been present were the experiment performed
using a simple optical microscope. The synthesis of orientational and chromophoric
selectivity in the methods developed in this work increase their utility, allowing one
to directly record data from processes that may otherwise only be obtainable through
a complex post-analysis — if at all. On this evidence, the design of composite
experimental and analytical techniques should serve as a fruitful strategy for future
investigations.
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M V K K F R G M F S
ATG GTG AAA AAA TTT CGT GGC ATG TTT TCC
N D L S I D L G T A
AAT GAC TTG TCC ATT GAC CTG GGT ACT GCG
N T L I Y V K G Q G
AAT ACC CTC ATT TAT GTA AAA GGA CAA GGC
I V L N E P S V V A
ATC GTA TTG AAT GAG CCT TCC GTG GTG GCC
I R Q D R A G S P K
ATT CGT CAG GAT CGT GCC GGT TCA CCG AAA
S V A A V G H D A K
AGC GTA GCT GCA GTA GGT CAT GAC GCG AAG
Q M L G R T P G N I
CAG ATG CTG GGC CGT ACG CCG GGC AAT ATT
A A I R P M K D G V
GCT GCC ATT CGC CCA ATG AAA GAC GGC GTT
I A D F F V T E K M
ATC GCC GAC TTC TTC GTG ACT GAA AAA ATG
L Q H F I K Q V H S
CTC CAG CAC TTC ATC AAA CAA GTG CAC AGC
N S F M R P S P R V
AAC AGC TTT ATG CGT CCA AGC CCG CGC GTT
L V C V P V G A T Q
CTG GTT TGT GTG CCG GTT GGC GCG ACC CAG
V E R R A I R E S A
GTT GAA CGC CGC GCA ATT CGT GAA TCC GCG
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Q G A G A R E V F L
CAG GGC GCT GGT GCC CGT GAA GTC TTC CTG
I E E P M A A A I G
ATT GAA GAA CCG ATG GCT GCC GCA ATT GGT
A G L P V S E A T G
GCT GGC CTG CCG GTT TCT GAA GCG ACC GGT
S M V V D I G G G T
TCT ATG GTG GTT GAT ATC GGT GGT GGT ACC
T E V A V I S L N G
ACT GAA GTT GCT GTT ATC TCC TTG AAC GGT
V V Y S S S V R I G
GTG GTT TAC TCC TCT TCT GTG CGC ATT GGT
G D R F D E A I I N
GGT GAC CGT TTC GAC GAA GCT ATC ATC AAC
Y V R R N Y G S L I
TAT GTG CGT CGT AAT TAC GGT TCT CTG ATC
G E A T A E R I K H
GGT GAA GCC ACC GCA GAA CGT ATC AAG CAC
E I G S A Y P G D E
GAA ATC GGT TCG GCT TAT CCG GGC GAT GAA
V R E I E V R G R N
GTC CGT GAA ATC GAA GTT CGT GGC CGT AAC
L A E G V P R G F T
CTG GCA GAA GGT GTT CCA CGC GGT TTT ACC
L N S N E I L E A L
CTG AAC TCC AAT GAA ATC CTC GAA GCA CTG
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Q E P L T G I V S A
CAG GAA CCG CTG ACC GGT ATT GTG AGC GCG
V M V A L E Q C P P
GTA ATG GTT GCA CTG GAA CAG TGC CCG CCG
E L A S D I S E R G
GAA CTG GCT TCC GAC ATC TCC GAG CGC GGC
M V L T G G G A L L
ATG GTG CTC ACC GGT GGT GGC GCA CTG CTG
R N L D R L L M E E
CGT AAC CTT GAC CGT TTG TTA ATG GAA GAA
T G I P V V V A E D
ACC GGC ATT CCA GTC GTT GTT GCT GAA GAC
P L T C V A R G G G
CCG CTG ACC TGT GTG GCG CGC GGT GGC GGC
K A L E M I D M H G
AAA GCG CTG GAA ATG ATC GAC ATG CAC GGC
G D L F S E E *
GGC GAC CTG TTC AGC GAA GAG TAA
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Below is list of protocols for the some of the fundamental techniques that would be
required to reproduce the work detailed in this report.
B.1 Gel electrophoresis
First make up a 0.8% agarose gel by weighing out 3.2 g of electrophoresis grade
agarose, and making it up to 400 mL using TAE buﬀer (containing a mixture of
Tris base, acetic acid and EDTA).
Add 1 µL ethidium bromide per 20 µL of 0.8% agarose gel, and pour mixture
into a gel tray with the well comb in place.
Allow to set in the cold room - approximately 10 minutes.
Remove ends of gel tray, along with the well comb, and place tray into the gel
box (electrophoresis unit).
Fill gel box with 1⇥TAE until the gel is covered.
Add 5 µL of GeneRuler 1 kb DNA Ladder (0.5 µg/µL) to left hand well. Then
mix 5 µL of each DNA sample with 1 µL of 6⇥ TriTrack DNA Loading Dye,
and pipette into the other wells.
Run for 25 minutes at 110 V.
Transfer the gel to the SYNGENE G:BOX gel imaging plate (black surface for
DNA gels). Then use the GeneSnap software to view the gel, by setting the light
source to ‘Transilluminator’ and pressing the green button.
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B.2 Prepare LB agar antibiotic plates
Melt 200 mL of LB agar in the microwave and allow to cool slightly in a biological
containment cabinet.
Add the appropriate volume of antibiotic. For kanamycin resistance this should
be 200 µL of 50 mg/mL stock solution, so that the final concentration of
kanamycin in the solution is 50 µg/mL.
Lay out 6 sterile 92⇥16 mm petri dishes in the containment cabinet, with the
lids slightly ajar.
Pour in the LB agar antibiotic solution, leaving the lids ajar for 5 minutes to
reduce condensation.
Once the LB agar antibiotic solution has gone opaque, it has set and can be
removed from the containment hood.
Label the underside of each plate with the name of the antibiotic used.
B.3 Plasmid transformation
Plasmid transformation is the transfer of plasmid DNA into competent E. coli cells,
which are able to take in exogenous DNA.
Add 3 µL of plasmid to 50 µL of competent E. coli Top10 cells, and incubate
on ice for 30 minutes.
‘Heat shock’ the mixture by placing it in a 45 C water bath for 45 seconds.
This increases the eﬃciency of transforming into E. coli cells approximately 15
fold [176].
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Incubate on ice for a further 2.5 minutes, and add 150 µL of LD media to the
mix.
Place in an incubator at 37 C, and shake at 180 rpm for 60 minutes. This time
allows the newly transformed cells to express the antibiotic resistance genes.
After the hour has passed, remove the cells from the incubator and aseptic
technique pipette 75 µL onto an LB agar antibiotic plate. Flame a glass spreader
to remove any residual ethanol, and spread the solution over the plate.
Finally, incubate the plate upside down at 37 C overnight.
B.4 Overnight cultures
Pipette 5 mL of LB media into a universal tube, in addition an appropriate
volume of antibiotic; 5 µL of 50 mg/mL kanamycin solution for plasmids with
kanamycin resistance. If the overnight culture is to be used for the expression of a
protein from a pET vector, one may wish to add glucose to a mass concentration
of 0.2.
Pick a single colony of cells transformed with the plasmid (Appendix B.3) with
a small inoculating loop, and add to the solution contained within the universal
tube.
Place the universal tubes in an incubator at 37 C, and shake at 180 rpm
overnight.
The resulting culture may be used to inoculate a larger volume of media for
protein expression, or it can be used to harvest more plasmid from the cells by
mini-preparation.
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B.5 Buﬀer preparation
The mass of each element of the buﬀer to make the concentration given below in a
1 L volume are weighed out and placed in a large beaker. Deionised water is added
to the beaker, up to a volume of approximately 950 mL. The solution is stirred to
dissolve the solid constituents, and its pH measured with a pH meter. Concentrated
HCl or NaOH is added to the solution to correct the pH to the desired value, before
the whole solution is poured into a 1 L measuring cylinder. Deionised water is then
added up to a volume of 1 L. Finally, the buﬀer is filter sterilised.
Buﬀer A (pH = 8)
TRIS: 10 mM
KCl: 0.1 M
Imidazole: 10 mM
Buﬀer B (pH = 8)
TRIS: 10 mM
KCl: 0.1 M
Imidazole: 500 mM
Buﬀer C (pH = 8)
Sodium Phosphate Buﬀer: 10 mM
KCl: 0.1 M
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B.6 SDS-PAGE
To prepare an SDS-PAGE, first a resolving gel must be prepared, as given in
Table B.1. The TEMED initiator must be added last and then the mixture is
immediately pipetted into a gel caster. Once the gel has set, a stacking gel is
prepared using the ingredients given in Table B.2. The stacking gel is added on
top of the revolving gel in the gel caster, and a comb is inserted into it to leave
gaps for the denatured protein-loading dye mix to be added. It is useful to also
add a small amount of bromophenol blue to the stacking gel so that these gaps
are more visible. After the protein has been added, the gel can be places in an
electrophoresis machine connected to a power source, and run at 180 V for 45
minutes.
Table B.1: 15% Resolving Gel
Reagent Volume (µL)
H2O 2.3 mL
1.5 M Tris, pH 8.8 2.5 mL
30 % Acrylamide mix 5 mL
10 % SDS 100 µL
10 % ammonium persulphate 100 µL
TEMED 4 µL
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Table B.2: 5% Stacking Gel
Reagent Volume (µL)
H2O 2.7 mL
1 M Tris, pH 6.8 500 µL
30 % Acrylamide mix 670 µL
10 % SDS 40 µL
10 % ammonium persulphate 40 µL
TEMED 4 µL
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C.1 Beyond the Discovery Void: New targets for
antibacterial compounds
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ABSTRACT
Antibiotics save many lives, but their efficacy is under threat: overprescription, population 
growth, and global travel all contribute to the rapid origination and spread of resistant 
strains. Exacerbating this threat is the fact that no new major classes of antibiotics 
have been discovered in the last 30 years: this is the “discovery void.” We discuss the 
traditional molecular targets of antibiotics as well as putative novel targets.
Keywords: antibiotics, bacterial resistances to antibiotics, MRSA, discovery void, cell 
wall, cell division.
1. Introduction
Antimicrobial drugs are among the resounding triumphs of modern medical 
science1. Millions of people alive today probably owe their lives, directly or 
indirectly, to our ability to halt the spread of dangerous bacteria inside the 
human body. Despite these successes, there are dark clouds on the horizon. As 
there are more people on the planet, and as they are travelling further, there are 
many more opportunities for resistant strains to arise and proliferate rapidly. 
Routine prescription of antibiotics, even when not strictly needed, adds further 
to the evolutionary pressure on pathogenic bacteria to develop resistance since 
a resistant mutant may actually be less fit than a wild-type in a non-antibiotic 
environment and thus not likely to take over in the absence of the drug.
Taken together, these worrying developments mean that our arsenal of 
antibiotics desperately needs to be broadened, and novel molecular targets must 
be found. Here, we review the history of antibiotics and we consider in detail 
what makes a good antibiotic. This review is written from the perspective that 
if we understand bacterial cell division at the molecular level then we may be 
able to identify new targets for antibacterial drug design, since this process 
is currently unexploited. We discuss the molecular machinery of the classic 
antibacterial target, the peptidoglycan cell wall, in the model Gram-negative 
organism Escherichia coli, and we describe the protein factors involved in 
the switch from peptidoglycan synthesis in cell elongation to peptidoglycan 
synthesis in cell division. We describe the structural components of the cell 
division machinery and the progress to date in the development of antibacterial 
drugs targeted to the inhibition of cell division.
2. A brief history of antibiotic drug discovery and an emerging 
threat
Ever since the germ theory of disease gained acceptance following Pasteur’s 
discoveries and the formulation of Koch’s postulates2 in the late 19th century3, 
the search has been on for a “magic bullet” that would subdue these germs. 
Following the early successes of synthetic agents such as Salversan and the 
sulfa drugs3 – 5, efforts shifted towards natural compounds when Fleming 
demonstrated the antibacterial properties of Penicillium and the subsequent 
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purification of the active compound penicillin by Florey and Chain in 19406 
made its use practicable. Many more natural antibacterial compounds followed 
during the so-called “golden era” of antibiotic drug discovery from 1940 to 
1960. In the 1970s the focus shifted once more, this time toward chemical 
modification of the antimicrobial compounds that were already in use3.
The discovery of daptomycin in 1987 marked the last novel class of 
antimicrobial compounds7, although additional chemical structures have found 
use in the clinic, by virtue of chemical modification strategies. The dearth of 
novel classes becomes an ever more pressing problem as clinically relevant 
bacteria develop resistance to the compounds used in the clinic. Whenever 
resistance to one class becomes widespread, that class can no longer be used 
with guaranteed success and no novel class resides in the pipeline to replace it. 
The result is the so-called Discovery Void (Figure 1).
Modern antibacterial drug design still relies on the well-established 
strategies of whole-cell screening of natural fermentation products and 
the systematic chemical modification of lead compounds. However, these 
techniques are now used in conjunction with high-throughput, in vitro screens 
for inhibition of activity of a purified protein. In addition, the binding of 
Figure 1 Antimicrobial drug discovery timeline. Dates indicate initial discovery or patent 
registration. Compounds named are exemplars for classes, colour-coded by target process 
as follows: green: cell wall formation; orange: folate metabolism; blue: protein synthesis; 
red: DNA replication; black: unique modes of action. Adapted from Silver7.
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a compound to an individual drug target may be tested in silico by running 
“docking” simulations. Indeed, the molecular structure of a large number of 
putative targets has been resolved as a result of the widespread use of protein 
X-ray crystallography.
Resistance is fast becoming a clear and present danger. In 2013 the UK 
Chief Medical Officer (CMO) recommended that antimicrobial resistance 
be put on the national risk register for civil emergencies1. This was one of a 
score of recommendations put forward in the CMO Annual Health Report 
to address the emerging crisis1. Other recommendations included improved 
international collaboration in research, more thorough global surveillance 
and data collection, and the implementation of significant changes to clinical 
practice in the prescription of antimicrobial drugs to both humans and 
animals1. The UK Government responded with the publication of its Five Year 
Antimicrobial Resistance Strategy 2013 – 2018 that detailed targets to improve 
public awareness and understanding of the issue, which should increase patient 
compliance with treatment regimes, and the decisions to conserve the currently 
available treatments, and to invest in new treatments with a focus on vaccination 
which will reduce the requirement for antibacterial drugs. Further improvements 
are a reduction of the number of antibacterial prescriptions and the introduction 
of genomic-level pathogen identification at the point of care. Finally, the report 
envisages changes to the EU regulatory landscape, for instance with regards 
to the agricultural use of antibiotics, tighter research collaboration between 
universities and industry, and financial incentives to commit the pharmaceutical 
industry to carry out more research8.
There are several mechanisms that confer antibacterial resistance. These 
include modification of the drug target by mutation, modification of transport 
proteins which decreases the uptake of the drug into the bacterial cell, drug 
inactivation by enzyme activity, and an increase in the efflux of the drug from 
the cell7. The adaptations that confer resistance may be constitutively active, 
or they may be inducible, for instance as part of a generalised stress response, 
or specifically in response to exposure to the particular drug. Examples of the 
latter are the induction of β-lactamase and aminoglycoside kinase enzymes, 
which are expressed specifically in response to β-lactam- and aminoglycoside-
type drugs, respectively3.
Once resistance-conferring genes have arisen, they can spread. Such genes 
are often acquired through horizontal gene transfer via plasmids, which often 
encode resistance to more than one drug class3. The timescales of resistance 
development are quite unpredictable. For example, resistance of Staphylococcus 
aureus to β-lactam drugs was reported immediately after the introduction of 
penicillin. In contrast, 33 years went by before vancomycin resistance was 
finally recognised7.
Although the incidence of the notorious “superbug” methicillin-resistant 
S. aureus (MRSA) has been in decline in the UK since its peak in 2003 (largely 
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due to improved hospital procedures) MRSA and other drug-resistant strains 
are still of major concern. Carbapenem-resistant Enterobacteriaceae, penicillin-
resistant Streptococcus pneumoniae, vancomycin-resistant Enterococci, and 
multidrug-resistant Mycobacterium tuberculosis and Neisseria gonorrhoeae 
have been earmarked as serious threats1,3,9.
Antibacterial drugs in current use mainly target the synthesis of 
macromolecular assemblies, such as deoxyribonucleic acid (DNA), ribonucleic 
acid (RNA), proteins, or the cell wall. Examples include fluoroquinolones, which 
are DNA topoisomerase inhibitors and rifamycins, which are RNA polymerase 
inhibitors. Drugs that target protein synthesis are named for the ribosomal 
subunit they attack (50S inhibitors include macrolides and amphenicols, 
whereas 30S inhibitors include tetracyclines and aminoglycosides), and drugs 
acting at the level of cell wall synthesis include penicillin binding protein 
(PBP) inhibitors such as β-lactams and transpeptidase inhibitors such as 
glycopeptides10. The success of the inhibitors of cell wall synthesis is due to 
the uniqueness of the molecular targets to the prokaryotes. This is also true of 
many of the components of the cell division machinery which therefore forms 
an attractive new target, although compounds acting at this level have yet to 
reach the market10.
3. What makes a good antimicrobial agent?
An ideal antibacterial target molecule fulfils several desiderata7. First, it 
should be essential to life so that the bacteria perish when the target’s regular 
physiological function is disrupted. Second, the target should be well conserved 
across a range of pathogens so that the drug has a wide range of applicability. 
Third, the target machinery should exhibit little functional redundancy so that 
the bacteria cannot readily evolve a “work-around” that bypasses the need for 
whatever component is targeted. Finally, the target should have no structural 
homologue in mammalian cells (or be unlike mammalian machinery serving a 
comparable function) so that the compound is not toxic to mammalian patients. 
For the antibacterial drugs targeted to DNA synthesis, RNA synthesis and 
protein synthesis, the drug must be highly specific for the prokaryotic target 
since the functions are also essential to the eukaryotic host. Several proteins 
of the machinery that drives cell division meet these desiderata and are hence 
potential targets11. While a compound that hits one of them may be discovered 
serendipitously, it seems reasonable to suppose that an understanding of 
the macromolecular machinery will aid the design and development of new 
antibacterial drugs.
4. A classic target: the cell wall and its associated machinery
Many of the components of the cell wall synthesis machinery were first 
identified as “penicillin-binding proteins” (PBPs). The naming convention has 
retained this reference to the interaction with penicillin, although the binding of 
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an antibiotic can hardly be considered to be their primary physiological role. As 
a detailed discussion of this machinery will naturally lead us to putative novel 
targets, this will be our point of departure.
4.1 The prokaryotic cell wall
The cell wall of a Gram-negative bacterium such as E. coli consists of an inner 
plasma membrane, a 3 – 6 nm thick, single-molecule, peptidoglycan layer, 
and an outer membrane12, as shown in Figure 2. The peptidoglycan layer, also 
known as the murein cell wall, forms a net-like structure, the sacculus, which 
allows the cell to withstand the large internal turgor pressure and to maintain 
cell morphology. Seemingly at odds with this load-bearing “exoskeletal” role, 
the sacculus must somehow permit growth to take place; this requires a degree 
of dynamic adaptability while new material is added and the ability of the cell 
envelope to separate into two components when the cell divides13. During 
growth, the rod-shaped cell elongates while the diameter remains constant. 
Once the cell has approximately doubled in length, it divides by the controlled 
invagination and separation of both inner and outer membrane, sandwiching the 
periplasmic space between them14.
Outer
membrane
Inner
membrane
Periplasm
LPS Porin
Lipoprotein
Peptidoglycan
Figure 2 The cell wall of Gram-negative bacteria. LPS: lipopolysaccharide. Adapted 
from Cabeen and Jacobs-Wagner13.
The sacculus consists of glycan chains that are covalently cross-linked 
by peptides forming a network that lies in an orientated fashion on the cell 
surface, in a single layer (Figure 3), as has been demonstrated by electron cryo-
tomography; in particular, the structure was found to be fairly disordered, with 
the glycan chains lying mainly perpendicular to the long axis of the cell15.
The glycan chains of peptidoglycan consist of alternating units of N-acetyl-
glucosamine (GlcNAc) and N-acetyl-muramic acid (MurNAc), linked by a 
β-1,4-glycosidic bond, and the MurNAc subunit bears a pentapeptide via a 
peptide bond. These linear glycan strands are cross-linked by peptide bonds 
that link the pentapeptides on adjacent strands, the result being an extended 
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peptidoglycan network16, as shown in Figure 4 (the arrangement in this figure is 
more regular than is likely to be the case in vivo; cf. Figure 3).
Peptidoglycan synthesis begins in the cytoplasm where a series of enzymes 
generates uridine-5′-diphosphate (UDP)-GlcNAc from fructose-6-phosphate. 
MurA and MurB enzymes then catalyse the formation of UDP-MurNAc from 
UDP-GlcNAc12,17,18 as shown in Figure 5.
Next, the enzymes MurC–F sequentially add the pentapeptide stem to 
the carboxyl group of the lactoyl moiety of MurNAc (Figure 5): MurC adds 
Figure 3 The organisation of the peptidoglycan cell wall in E. coli. Left: bacterial cell 
with long axis indicated as a black line and circumference as a white band. Right: glycan 
strands (green and amber) lying approximately perpendicular to the long axis of the cell, 
in an otherwise fairly disorganised arrangement, with peptide links between these strands 
shown in red. Adapted from Gan et al.15.
Figure 4 Idealised chemical structure of E. coli peptidoglycan, adapted from Vollmer et 
al.17. M and G correspond to MurNAc and GlcNAc, respectively, and amino acid residues 
are represented as elliptical beads. Peptide bonds that link the glycan strands are indicated 
in red.
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L-alanine and MurD follows, adding D-glutamate, MurE adds meso-2,6-
diaminopimelic acid (an intermediate in lysine biosynthesis) to the γ-carboxylate 
group of the D-glutamate, and MurF adds the D-Ala-D-Ala dipeptide that has 
previously been dimerised by Ddl19.
Next, the phosphorylated MurNAc-pentapeptide precursor is transferred by 
MraY to the membrane-embedded acceptor undecaprenyl-phosphate, yielding 
undecaprenyl-pyrophosphoryl-MurNAc (lipid I); uridine-5′-monophosphate is 
released. Lipid I then receives a GlcNAc donated by UDP-GlcNAc; this step 
is catalysed by MurG and results in undecaprenyl-pyrophosphoryl-MurNAc-
pentapeptide-GlcNAc (lipid II) with the release of UDP20.
Lipid II (a lipid-disaccharide-protein conjugate) then moves to the 
periplasmic phase, where the disaccharide group will be linked up into glycan 
chains (Figure 6). This “volte-face” is mediated by an enzyme whose identity 
remains unclear, FtsW being one candidate21 and MurJ another22.
Once lipid II has been transported to the periplasmic face of the inner 
membrane, glycosyltransferase enzymes (GTases) catalyse the addition of the 
GluNAc-MurNAc disaccharide to a growing glycan chain while transpeptidases 
(TPases) catalyse the peptide crosslinking reactions, the peptidoglycan 
synthases being anchored to the inner membrane12,17,18. The peptide crosslink 
usually observed in E. coli cell walls consists of a peptide bond between the 
carboxyl terminus of the D-Ala of position 4 and the free amino group of meso-
2,6-diaminopimelic acid. The terminal D-Ala of the original pentapeptide stem 
is discarded in the process. Each glycan strand terminates with a 1,6-anhydro-
MurNAc residue, which contains an intra-molecular ring from carbon 1 to 
carbon 6 of the sugar; this prevents any further elongation of the glycan 
chain but it is unclear if this structure is formed during synthesis or in later 
remodelling18. The average glycan chain length is estimated to be between 20 
and 35 disaccharide units for E. coli. Lengths vary from as little as 10 units to as 
high as 45 and growth conditions may be relevant, since in the transition from 
exponential phase to stationary phase, peptide cross linkage and lipoprotein 
content increase and the mean glycan chain length decreases23 – 25. There are 
three classes of peptidoglycan synthase enzymes, the monofunctional GTases, 
the monofunctional TPases, and the bifunctional GTase and TPases26. The 
proteins were originally identified as ligands of penicillin and are still referred 
Figure 5 The synthesis of UDP-MurNAc from UDP-GlcNAc by MurA and MurB. PEP is 
phosphoenolpyruvate. Adapted from Barreteau et al.19.
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to as the penicillin-binding proteins (PBPs)27,28. E. coli has three class-A 
bifunctional PBPs (PBP1A, PBP1B, and PBP1C) and two monofunctional 
TPases (PBP2 and PBP3). The presence of either PBP1A or PBP1B is essential 
for life29. Although PBP1A has been shown to act in elongation and PBP1B in 
cell division, each protein can compensate for the absence of the other. PBP1C 
is non-essential and its over-expression cannot compensate for the loss of both 
PBP1A and PBP1B30. The monofunctional GTase MtgA is non-essential in 
E. coli and may play a role in cell division31.
The peptidoglycan wall is also linked to the outer membrane via Braun’s 
lipoprotein (Lpp), a small 58-residue protein with an S-glycerylcysteine at the 
N-terminus, which is modified with three fatty acids. These are embedded in the 
outer membrane in vivo. The C-terminal lysine residue is covalently attached to 
peptidoglycan via a peptide bond between the ε-amino group of the lysine side 
chain and the α-carbonyl of meso-2,6-diaminopimelic acid32,33.
4.2 The elongasome
Cell growth and division both require that new peptidoglycan be synthesised and 
covalently linked to the old peptidoglycan sacculus within the periplasm13,14. In 
cell division this is achieved by the organisation and activation of the divisome 
protein complex34, which is discussed below. In cell growth, a different set of 
proteins assembles at the inner membrane; this is the “elongasome”, named as 
such since the addition of new cell wall material results in cell growth along 
the long axis in rods such as E. coli35. Whereas mutations of the divisome 
components result in cell filamentation, a loss of function within the elongasome 
results in a spherical phenotype35,36.
Figure 6 Peptidoglycan synthesis at the inner membrane. M and G correspond to MurNAc 
and GlcNAc, respectively. The pentapeptide stem is represented as a string of coloured 
beads. On the periplasmic side of the membrane (top), the polysaccharide is formed by 
the polymerisation of the basic GlcNAc-MurNAc-pentapeptide disaccharide subunit 
(M-G-pentapeptide); PBPs are penicillin binding proteins. The units are delivered to the 
cytoplasmic face of the membrane (bottom) by the enzymes MraY and MurG. Adapted from 
Bouhss et al.20.
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Elongasome complexes are dispersed along the entire cell wall, so that new 
peptidoglycan is incorporated diffusely along the long axis of the cell while the 
length of the short axis remains constant14. Polar peptidoglycan is stable and 
tends not to be remodelled over time37.
The elongasome comprises MreB, MreC, and MreD, proteins that are 
essential for the maintenance of the rod shape of E. coli38. MreB is an actin 
homologue39 that was shown to form polymers in vitro in the presence of 
ATP, when purified from Thermotoga maritima40. MreB polymerises in vivo 
and binds directly to the inner cell membrane via an amphipathic helix41. 
This protein was once believed to form a large helical structure that extended 
along the long axis of the cell in both E. coli and Bacillus subtilis42, but this 
has since been disputed43. It is now thought that MreB forms short filaments 
in vivo and that elongasome complexes form discrete patches in the membrane 
that move along the cell wall41. However, the mechanism of movement is as 
yet unclear. Discrete foci appear to move around the circumference of the cell, 
which suggests that the complex may follow the direction of the glycan chains 
of peptidoglycan. This rotation depends on the synthesis of peptidoglycan in 
the periplasm, and not on the ATPase activity of MreB44. On the cytoplasmic 
face of the inner membrane, MreB recruits components of the lipid II synthesis 
machinery MurG and MraY to the elongasome complex45. The RodZ protein, 
which contains a single transmembrane domain is also recruited to the 
elongasome via a direct interaction with MreB46,47.
Interestingly, the diameter of the round cells produced on RodZ mutation is 
close to that of the short axis of wild-type cells, whereas treatment of cells with 
the MreB inhibitor A22, which causes MreB to dissociate from the membrane48, 
results in spherical cells whose diameter is close to the length of the long axis 
of the wild-type cells. This suggests that MreB controls the maintenance of the 
short-axis length while RodZ determines the long-axis length49.
MreC is an inner membrane protein with a large C-terminal periplasmic 
domain that forms filaments in vivo50. MreC interacts with MreB, MreD, and 
with large periplasmic PBPs, thus recruiting peptidoglycan synthetic enzymes 
to the elongasome50. Sequence analysis indicates that the protein is mostly 
hydrophobic with several transmembrane domains51.
Another elongasome component is RodA; loss of this protein also results 
in a spherical phenotype. It has been suggested that RodA may mediate lipid II 
translocation in the elongasome, since it shares 30% sequence identity with 
FtsW35,52. However, as discussed, the lipid II translocase activity of FtsW is 
disputed21,22.
The “diffuse” insertion of new peptidoglycan, associated with the 
elongasome, is quite distinct from the insertion of material at the midcell/cell 
pole (every cell pole is a former midcell), associated with the divisome: the 
two processes appear to employ different (but overlapping) sets of enzymes, 
as attested by the fact that cells treated with PBP2-specific mecillinam become 
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spherical and then lyse, whereas cells treated with PBP3-specific aztreonam 
become filamentous, with aborted Z-ring constrictions. This suggests that PBP2 
is an elongasome component while PBP3 belongs with the divisome27. In fact, 
although PBP2 is part of the elongasome, it may also contribute to the initial 
stages of cell division as it transiently localises to the midcell, a process that 
requires active PBP3, as PBP2 did not localise to the midcell under aztreonam 
treatment26.
As previously noted, notwithstanding the apparent different physiological 
functions of PBP1A and PBP1B, each can compensate for the absence of the 
other in vivo29. Whereas PBP1A binds PBP2 and is thought to be active in 
cell elongation and in the early stage of cell division26, PBP1B binds PBP3, 
suggestive of a role in late cell division53. In the absence of PBP1A, cells have 
a smaller diameter with a longer time period between cell divisions, indicative 
of sluggish elongation54. The “diffuse” localisation of PBP1A supports a role 
in elongation, although in the absence of PBP1B, the midcell localisation of 
PBP1A increases in keeping with its compensatory role54. The activators of 
PBP1A and PBP1B, LpoA and LpoB respectively, do localise to the midcell 
during cell division, although LpoA localisation is relatively weak55,56.
Some components of the elongasome complex, such as MreB, PBP2, 
and MurG, migrate simultaneously to the midcell, which might underpin the 
transition from elongating growth to the formation of the septum that will 
divide the daughter cells57. A transitory elongasome/FtsZ complex prevails 
between 20% to 60% of the cell cycle time, when the preseptal peptidoglycan 
synthesis occurs; an interaction between PBP2 and PBP3 was also measured 
during the mixed phase by Förster resonance energy transfer (FRET)57. When 
the elongasome components leave the complex, the late divisome completes 
cell separation57.
4.3 Peptidoglycan turn-over and remodelling
Half of the cell wall material is turned over during each cell generation and 
most of this material is re-incorporated into the sacculus. The products of 
peptidoglycan hydrolysis accumulate in the periplasm and are transported back 
into the cytoplasm for recycling58.
There are several enzymes that degrade peptidoglycan (Figure 7): 
N-acetylmuramidases and N-acetylglucosaminidases hydrolyse the β-1,4-
glycosidic bonds of the glycan chains; N-acetylmuramidases cleave between 
MurNAc and GlcNAc subunits to produce a GlcNAc-MurNAc product (these 
enzymes are further categorised as lysozymes and lytic transglycosylases 
based on their generation of reduced MurNAc or 1,6-anhydro-MurNAc 
respectively)59,60; N-acetylglucosaminidases cleave between successive 
GlcNAc and MurNAc units to produce a MurNAc-GlcNAc degradation 
product60; DD-endopeptidases including PBP4, PBP7, and MepA cleave 
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the crosslink peptide bond between the D-Ala of one strand and the meso-
2,6-diaminopimelic acid of the neighbouring strand60,61; MurNAc-L-alanine 
amidases or peptidoglycan amidases including AmiA, AmiB, and AmiC 
hydrolyse the peptide bond between MurNAc and L-Ala at the first position of 
the peptide side chain62; LD-endopeptidases cleave between L-Ala and D-Glu at 
positions 1 and 2 of the peptide stem; DL-endopeptidases cleave between D-Glu 
and meso-2,6-diaminopimelic at positions 2 and 3; LD-carboxypeptidases 
cleave between meso-2,6-diaminopimelic and D-Ala at positions 3 and 4, and 
D,D-carboxypeptidases such as PBP4, PBP5, and PBP6 cleave between D-Ala 
and D-Ala at positions 4 and 5 60,63.
The peptides released into the periplasm are transported back into the 
cytoplasm by the MppA-OppBCDF permease complex64. Penta-, tetra-, and 
tripeptide GlcNAc-1,6-anhydro-MurNAc degradation products are transported 
into the cytoplasm by the inner membrane AmpG permease65. Subsequently, 
the enzyme NagZ cleaves the glycosidic bond of the disaccharide66,67, 
AmpD removes the peptide stem of 1,6-anhydro-MurNAc peptides68,69, and 
LD-carboxypeptidase (LdcA) removes the D-Ala from the tetrapeptides70. 
The peptides are also directly recycled by the formation of a peptide bond 
with MurNAc, catalysed by Mpl60,61,71. The monosaccharide units are fed back 
into the UDP-GlcNAc synthesis pathway by conversion to glucosamine-6-
phosphate60,72.
Figure 7 Peptidoglycan degradation and recycling. Several peptidoglycan hydrolysis 
enzymes act in the periplasm; the resulting degradation products are transported back to 
the cytoplasm by AmpG and subsequently processed and regenerated into lipid II; “anh-
MurNAc” stands for 1,6-anhydro-MurNAc. Adapted from Sobhanifar et al.60.
165www.scienceprogress.co.uk New targets for antibacterial compounds
A cut-and-insert model of peptidoglycan synthesis was originally proposed 
in which the peptidoglycan must be locally degraded, before insertion of new 
material that is then crosslinked73,74. Later work suggested that new material 
was added as single strands75. However, in another model of peptidoglycan 
synthesis, three new peptidoglycan strands are synthesised and inserted into the 
sacculus with degradation of one old glycan strand14,25, every second strand being 
replaced by three new strands per cell generation76. Possibly, a monofunctional 
transglycosylase synthesises a glycan strand, while one or more bifunctional 
PBPs synthesise a strand on either side and catalyse the attachment of the outer 
strands to the central strand. In this model, PBP4 or PBP7 cut the old inter-strand 
linkages whereas PBP2 or PBP3 link the new glycan triplet to the sacculus. An 
outer membrane lytic transglycosylase such as Slt70, MltA, or MltB might then 
remove the original docking strand76. In this manner, multiprotein complexes 
would co-ordinate the synthesis and degradation of peptidoglycan and the pre-
existing peptidoglycan matrix can serve as a template to maintain a constant 
cell diameter through each generation77.
Notwithstanding the attractiveness of this model, a discrete macromolecular 
complex remains to be identified in vivo. Nevertheless, an interaction between 
PBP1B and MltA was observed in vitro78, and the formation of a complex of 
the lytic transglycosylase Slt70, the DD-endopeptidase PBP7 and PBP3 has 
been reported79. Furthermore, MltB interacts with PBP1B, PBP1C, and PBP380, 
which might contribute to septum formation79.
4.4 PBP3-independent peptidoglycan synthesis at the midcell region
E. coli is characterised by a constrictive mode of cell division in which the 
invagination of the inner and outer membranes and the synthesis of new cell 
wall material occur simultaneously; this stands in contrast to many Gram-
positive bacteria in which the new cell wall is synthesised along the midcell 
before membrane invagination18,35,58. In E. coli, peptidoglycan remodelling may 
contribute a pushing force from outside of the inner membrane in the periplasm 
in addition to the inner pull from the constriction machinery81.
Whereas the Z-ring forms at 39% of the way through the cell cycle time, 
PBP3 (also separately named as FtsI) and the cell-division trigger FtsN (see 
Section 5.4) are not recruited until 59% of the cell cycle time, a delay that 
allows the PBP3-independent synthesis of pre-septal peptidoglycan at the 
division site82. This was confirmed by a pulse-chase labelling experiment using 
D-cysteine which indicated that the “diffuse” insertion of new peptidoglycan 
during growth and cell elongation is followed by “local” synthesis at the 
midcell consequent on the formation of the Z-ring that drives septum formation 
and constriction at the midcell37, as shown in Figure 8. Following cell division, 
the peptidoglycan synthesised at the new cells’ poles remains stable throughout 
the following division cycles37. This division-zone peptidoglygan synthesis is 
critically dependent on the presence of a Z-ring83.
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5. Putative novel targets: the divisome and the Z-ring
Cell constriction, septal/polar peptidoglycan synthesis, and the coordination 
of cytokinesis go hand in hand. We have previously reviewed the divisome84, 
represented schematically in Figure 9, in full detail and therefore will focus our 
attention here on critical processes that might pose good candidates for novel 
antibiotics.
5.1 Breaking down the Z-ring: ClpXP
The core component of the division machinery is the Z-ring (Figure 9), which is 
composed of filaments of the FtsZ protein. Enhancing the turn-over of this key 
protein could be one avenue of disrupting cell division.
FtsZ is degraded by ClpXP85, a complex of ClpX and ClpP. The former 
belongs to the AAA+ protein family and can either act alone, remodelling 
proteins and disassembling polymers, or it may engage the serine protease ClpP 
in protein degradation, where ClpP forms two stacked heptameric rings, capped 
at one or both sides by a hexameric ring of ClpX, which controls the transfer of 
substrates into the proteolytic cavity86.
ClpXP degrades FtsZ polymers in vitro in the presence of ATP and GTP, 
with polymers being the preferred substrate although monomers are also 
degraded87. The C-terminal tail of FtsZ is required for efficient ClpXP binding 
and degradation87 and MinC competes with ClpXP for binding to FtsZ88. 
In the absence of ATP, ClpX appears to exist predominantly as a dimer with 
the N-terminal domain accessible for FtsZ binding, sequestering FtsZ and 
inhibiting polymerisation, whereas in the presence of ATP, the ATP-independent 
sequestering effect becomes sterically less favoured but ATP-dependent 
degradation of FtsZ by the ClpXP complex can proceed89.
Figure 8 PBP3-independent peptidoglycan synthesis at the midcell. A temperature-
sensitive PBP3 E. coli strain was grown at 42 °C during the chase period. (A) Sacculi 
were purified and labelled using an anti-peptidoglycan antibody. (B) D-Cys residues 
incorporated during the pulse phase were biotinylated and labelled with an anti-biotin 
antibody. Dark regions in (B) that are stained in (A) indicate new peptidoglycan synthesised 
in the chase phase. Scale bar indicates 1 μm. From Potluri et al.83.
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The ClpXP complex was shown to interact with FtsZ in vivo. On addition 
of spectinomycin to prevent protein synthesis, the half-life of FtsZ in wild-
type cells was 115 minutes, which corresponds to a loss of 13% of FtsZ per 
cell cycle. In cells lacking ClpX, the FtsZ half-life increased to 205 minutes 
whereas in cells over-expressing ClpXP, it decreased to 45 minutes87. The 
ATPase activity of ClpX is required for FtsZ turnover in vivo90.
5.2 Z-ring stability: the Zap proteins
The Z-ring associated proteins ZapA–E support the stability and efficiency 
of the Z-ring91. Light scattering and electron microscopy indicated that ZapA 
induces the bundling of FtsZ polymers92. In contrast to the lack of phenotype 
on the loss of ZapA in B. subtilis, deletion of the zapA gene in E. coli has 
been shown to affect cell growth93, as localisation of the Z-ring becomes 
less reliable94. In E. coli, ZapA interacts with FtsZ which promotes polymer 
bundling and reduces GTPase activity by 20 – 24%93,95.
ZapA is a dimer of dimers where each of the N-terminal domains interacts 
with an FtsZ subunit96. The ZapA tetramer therefore crosslinks two FtsZ 
filaments that each contain two FtsZ polymers arranged antiparallel. The ZapA 
tetramer links FtsZ filaments in a “rungs of a ladder” structure93,96,97.
ZapA also interacts with ZapB, possibly via an interaction at the coiled-
coil domain of ZapA94. In the absence of ZapB in E. coli, division is delayed 
and ectopic Z-rings are observed98. The ZapB protein is a coiled-coil dimer 
and it was shown to polymerise into filaments in vitro98, whereas in vivo it 
forms a ring at the midcell with a slightly smaller diameter than the FtsZ ring, 
constricting just prior to the FtsZ-ring during cytokinesis99. This ZapB ring has 
been suggested to stabilise the FtsZ ring at its inner face94. ZapB has also been 
shown to interact with MatP (see Section 5.5), suggestive of a link between 
DNA replication and cytokinesis100. Indeed, on ZapB over-expression, the 
Figure 9 The prokaryotic divisome, the complex of proteins that orchestrates cytokinesis 
in prokaryotic cells. Cylinders represent transmembrane domains.
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nucleoid appears condensed and aberrant cell division occurs, resulting in very 
small cells as well as filaments98.
ZapC localises to the Z-ring as an early cell division protein in vivo; cells 
lacking ZapC are elongated. Moreover, at high concentrations, ZapC causes 
the formation of ectopic Z-rings, leading to cell filamentation101. ZapC binds 
directly to FtsZ, promoting bundling in vitro102 with a reduction of the GTPase 
activity of FtsZ of up to 60%101.
ZapD binds directly to FtsZ, inducing FtsZ polymer bundling and a 
reduction of GTPase activity in vitro of up to 60%91. Purified as a dimer in vitro, 
ZapD binds to the C-terminal tail of FtsZ91. Whereas ZapD is non-essential, 
combined loss of ZapA and ZapD leads to cells that are longer than is observed 
on loss of either gene by itself. Overexpression of ZapD led to cell filaments 
and aberrant Z-ring formation91.
In contrast to the other Zap proteins, ZapE is a late recruit to the divisome, 
as was confirmed when the midcell localisation of ZapE was found to coincide 
with cell constriction103. ZapE disrupts the formation of Z-rings when over-
expressed in vivo and cells become filamentous; no Z-rings have been observed 
when ZapE is overexpressed103. This effect may be linked to ZapE’s ability to 
hydrolyse ATP in vitro and to bundle FtsZ polymers into large, destabilised 
three-dimensional structures in the presence of ATP103.
5.3 Coordination of midcell peptidoglycan remodelling: FtsEX
FtsEX is an apparent ABC transporter, consisting of FtsX, which is an integral 
membrane protein, and FtsE, which contains the ATP binding domain and 
interacts directly with FtsZ (Figure 10). The interaction does not appear to 
require ZipA, FtsA, or the C-terminal tail of FtsZ104,105. Loss of the FtsEX 
complex is conditionally lethal in E. coli. When grown in low-salt medium (less 
than 0.5% NaCl) cells filament, despite apparent Z-ring formation, as late cell 
Figure 10   Recruitment and activation of peptidoglycan amidases by the FtsEX complex. 
The periplasmic loop of FtsX is required for the recruitment of the amidase activator 
EnvC109.
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division proteins fail to be recruited104,106. Supplementation of other osmolytes 
including glucose, sucrose, or glycerol to the growth medium can rescue the 
loss of FtsEX.
In bacterial two-hybrid screens, FtsX was found to interact with FtsA and 
with FtsQ107. Moreover, FtsEX recruits and controls the activity of EnvC, an 
activator of the peptidoglycan amidases AmiA and AmiB, which are key 
to splitting the peptidoglycan sacculus during cell separation108. The large 
periplasmic loop of FtsX binds to EnvC and is required for the recruitment of 
the latter to the divisome. The ATPase activity of FtsE is thought to be required 
for EnvC activation as mutations of FtsE that are predicted to cause ATP-
binding or ATPase deficiencies did not affect the recruitment of EnvC to the 
midcell, however, division was impaired in these cells. Measurement of the 
ATPase activity of the mutant proteins has not been completed due to the poor 
solubility of purified FtsE in vitro109. A model for the activation of peptidoglycan 
amidases via FtsEX is given in Figure 10.
5.4 Triggering Z-ring constriction: the late division proteins
The late division proteins from FtsK to FtsN appear to assemble at the midcell 
concurrently82. FtsK is a DNA translocase. It resolves DNA dimers formed 
due to incomplete homologous recombination and may contribute to the link 
between chromosome segregation and cytokinesis110,111. The FtsK N-terminal 
domain, which contains four membrane-spanning helices, is required for the 
localisation of the protein to the midcell in vivo and therefore is essential, 
whereas the DNA translocase activity of its C-terminal domain was found to be 
non-essential112,113.
FtsBLQ is recruited to the midcell as a complex. FtsB and FtsL both 
contain a single transmembrane domain and a short C-terminal periplasmic 
domain that form a putative leucine zipper, which may mediate the FtsLB 
heterodimerisation. FtsQ also has a single transmembrane domain but with a 
large periplasmic C-terminal domain of unknown function34,114. It is thought 
that the BLQ complex has two stable configurations, one that blocks cell 
constriction, and one that promotes or triggers it. Interactions with FtsA and 
FtsN lead to transitions between these states115, as shown in Figure 11.
FtsW and FtsI(PBP3) also interact and form a complex, independently of 
the other late cell division proteins116. FtsW, which contains 10 transmembrane 
domains, features a 66-residue periplasmic loop region between transmembrane 
domains 7 and 8 that appears to be essential for the function of FtsW in vivo. 
FtsW may act as the lipid II translocase21, or this role may be served by 
MurJ22, or by both these proteins. The loop between transmembrane domains 
9 and 10 of FtsW mediates the docking of FtsI117. In addition to its role as a 
monofunctional transpeptidase in peptidoglycan synthesis, FtsI(PBP3) interacts 
with the bifunctional enzyme PBP1B in vitro as well as in vivo118. FtsI(PBP3) 
was also shown to interact directly with FtsN in vitro119.
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Cell constriction commences upon the arrival of the final essential cell 
division protein, FtsN, suggesting that this membrane protein acts as a 
trigger120,121. FtsN interacts directly with the early cell division protein FtsA, via 
domain 1C of FtsA, an interaction that may signal the completion of divisome 
assembly to FtsZ122.
Overexpression of FtsN can be used to compensate for the depletion of 
FtsA, FtsK, FtsI, and FtsQ123 and to restore cell division in cells lacking FtsEX 
grown in low salt medium124. FtsN was also the only late cell division protein 
to bypass the requirement for ZipA in E. coli when overexpressed125. Although 
ZipA is required for the recruitment of the downstream cell division proteins, it 
has been shown that only FtsA interacts with them directly121.
The interaction of FtsN with FtsA depends on the first 55 residues of 
FtsN, which comprise a short cytoplasmic region (residues 1 – 28) and the 
transmembrane domain (residues 29 – 55), a conserved motif at residues 4 – 6 
(R/KDY) of FtsN being the FtsA binding site125. This binding apparently 
promotes oligomerisation of FtsN which drives the accumulation of FtsN at the 
midcell120,122. Midcell localisation of FtsN is further enhanced by the C-terminal, 
periplasmic SPOR domain of FtsN (residues 242 – 316), which binds to glycan 
strands that lack stem peptides, and these are generated by the activity of the 
peptidoglycan amidases AmiA–C120,121,126. The enhanced localisation of FtsN via 
the SPOR domain depends on the presence of FtsI and at least one of AmiA–C at 
the midcell120. The essential function of FtsN resides in a small region, residues 
71 to 105. When targeted to the periplasm, this peptide supported the growth of 
ftsN – cells, although division was relatively inefficient and the fusion protein 
was found to be dispersed throughout the periplasm, rather than specifically 
localised to the midcell120.
In sum, it appears that the FtsBLQ complex localises to the midcell in 
the state where it suppresses cell constriction and peptidoglycan synthesis, 
Figure 11  A model for the activation of Z-ring constriction in E. coli. (A) Prior to the 
recruitment of FtsN, the FtsBLQ complex suppresses FtsI. (B) On recruitment of FtsN 
via an interaction with FtsA, the FtsBLQ complex is activated, leading to the initiation of 
peptidoglycan remodelling. The contraction of the Z-ring is activated via FtsA.
171www.scienceprogress.co.uk New targets for antibacterial compounds
involving perhaps a direct interaction with FtsWI. Binding of FtsN to FtsA 
supports initial midcell accumulation of FtsN, which interacts with the FtsBLQ 
complex and induces a state transition in the latter, which relieves the FtsBLQ-
mediated suppression of peptidoglycan synthesis and remodelling. As the latter 
two processes are disinhibited, cell separation can commence. The mechanism 
is represented schematically in Figure 11.
The peptidoglycan amidases AmiB and AmiC, as well as the AmiC activator 
protein NlpD108, are recruited downstream of FtsN127,128 and their presence, 
coupled with the activation of FtsWI by FtsBLQ leads to an increase in the 
local concentration of the substrate for binding of the SPOR region of FtsN. 
This acts as a positive feedback loop for the further recruitment of FtsN and 
maintains and augments the pro-constriction state.
Oligomerisation of FtsA may sterically hinder its binding to FtsN121. A 
mutant form, FtsA*, has a reduced self-interaction and appears to be more 
potent than wild-type FtsA, e.g. bypassing the ZipA requirement; in the wild-
type, ZipA may antagonise the self-interaction of FtsA, in addition to anchoring 
the Z-ring to the membrane125,129.
5.5 Formation and localisation of the Z-ring: SulA, Min, nucleoid 
occlusion, and MatP
In E. coli, the SulA protein, which is expressed in response to DNA damage, 
inhibits the formation of the Z-ring, and this arrests cell division until the DNA 
damage has been repaired130 – 133. If the latter is prevented from being completed, 
the persistent block on cell division leads to the filamentous phenotype134. 
SulA can arrest cell division even when expressed artificially, in the absence of 
DNA damage130,135.Once the DNA damage is repaired, recovery of cell division 
function is rapid134,136, due to the short half-life (~ 1 min) of SulA. When protein 
expression is blocked with spectinomycin, SulA is rapidly removed by Lon 
protease and a new Z-ring forms135.
Z-ring formation is restricted to the midcell region, as the Min system 
blocks Z-ring formation at the cell poles. As it is essential that chromosome 
replication and segregation are complete prior to cytokinesis, lest the nucleoid 
(the DNA-containing region of the cell) is severed by the contracting Z-ring137, 
a “nucleoid occlusion” (NO) mechanism bars Z-ring formation in regions of 
the cell that contain genetic material. The B. subtilis protein Noc was the first 
nucleoid occlusion factor found138 and SlmA was subsequently identified in 
E. coli139. The two proteins have no sequence or structural similarity and contain 
different DNA-binding domains137: Noc is similar to the ParB family140 whereas 
SlmA contains a TetR-like DNA-binding domain141.
SlmA inhibits FtsZ polymerisation in vitro and increases the GTPase 
activity of FtsZ by 36%. By binding to the C-terminal tail of FtsZ, SlmA 
induces polymer destabilisation and breakage of the filament142. Moreover, 
SlmA dimers may sequester FtsZ polymers into structures that are incompatible 
with Z-ring formation141.
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A third mechanism in Z-ring positioning, besides Min and NO, acts at the 
level of the replication termination region (Ter) of the E. coli chromosome, 
which is localised near the cell pole that arises upon cell division143. In 
particular, the MatP dimer binds to the Ter region and the two then move to 
the midcell. Moreover, the MatP focus splits and separates as Ter segregates143. 
Deletion of the matP gene causes cell filamentation, cell elongation, and the 
appearance of anucleate minicells in rich medium, whereas in minimal medium 
there is no division defect. In the absence of MatP, the positioning of the Ter 
region at the midcell is less precise and the separation of the Ter region occurs 
earlier in the cell cycle100,143.
The MatP protein provides a link between chromosome segregation and 
cell division as it has been shown to interact with ZapB, in the presence of 
ZapA100. MatP binding to the Ter region of DNA acts as a positive signal for 
Z-ring formation in the absence of the negative regulators MinC and SlmA144.
6. Drug candidates that target FtsZ
FtsZ appears to satisfy the criteria outlined in Section 3: it is essential to life and 
is well-conserved across most bacterial species; it is the first protein to localise 
to the midcell and is required for the downstream recruitment of all other cell 
division proteins18. Therefore, an inhibitor of the function of FtsZ is likely to 
be lethally disruptive to the division process. Although FtsZ is a structural 
homologue of eukaryotic tubulin, the disparate primary structures suggest that 
FtsZ-specific inhibitors are feasible11. Intriguingly, this has not been found to 
date, so in the final section of this review we consider what is known and suggest 
possible ways forward. We also refer to our mathematical model titled Critical 
Accumulation of Membrane-bound FtsZ Fibres (CAM-FF) that describes the 
formation of the Z-ring and the initiation of cell division. CAM-FF was used to 
assess the efficiency of the biochemical drug targets of the FtsZ molecule by the 
definition of a drug sensitivity co-efficient. A high co-efficient value corresponds 
to a site at which inhibition is highly toxic to the cell division process145,146.
A drug molecule might compete with GTP at the GTP-binding pocket, 
thus blocking FtsZ polymerisation. However, this approach risks toxicity to 
other processes that require GTP binding, such as protein synthesis, signal 
transduction, and tubulin polymerisation in mammalian cells. Alternatively, a 
drug that mimics the SulA:FtsZ interaction at the T7 loop of FtsZ could block 
FtsZ polymerisation. Other possibilities include a drug that stabilises polymers 
to prevent subsequent depolymerisation, or one that blocks the interaction of 
FtsZ with its binding partners through its C-terminal tail11.
The discovery of a specific inhibitor of FtsZ function is only part of the 
process, however. The drug’s pharmacokinetics, as well as access of the drug 
to the target in cells, must be addressed in drug development7. This stage of 
the drug design process suffers from poor follow-up of previously reported 
inhibitors in the literature147.
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To date, there have been several examples of success in the search for small 
molecule inhibitors of FtsZ. Several compounds found to have anti-FtsZ activity 
are shown in Figure 12. Both naturally-derived and synthetic inhibitors have 
been identified using whole-cell filamentation tests, high-throughput FtsZ in 
vitro assays, as well as computational and structure-based design initiatives148. 
Although an antibacterial drug active against the cell division machinery 
is yet to reach the market, the examples below demonstrate the potential for 
exploitation of this system in the design and development of the antibacterial 
drugs of the future11,148.
6.1 GTP analogues
To block the GTP-dependent polymerisation of FtsZ, C8-substituted GTP 
analogues have been tested and were shown to inhibit FtsZ polymerisation 
in vitro149,150. The small substitutions did not inhibit tubulin assembly150. 
Unfortunately, the C8-substituted guanine, guanosine, guanosine-5′-
monophosphate (GMP), and guanosine-5′-triphosphates were later found to be 
ineffective antibacterial agents against E. coli, despite the strong inhibition of 
FtsZ polymerisation in vitro; moreover, the lack of toxicity was not due to low 
intracellular accumulation, nor to the absence of conversion of the analogue to 
the inhibitory triphosphate form151. The solutions of the mathematical equations 
of CAM-FF may explain this result. According to CAM-FF, the GTP-binding 
site is a poor antibacterial target since the drug sensitivity co-efficient is low 
at 0.043145,146. As an alternative approach to blocking the N-terminal FtsZ 
polymerisation surface, Sorto et al. designed T7-loop mimics by in silico 
docking of compounds into the T7 binding region of the SulA:FtsZ co-crystal 
structure from Pseudomonas aeruginosa152. These compounds have been 
synthesised and tests of activity are under way153. According to CAM-FF, the 
T7 loop is a highly efficient antibacterial target since a low level of inhibition 
results in the disruption of cell division; the drug sensitivity coefficient is high 
at 1.035 145,146.
6.2 3-Methoxybenzamide analogues
An inhibitor of ADP-ribosyltransferase, 3-methoxybenzamide (3-MBA), was 
found to cause filamentation of B. subtilis but the phenotype could be suppressed 
by mutations in the ftsZ gene. This suggested that the target of 3-MBA was 
the FtsZ protein154. Subsequently, 500 analogues of 3-MBA were synthesised 
and tested for antibacterial activity; among these, the difluorobenzamide 
PC190723 (3-[(6-chloro[1,3]thiazolo[5,4-b]pyridin-2-yl)methoxy]-2,6-
difluorobenzamide) turned out to be a potent inhibitor of both B. subtilis and S. 
aureus. In the latter, both single-drug-resistant and multi-drug-resistant strains 
were susceptible, while PC190723 was non-toxic to human hepatocytes155,156.
Furthermore, in a mouse model of S. aureus infection, all animals survived 
following a single intravenous dose of PC190723, compared to nil survivors 
without treatment155.
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In later work, PC190723 was shown to be more effective than vancomycin 
and linezolid against MRSA growth, with a minimum inhibitory concentration 
of 0.2 μg/mL, compared to 2 μg/mL for vancomycin and linezolid. PC190723 
was also shown to act synergistically with imipenem and other β-lactam 
antibiotics in vivo. In a mouse model of MRSA infection, neither imipenem nor 
PC190723 (at higher doses than used in the original study) resolved the infection 
as a single agent. However, when co-administered, a significant reduction in the 
number of colony forming units in mouse thigh homogenates was observed156.
FtsZ-cyan-fluorescent-protein and green-fluorescent-protein-FtsZ fusions 
exhibited disrupted localisation in MRSA and B. subtilis, respectively, on 
treatment with PC190723: multiple rings and arcs of FtsZ, not restricted to 
the midcell, were observed155,156. PC190723 was shown to stabilise polymers 
of B. subtilis and S. aureus FtsZ and to reduce their GTPase activity. Curved 
structures, bundles, toroids, and helices of FtsZ were also observed in vitro 
using electron microscopy157. These effects were not observed for FtsZ purified 
from E. coli, which is not susceptible to growth inhibition by PC190723155,157.
The binding of PC190723 to S. aureus FtsZ stabilises the active form 
to promote polymerisation. This reduces the concentration required for 
polymerisation and leads to loss of the critical concentration and co-operativity 
of FtsZ polymerisation that is observed in the absence of the compound158. 
The crystal structure of S. aureus FtsZ in complex with PC190723, shown in 
Figure 13, revealed that the compound binds in the cleft between the interdomain 
helix H7 and the C-terminal domain with the benzamide moiety close to the T7 
loop. The site is similar to the taxol binding site of tubulin159. The stabilisation 
of FtsZ polymers may be initially beneficial to the cell in the formation of the 
Z-ring. Indeed, CAM-FF predicts that cells are better able to form the Z-ring 
and to initiate cell division if polymers are stabilised and the GTPase activity is 
reduced. However, the subsequent depolymerisation of the Z-ring is inhibited 
and this will prevent the progression of cell division after initiation145,146.
The low solubility of PC190723 hampers its use as an oral drug; to address 
this, a prodrug derivative referred to as TXY436 was developed. Whereas 
PC190723 was ineffective as an oral preparation, 100% of methicillin-sensitive 
S. aureus (MSSA)-infected mice that were treated with oral TXY436 survived, 
as did 67% of mice infected with MRSA, compared to 0% survival without 
treatment. Moreover, TXY436 had minimal toxicity to monkey kidney epithelial 
cells160. Compound 8j, shown in Figure 12 is closely related to PC190723 and 
was found to be more potent161. An alternative 3-MBA derivative, referred to as 
compound 1 (Figure 12), also displayed antibacterial activity as a single drug. 
Compound 1 and its succinate prodrug (referred to as compound 2) were both 
effective in the reduction of bacterial load in the murine model of S. aureus 
infection162.
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6.3 Nature’s pharmacopoeia
Several naturally occurring molecules have also been shown to inhibit FtsZ 
activity. For example, in a screen of > 105 extracts of microbial fermentation 
broths and plants, viriditoxin was identified as an inhibitor of the polymerisation 
and GTPase activity of E. coli FtsZ in vitro. Viriditoxin was purified from an 
Aspergillus viridinutans fermentation broth and was found to inhibit the growth 
of all of the drug-sensitive and multi-drug-resistant strains of Staphylococcus, 
Enterococcus, and S. pneumoniae that were tested163. However, viriditoxin 
was later synthesised164 but was found to be inactive against FtsZ from both 
B. subtilis and E. coli; chemical lability of the preparation was suggested to 
be the cause but a trace impurity may have been the active compound in the 
original study148.
Plant-derived compounds have also been reported to be active against 
FtsZ; these include curcumin (1,7-bis-(4-hydroxy-3-methoxy-phenyl)hepta-
1,6-diene-3,5-dione), which inhibits the growth of E. coli and B. subtilis and 
disrupts FtsZ polymerisation by an increase in the rates of GTPase activity and 
the subsequent depolymerisation165. However, curcumin has also been shown 
to inhibit other proteins including FabI in E. coli, as well as HIV integrase and 
human glyoxylase I and monoamine oxidase, which suggests that curcumin is a 
promiscuous inhibitor and therefore may not be useful as a drug lead7.
The plant-based polyphenol coumarins were also shown to inhibit 
B. subtilis cell division and to inhibit E. coli FtsZ polymerisation and GTPase 
activity in vitro. Docking studies suggested that they bind to the T7 loop of 
FtsZ. These compounds were also shown to be non-toxic to NIH/3T3 mouse 
Figure 13  S. aureus FtsZ in complex with PC190723. The compound binds in the cleft 
between the inter-domain helix H7 and the C-terminal domain159.
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embryonic fibroblasts and to human embryonic kidney cell lines166. Berberine 
has also been shown to inhibit the growth of several species including E. coli, 
S. aureus (including MRSA), Streptococcus pyogenes, Vibrio cholerae, 
Clostridium perfringens, and multi-drug-resistant M. tuberculosis. Berberine 
inhibits E. coli FtsZ polymerisation and GTPase activity by competition with 
GTP for binding to FtsZ167. The plant compound sanguinarine was also found 
to inhibit the growth of several Gram-negative and Gram-positive species 
and to inhibit FtsZ polymerisation and GTPase activity in vitro168. However, 
sanguinarine also inhibits tubulin in vitro and may be toxic to eukaryotic 
cells168. Finally, cinnamaldehyde also inhibited E. coli FtsZ polymerisation and 
GTPase activity in vitro and was antibacterial against E. coli and B. subtilis169.
6.4 The chemist’s pharmacopoeia
Several high-throughput screens of chemical libraries have yielded further 
small molecules that are active against FtsZ. For example, the five chemically 
distinct Zantrins were identified in a screen of over 18,000 chemicals for 
inhibition of the GTPase activity of E. coli FtsZ170. These compounds were also 
shown to inhibit the GTPase activity of FtsZ from M. tuberculosis. Zantrins Z1 
and Z4 were shown to decrease the number and length of E. coli FtsZ filaments 
using electron microscopy, whereas Z2, Z3, and Z5 stabilised the filaments. The 
compound Z1 abolished growth of P. aeruginosa, S. pneumonia, and Bacillus 
cereus and Z1 and Z2 killed E. coli, as did Z3 and Z5 in an E. coli strain lacking 
the major drug pump AcrAB. Furthermore, Z1 – Z3 were active against Shigella 
dysenteriae and Vibrio cholera and Z1 – Z4 were active against MRSA. Zantrins 
were also shown to perturb Z-ring assembly in E. coli170.
Competitive ligands UCM05, UCM44, and UCM53 were likewise 
identified by means of a chemical library screen by using FtsZ from B. subtilis 
and detection of competitive binding to FtsZ with mant-GTP. UCM53 was 
found to be active against B. subtilis and drug-resistant strains of S. aureus, as 
well as ampicillin- and levofloxacin-resistant Enterococcus faecium171. Finally, 
in a cell filamentation screen of 151 rhodanine compounds, compound CCR-11 
was identified as an inhibitor of B. subtilis; this compound was subsequently 
shown to disrupt the localisation of Z-rings in cells and to inhibit the assembly 
and GTPase activity of B. subtilis FtsZ in vitro172.
6.5 Blocking interactions with ZipA
The search for small molecule inhibitors of the FtsZ:ZipA interaction is 
hampered by the fact that protein – protein interactions are difficult to disrupt 
using small molecules since large areas of the two protein surfaces are buried in 
the interaction173. However, in a high-throughput screen of 250,000 compounds, 
29 were found to compete for the FtsZ binding site of ZipA. The most successful 
competitor was co-crystallised with ZipA from E. coli and was found to bind 
to the FtsZ-binding cleft of ZipA174. Top-scoring compounds that were found 
C.E. Broughton, H.A. Van Den Berg, A.M. Wemyss, D.I. Roper, and A. Rodger178
to bind to different but overlapping sites of the ZipA cleft were chemically 
combined and these hybrid molecules were found to have increased potency. 
However, their antibacterial activity against Gram-positive bacteria suggests 
that the compound is acting on additional cell targets, since ZipA homologues 
appear to be absent in these species175.
An NMR-based assay was used to screen 825 compounds for binding 
to ZipA173. Seven compounds showed binding to residues at the ZipA:FtsZ 
interface. Building on the highest affinity hit, a further 87 chemically similar 
molecules were tested with some improvement to ZipA affinity, although the 
latter remained too low at 2 mM173. CAM-FF predicts that the inhibition of the 
FtsZ:ZipA interaction has an intermediate effect on the cell division process; 
for the inhibition of the T7 loop of FtsZ, the drug sensitivity co-efficient is 
0.204 145,146.
7. Conclusion
Taken together, these studies show that the road to drug discovery is long 
and arduous, most compounds fall by the wayside for some reason or other. 
However, the divisome complex represents a collection of numerous possible 
targets within the bacterium’s machinery that remains to be explored and 
exploited. As the threat of a post-antibiotic era looms, the search for potential 
drug interactions must utilise all of the available tools. In silico experimentation 
will aid the discovery of drug leads and, as in the application of CAM-FF, 
mathematical descriptions of the cell division process should be employed to 
target the research effort. Despite the setbacks, the examples presented here 
give hope that the cell division machinery will hold a way to fill the Discovery 
Void.
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